Terminologies de Santé
1.0.0 - final-text
Terminologies de Santé
1.0.0 - final-text
This page is part of the Guide d'implémentation des terminologies de Santé (v1.0.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
| Official URL: https://smt.esante.gouv.fr/terminologie-nuva | Version: 1.0.930 | |||
| Active as of 2025-06-05 | Responsible: Agence du numérique en santé | Computable Name: NUVA | ||
| Other Identifiers: OID:1.3.6.1.4.1.48601.1 (use: usual, ), https://smt.esante.gouv.fr/#terminologie-nuva (use: secondary, ) | ||||
Copyright/Legal: SYADEM |
||||
La nomenclature unifiée des vaccins (NUVA) liste les spécialités vaccinales commercialisées ou ayant été commercialisées en France ou à l’étranger. Ces spécialités sont associées à une dénomination générique et à une description structurée notamment au niveau des valences et des pathologies cibles.Elle permet de constituer un historique vaccinal complet, aussi précis que le permettent les sources des données, interprétable par des systèmes d’information.
This Code system is referenced in the content logical definition of the following value sets:
Generated Narrative: CodeSystem terminologie-nuva
version: 17; Last updated: 2025-06-05 13:30:15+0000
Profil: Shareable CodeSystem
Propriétés
Cette terminologie de référence (CodeSystem) définit les propriétés suivantes pour ses concepts
| Nom | Code | URI | Type | Description |
| type | type | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | code | |
| created | created | http://purl.org/dc/terms/created | dateTime | |
| modified | modified | http://purl.org/dc/terms/modified | dateTime | |
| containedInVaccine | containedInVaccine | http://data.esante.gouv.fr/NUVA/nuvs#containedInVaccine | code | |
| prevents | prevents | http://data.esante.gouv.fr/NUVA/nuvs#prevents | code | |
| comment | comment | http://www.w3.org/2000/01/rdf-schema#comment | string | |
| containsValence | containsValence | http://data.esante.gouv.fr/NUVA/nuvs#containsValence | code | |
| isAbstract | isAbstract | http://data.esante.gouv.fr/NUVA/nuvs#isAbstract | boolean | |
| hiddenLabel | hiddenLabel | http://www.w3.org/2004/02/skos/core#hiddenLabel | string | |
| Parent | parent | http://hl7.org/fhir/concept-properties#parent | code | Codes des parents du concept courant |
| Child | child | http://hl7.org/fhir/concept-properties#child | code | Codes des enfants du concept courant |
| imported | imported | boolean | Indicates if the concept is imported from another code system. | |
| root | root | boolean | Indicates if this concept is a root concept (i.e. Thing is equivalent or a direct parent). |
Filters
| Code | Description | Op | Valeur |
| root | = | True or false. | |
| deprecated | = | True or false. | |
| imported | = | True or false |
Concepts
This code system https://smt.esante.gouv.fr/terminologie-nuva defines the following codes:
| Code | Display | Parent | Child |
| VAL152 | Valence grippe, inactivée, entière, sans précision | VAL365, VAL365 | |
| VAL370 | Valence pneumocoque, polyosidique conjuguée, sérotype 15C | VAL184, VAL184 | |
| VAC1062 | Immunoglobulines CMV, sans précision | ||
| DIS078 | Lèpre | ||
| VAC1280 | Vaccin Pneumocoque conjugué 21-valent, sans précision | ||
| VAC0878 | TRITANRIX | ||
| VAC0527 | VACCIN DIPHTERIQUE ET TETANIQUE ADSORBE | ||
| VAC0745 | MF59 ADJUVANTED SARS-CoV-2 SCLAMP VACCINE | ||
| VAC1195 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus 26 codant la protéine de pointe du SARS-CoV-2, en essai clinique, sans précision | ||
| VAC0830 | Vaccin Zona sous-unitaire, sans précision | ||
| VAL067 | Valence tétanos, anatoxine | ||
| VAC0612 | DTP-vax FINLAY | ||
| VAL285 | Valence grippe, trivalente, inactivée, obtenue sur culture cellulaire, fractionnée ou sous-unité, dose normale | VAL360, VAL360 | |
| VAC0963 | ANATOXAL DI TE PER | ||
| VAC0082 | MENBVAC | ||
| VAL020 | Valence zona, vivant atténué | VAL160, VAL160 | |
| VAL371 | Valence pneumocoque, polyosidique conjuguée, sérotype 16F | VAL184, VAL184 | |
| DIS077 | Entérovirus | ||
| VAC1281 | PENTABIO | ||
| VAC0529 | IMOVAX TETANO | ||
| VAC0528 | MOSQUIRIX | ||
| VAC0613 | BORYUNG DTap VACCINE | ||
| VAC0879 | ACELLUVAX | ||
| VAC1063 | Vaccin Hépatite C, sans précision | ||
| DIS076 | Infection urinaire | ||
| VAC1196 | Vaccin Encéphalite japonaise, entier inactivé préparé sur tissu cérébral murin, sans précision | ||
| VAL068 | Valence hépatite B, sans précision | VAL090, VAL291, VAL158 | |
| VAC0964 | ANATOXAL DI | ||
| VAL153 | Valence Haemophilus influenzae type b, polyoside de PRP conjugué à l'anatoxine diphtérique | VAL103, VAL103 | |
| VAC0831 | Vaccin Ebola, sans précision | ||
| VAL286 | Valence hépatite A, vivant atténué, sans précision | VAL288, VAL288 | |
| VAC0083 | SYNFLORIX | ||
| VAL283 | Valence hépatite A, inactivée, entière, dose pédiatrique, sans précision | VAL125, VAL125 | VAL142, VAL143 |
| VAL150 | Valence dengue, sans précision | VAL087, VAL065 | |
| VAC1193 | Vaccin Encéphalite japonaise, vivant recombinant atténué, sans précision | ||
| VAC0307 | MORUBEL | ||
| VAC1060 | SPIKEVAX XBB.1.5 50 µg MODERNA | ||
| DIS075 | Fièvre de la vallée du Rift | ||
| VAC0525 | INFANRIX PENTA | ||
| VAC0658 | COMIRNATY 30 µg BIONTECH-PFIZER | ||
| VAC0743 | BBV154 | ||
| VAC0961 | ANATOXAL TE N | ||
| VAL198 | Valence pneumocoque, polyosidique conjuguée, sérotype 14 | VAL184, VAL184 | |
| VAC0876 | CINQUERIX | ||
| VAC0610 | Vaccin dTca - Diphtérie-Tétanos-Coqueluche, dose réduite, sans précision | ||
| VAL065 | Valence dengue, vivante atténuée, tétravalente, chimérique recombinante | VAL150, VAL150 | |
| VAC0080 | BCG PASTEUR | ||
| VAL284 | Valence hépatite A, inactivée, entière, dose adulte, sans précision | VAL125, VAL125 | VAL144, VAL145 |
| VAL151 | Valence tularémie, sans précision | ||
| VAC1061 | PENBRAYA | ||
| VAC1194 | Vaccin Tétanos, Typhoïde et Paratyphoïde A et B, sans précision | ||
| VAC0308 | MORUMAN BERNA PRODUCTS | ||
| VAC0309 | MORUPAR | ||
| VAC0659 | ZIFIVAX ANHUI COVID-19 VACCINE | ||
| VAC0877 | INFANRIX HEPB | ||
| DIS074 | Streptococcus pyogenes | ||
| VAC0526 | HECOLIN | ||
| VAC0611 | SHAN-5 | ||
| VAC0962 | ANATOXAL DI TE N ADULT | ||
| VAL199 | Valence pneumocoque, polyosidique conjuguée, sérotype 15B | VAL184, VAL184 | |
| VAC0744 | COVID-19 INACTIVATED VACCINE | ||
| VAL066 | Valence covid 19, vecteur viral réplicatif, virus influenza codant la protéine de pointe du SARS-CoV-2 | VAL398, VAL398 | |
| VAC0086 | TETAVAX | ||
| DIS073 | Mélanome | ||
| VAC1066 | Vaccin Mélanome, sans précision | ||
| VAL289 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 10 microgrammes | VAL303, VAL303 | |
| VAC0701 | BACTRL-SPIKE | ||
| VAC1151 | Vaccin quadrivalent DTCeP - Diphtérie-Tétanos-Coqueluche-Polio, sans précision | ||
| VAC0967 | HEPASOMA | ||
| VAC1284 | NUSAGARD | ||
| VAL156 | Valence Haemophilus influenzae type b, polyoside de PRP conjugué à l’anatoxine tétanique | VAL103, VAL103 | |
| VAL023 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intradermique, sans précision | VAL024, VAL024 | |
| VAL241 | Valence papillomavirus, VLP, type 18 | VAL236, VAL236 | |
| VAC1199 | Vaccin Ebola à vecteur viral réplicatif de la stomatite vésiculaire recombinant (rVSV) - glycoprotéine GP d'EBOV, sans précision | ||
| VAL374 | Valence pneumocoque, polyosidique conjuguée, sérotype 23B | VAL184, VAL184 | |
| VAC0171 | PREPANDEMIC INFLUENZA VACCINE (H5N1) NOVARTIS | ||
| VAC0172 | DIFTAVAX | ||
| VAC0087 | VAXICOQ | ||
| VAC0969 | LYSSAVAC N BERNA | ||
| VAC1370 | JENVAC | ||
| VAC1285 | NOPV2 BIO FARMA | ||
| VAC0968 | INFLEXAL V | ||
| VAC0835 | FIOCRUZ COVID-19 VACCINE | ||
| VAL157 | Valence covid 19, sans précision | VAL164, VAL165 | |
| VAC0702 | RRBD PRODUCED IN CHO-CELL CHEMICALLY CONJUGATE TO TETANUS TOXOID | ||
| VAC1152 | Vaccin Méningocoque B contenant la fHbp des sous-familles A et B, sans précision | ||
| VAL024 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, sans précision | VAL058, VAL058 | VAL023, VAL231 |
| VAL375 | Valence pneumocoque, polyosidique conjuguée, sérotype 24F | VAL184, VAL184 | |
| VAC0920 | Vaccin dT - Diphtérie-Tétanos, sans précision | ||
| VAL242 | Valence papillomavirus, VLP, type 31 | VAL236, VAL236 | |
| DIS072 | Infection à VIH | ||
| VAC1067 | Vaccin Streptococcus pyogenes, sans précision | ||
| VAC0390 | TETRACT-HIB | ||
| VAC0084 | Vaccin Grippe prépandémique H5N1, sans précision | ||
| VAL372 | Valence pneumocoque, polyosidique conjuguée, sérotype 20A | VAL184, VAL184 | |
| VAC1282 | FLUBIO INFLUENZA HA | ||
| VAC1197 | Vaccin Covid 19 à adénovirus de chimpanzé et à ARNm auto-amplifiant, sans précision | ||
| VAC0965 | ANATOXAL TE TAB | ||
| VAC1064 | Vaccin VIH, sans précision | ||
| VAL069 | Valence covid 19, vecteur viral non réplicatif, adénovirus de chimpanzé ChadOx1 codant la protéine de pointe du SARS-CoV-2 | VAL397, VAL397 | |
| VAC0614 | TDAPBOOSTER AJ VACCINES | ||
| VAL287 | Valence grippe, quadrivalente, recombinante | VAL361, VAL361 | |
| VAC0832 | Vaccin Herpes Simplex, sans précision | ||
| VAL154 | Valence Haemophilus influenzae type b, oligosides de PRP conjugués à la toxine diphtérique mutante CRM197 | VAL103, VAL103 | |
| DIS071 | Hépatite C | ||
| VAL021 | Valence choléra, inactivée, entière, orale | VAL359, VAL359 | VAL062, VAL367, VAL368 |
| VAC0085 | T POLIO MERIEUX | ||
| VAL240 | Valence papillomavirus, VLP, type 16 | VAL236, VAL236 | |
| VAC1150 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, virus originel, 30 microgrammes, sans précision | ||
| VAC0966 | JYNNEOS | ||
| VAC0615 | VACCIN T.P. PASTEUR | ||
| VAC0833 | COMIRNATY 10 µg BIONTECH-PFIZER | ||
| VAC1065 | Vaccin Lèpre, sans précision | ||
| VAC1198 | Vaccin Chinkungunya, vivant atténué, sans précision | ||
| VAC1283 | INDOVAC | ||
| VAL155 | Valence Haemophilus influenzae type b, polyoside de PRP conjugué à la protéine de membrane externe de Neisseria meningitidis sérogroupe B | VAL103, VAL103 | |
| VAL288 | Valence hépatite A, sans précision | VAL125, VAL286 | |
| DIS070 | Cytomégalovirus | ||
| VAL022 | Valence variole, vivant atténué, sans précision | VAL418, VAL418 | VAL028, VAL295, VAL294 |
| VAL373 | Valence pneumocoque, polyosidique conjuguée, sérotype 23A | VAL184, VAL184 | |
| VAC0170 | AFLUNOV | ||
| VAC0301 | MMR | ||
| DIS038 | Papillomavirus | ||
| VAC0216 | ANATOXAL DI TE | ||
| VAC0349 | QUADRIGEN | ||
| VAL027 | Valence covid 19, vecteur viral non réplicatif, adénovirus 26 codant la protéine de pointe du SARS-CoV-2 | VAL070, VAL070 | |
| VAL245 | Valence papillomavirus, VLP, type 52 | VAL236, VAL236 | |
| VAL378 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), 15 microgrammes | VAL090, VAL090 | |
| VAL112 | Valence grippe, quadrivalente, inactivée, obtenue sur culture cellulaire, fractionnée ou sous-unité, dose normale | VAL360, VAL360 | |
| VAC0567 | SHINGRIX | ||
| VAC0434 | VACINA TRIPLICE VIRAL | ||
| VAC0785 | BOOSTAGEN | ||
| VAL330 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2, 25 microgrammes | VAL396, VAL396 | |
| VAC0870 | TYPBAR | ||
| VAC0652 | CONVIDECIA | ||
| VAC1414 | Vaccin anti-covid 19 à sous-unité protéique, protéine de pointe recombinante dans des nanoparticules, avec adjuvant (Matrix M), sous-variant Omicron JN.1 | ||
| VAC1329 | FLU-M | ||
| VAC0217 | DITOXIM | ||
| VAL028 | Valence variole, troisième génération, vivant atténué | VAL022, VAL022 | VAL018, VAL296 |
| VAL379 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2, 30 microgrammes | VAL395, VAL395 | |
| VAL246 | Valence papillomavirus, VLP, type 45 | VAL236, VAL236 | |
| VAL113 | Valence papillomavirus, VLP, bivalent, types 16 et 18 | VAL237, VAL237 | |
| VAC0568 | BOOSTRIX-POLIO | ||
| VAL331 | Valence CMV, immunoglobulines | ||
| VAC0435 | VAKSIN CACAR | ||
| VAC0653 | Vaccin Hépatite A et B enfant, sans précision | ||
| VAC0786 | PREVNAR 20 | ||
| VAC0520 | IMVANEX | ||
| VAC1415 | Vaccin polyvalent contre la bactérie Pseudomonas aeruginosa | ||
| VAC0871 | SUPEMTEK | ||
| VAC0214 | DIF-TET-ALL | ||
| VAC0347 | QUADRACEL | ||
| VAC0129 | HB VAX DNA 40 µg | ||
| DIS036 | Choléra | ||
| VAL158 | Valence hépatite B, plasmatique | VAL068, VAL068 | |
| VAL025 | Valence paludisme, sans précision | VAL009, VAL311 | |
| VAL243 | Valence papillomavirus, VLP, type 33 | VAL236, VAL236 | |
| VAL376 | Valence pneumocoque, polyosidique conjuguée, sérotype 31 | VAL184, VAL184 | |
| VAL110 | Valence tétanos, immunoglobuline | ||
| VAC0698 | hAd5-COVID-19 | ||
| VAC0783 | R-COVI | ||
| VAC0432 | VACINA DUPLA | ||
| VAC1327 | HEPATITIS B SII | ||
| VAC1412 | Vaccin à ARNm contre la covid 19, subvariant Omicron JN.1, 10 microgrammes, dose pédiatrique (5-11 ans) | ||
| VAC0650 | VAXZEVRIA ASTRAZENECA | ||
| VAC1109 | Vaccin Méningocoque ACW non conjugué, sans précision | ||
| VAC0300 | MEVILIN-L | ||
| VAC0348 | QUADRACEL/HIBEST | ||
| VAL159 | Valence zona, sous-unitaire | VAL160, VAL160 | VAL013 |
| VAL026 | Valence méningocoque B, protéines de vésicules de membrane externe | VAL118, VAL118 | |
| VAL377 | Valence pneumocoque, polyosidique conjuguée, sérotype 35B | VAL184, VAL184 | |
| VAC0699 | IIBR's RECOMBINANT VSV-DeltaG-spike VACCINE | ||
| VAL244 | Valence papillomavirus, VLP, type 58 | VAL236, VAL236 | |
| VAL111 | Valence charbon, acellulaire | VAL340, VAL340 | VAL415 |
| VAC0566 | PNEUMOCOCCAL POLYSACCHARIDE VACCINE MSD | ||
| VAC0433 | VACINA TRIPLICE | ||
| VAC0651 | CORONAVAC COVID-19 VACCINE | ||
| VAC1413 | Vaccin à ARNm contre la covid 19, subvariant Omicron JN.1, 3 microgrammes, dose (6 mois-4 ans) | ||
| VAC0784 | PERTAGEN | ||
| VAC1328 | TUBERVAC | ||
| VAC0305 | MOPV | ||
| DIS034 | Leptospirose | ||
| VAC1191 | Vaccin Infections urinaires chez la femme, sans précision | ||
| VAL116 | Valence VRS, anticorps monoclonal, palivizumab | VAL320, VAL320 | |
| VAC0438 | VAKSIN SERAP | ||
| VAC0789 | COMVAC4 | ||
| VAL201 | Valence pneumocoque, polyosidique conjuguée, sérotype 19A | VAL184, VAL184 | |
| VAL334 | Valence mélanome, sans précision | ||
| VAC0874 | INNOFLU | ||
| VAC0523 | GARDASIL 9 | ||
| VAC0656 | SPIKEVAX 0,2 mg/mL MODERNA | ||
| VAC0741 | COVID-EVAX | ||
| VAL249 | Valence encéphalite japonaise, sans précision | VAL248, VAL089 | |
| VAC1418 | Vaccin à ARNm contre la covid 19, subvariant Omicron KP.2, 30 microgrammes, adulte (+ 12 ans) | ||
| DIS033 | Zona | ||
| VAC0306 | MORBILVAX | ||
| VAC1192 | Vaccin pentavalent DTCePHibHepB - Diphtérie-Tétanos-Coqueluche-Hib OC-HépatiteB 10µg, sans précision | ||
| VAL335 | Valence Streptococcus pyogenes, sans précision | ||
| VAC0439 | VAMOAVAX | ||
| VAL202 | Valence pneumocoque, polyosidique conjuguée, sérotype 19F | VAL184, VAL184 | |
| VAC0657 | SINOPHARM WUHAN COVID-19 VACCINE | ||
| DIS032 | Rotavirus | ||
| VAC0524 | TEVAX | ||
| VAL420 | Valence botulisme, produits d'immunisation passive | VAL419, VAL419 | VAL063, VAL358 |
| VAC0875 | PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA | ||
| VAC0742 | COVIGEN | ||
| VAC0960 | VIATIM | ||
| VAC1419 | Vaccin Chikungunya à base de VLP (recombinant, adsorbé) | ||
| VAL117 | Valence coqueluche, acellulaire, dose non précisée | VAL003, VAL003 | VAL008, VAL017 |
| VAC0303 | MONIARIX | ||
| VAC0218 | DOUBLE ANIGEN B. | ||
| VAL247 | Valence encéphalite japonaise, virus chimérique vivant atténué | VAL248, VAL248 | |
| VAL114 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), 10 microgrammes | VAL090, VAL090 | |
| DIS031 | Dengue | ||
| VAC0569 | INFANRIX-IPV | ||
| VAC0787 | Vaccin DiphTRub - Diphtérie-Tétanos-Rubéole, sans précision | ||
| VAC0436 | VAKSIN CAMPAK KERING | ||
| VAL332 | Valence hépatite C, sans précision | ||
| VAC0654 | Vaccin Hépatite A et B adulte, sans précision | ||
| VAC0521 | FLUENZ TETRA | ||
| VAC0872 | INFLUPOZZI SUBUNITA | ||
| VAC1416 | Vaccin à ARNm contre la covid 19, subvariant Omicron KP.2, 3 microgrammes, dose pédiatrique (6 mois-4 ans) | ||
| VAL029 | Valence grippe, VLP, sans précision | VAL364, VAL364 | VAL363 |
| VAC1190 | Vaccin Covid 19 à vecteur viral réplicatif, virus de la stomatite vésiculaire codant la protéine de pointe du SARS-CoV-2, sans précision | ||
| VAC0304 | MOPAVAC SEVAC | ||
| VAC0219 | DRYVAX | ||
| DIS079 | Pseudomonas aeruginosa | ||
| VAL115 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), 20 microgrammes | VAL090, VAL090 | |
| VAL248 | Valence encéphalite japonaise, vivant atténué, sans précision | VAL249, VAL249 | VAL100, VAL247 |
| DIS030 | Rage | ||
| VAL333 | Valence VIH, sans précision | ||
| VAC0437 | VAKSIN KOTIPA | ||
| VAL200 | Valence pneumocoque, polyosidique conjuguée, sérotype 18C | VAL184, VAL184 | |
| VAC0655 | Vaccin Diphtérie, sans précision | ||
| VAC0788 | Vaccin Haemophilus influenzae b et Poliomyélite, sans précision | ||
| VAC0873 | INFLUPOZZI ADIUVATO | ||
| VAC0740 | PTX-COVID19-B | ||
| VAC1417 | Vaccin à ARNm contre la covid 19, subvariant Omicron KP.2, 10 microgrammes, dose pédiatrique (5-11 ans) | ||
| VAC0341 | PREVNAR | ||
| VAC0123 | PREVENAR 13 | ||
| VAC0256 | IMOVAX MUMPS | ||
| VAC0038 | TICOVAC 0,5 mL | ||
| VAC0389 | TETAMUN SSW | ||
| VAC1103 | HIB-VAX | ||
| VAC1321 | HAEMOPHILUS INFLUENZAE B SII | ||
| VAC1369 | INDIRAB | ||
| VAC1018 | NOORA VACCINE | ||
| VAC0474 | DARONRIX | ||
| VAC1236 | Vaccin Covid 19 à sous-unité protéique, protéine de pointe recombinante dans des nanoparticules, sous-variant Omicron XBB.1.5, sans précision | ||
| VAC0692 | COVAXX | ||
| VAL205 | Valence pneumocoque, polyosidique conjuguée, sérotype 33F | VAL184, VAL184 | |
| VAL338 | Valence VRS, anticorps ou vaccin, sans précision | VAL317, VAL318 | |
| VAC0124 | FOCETRIA (multidose) | ||
| VAC0257 | IMOVAX PAROTIDITIS | ||
| VAC0039 | TICOVAC 0,25 mL | ||
| VAC1322 | PNEUMOSIL | ||
| VAC1019 | SPIKEVAX 0,1 mg/mL MODERNA | ||
| VAC0475 | FOCLIVIA | ||
| VAC0693 | VXA-COV2-1-COVID | ||
| VAC1104 | DIPHTHERIA ANTITOXIN B.P. | ||
| VAC1237 | Vaccin Paludisme pré-érythrocytaire, sans précision | ||
| VAC0560 | VAXIGRIPTETRA | ||
| VAL339 | Valence Borrelia burgdorferi, sans précision | VAL030 | |
| VAL206 | Valence pneumocoque, polyosidique non conjuguée, sérotype 1 | VAL185, VAL185 | |
| VAC0254 | IMOVAX D.T. | ||
| VAC0121 | PRIORIX-TETRA | ||
| VAC0036 | TETAGRIP | ||
| VAC0387 | TETANOL | ||
| VAC0169 | OPTAFLU | ||
| VAC0918 | Vaccin Haemophilus influenzae b, PRP-D, sans précision | ||
| VAL203 | Valence pneumocoque, polyosidique conjuguée, sérotype 22F | VAL184, VAL184 | |
| VAL336 | Valence fièvre de la vallée du Rift, sans précision | ||
| VAL421 | Valence fièvre hémorragique d'Argentine, virus Junin, sans précision | VAL173 | |
| VAC1234 | Vaccin Pneumocoque non conjugué 15-valent, sans précision | ||
| VAC1367 | HNVAC | ||
| VAC1101 | DOTARICIN | ||
| VAC1016 | IDFLU | ||
| VAC1149 | Vaccin Choléra vivant atténué oral, sans précision | ||
| VAC0472 | PREPANDRIX | ||
| VAL118 | Valence méningocoque B, sans précision | VAL161, VAL026 | |
| VAC0690 | CHINESE-AD5-NCOV-COVID | ||
| VAC0255 | IMOVAX GRIPPE | ||
| VAC0388 | TETASORBAT SSW | ||
| VAC0919 | Vaccin Haemophilus influenzae b, hbOC, sans précision | ||
| VAC0037 | TETRAVAC-ACELLULAIRE | ||
| VAL204 | Valence pneumocoque, polyosidique conjuguée, sérotype 23F | VAL184, VAL184 | |
| VAL422 | Valence peste, sans précision | VAL131 | |
| VAC1102 | HIB-IMMUNE | ||
| VAC1235 | Vaccin Rotavirus monovalent RIX4414, sans précision | ||
| VAC1320 | DIPHTHERIA, TETANUS, PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE B SII | ||
| VAC1368 | INCOVACC | ||
| VAC1017 | SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1 (50 µg/50 µg)/mL MULTIDOSE MODERNA | ||
| VAC0473 | PRE-PANDEMIC INFLUENZA VACCINE H5N1 | ||
| VAC0691 | FINLAY-FR-1 | ||
| VAL119 | Valence méningocoque, monovalent, polyosidique non conjugué | VAL234, VAL234 | |
| VAL337 | Valence variole, immunoglobuline | VAL418, VAL418 | |
| VAC0212 | DI TE PER POL IMPFSTOFF | ||
| VAC0345 | Vaccin Haemophilus influenzae b PRP-T, sans précision | ||
| VAC0127 | HB VAX DNA 5 µg | ||
| VAC0478 | COVAXIS | ||
| VAC1410 | Vaccin à ARNm contre la covid 19, subvariant Omicron JN.1, 25 microgrammes par dose, flacon multidose | ||
| VAC0563 | ALPHA-RIX-TETRA | ||
| VAC0696 | KCONVAC MINHAI COVID-19 VACCINE | ||
| VAC1107 | Vaccin Choléra entier inactivé, sans précision | ||
| VAC0781 | RABIVAC | ||
| VAC0430 | VACCIN DIFTERIC ADSORBIT | ||
| VAL209 | Valence pneumocoque, polyosidique non conjuguée, sérotype 4 | VAL185, VAL185 | |
| VAC1325 | GENEVAC-B 10 µg | ||
| VAC0213 | DI-TE-POL | ||
| VAC0346 | PURIVAX | ||
| VAC0128 | HB VAX DNA 10 µg | ||
| VAC0479 | TRIAXIS | ||
| VAC0697 | V590 (COVID-19) | ||
| VAC1411 | Vaccin à ARNm contre la covid 19, subvariant Omicron JN.1, 30 microgrammes, dose adulte (+ 12 ans) | ||
| VAC1326 | GENEVAC-B 20 µg | ||
| VAC0431 | VACCINUM MORBILLORUM VIVUM | ||
| VAC0782 | RASILVAX | ||
| VAC1108 | Vaccin bivalent Covid 19 à ARNm contre le virus originel et le variant Omicron BA.1, sans précision | ||
| VAC0210 | D.S.D.P.T. | ||
| VAC0343 | ProHIBiT | ||
| VAC0258 | IMOVAX R.O.R. | ||
| VAC0125 | AREPANRIX | ||
| VAC1323 | MENFIVE | ||
| VAC0476 | PANDEMIC INFLUENZA VACCINE H5N1 BAXTER | ||
| VAC1238 | Vaccin Hépatite B et Paludisme, sans précision | ||
| VAC0694 | LMU-MVA-SARS-2-S-COVID | ||
| VAC0561 | IMOJEV | ||
| VAC1105 | BAT EMERGENT BIOSOLUTIONS | ||
| VAL207 | Valence pneumocoque, polyosidique non conjuguée, sérotype 2 | VAL185, VAL185 | |
| VAC0211 | DAPTACEL | ||
| VAC0344 | Vaccin Haemophilus influenzae b PRP-OMP, sans précision | ||
| VAC0126 | HEVAC B | ||
| VAC0259 | IMOVAX Rabies | ||
| VAC0477 | PUMARIX | ||
| VAC0695 | RBD-HBsAg-VLPs-Covid | ||
| VAC1106 | Vaccin Covid 19 VLP, sans précision | ||
| VAC1239 | Vaccin Pneumocoque conjugué 15-valent, sans précision | ||
| VAC0562 | INFLUVAC TETRA | ||
| VAC1324 | NASOVAC-S | ||
| VAL208 | Valence pneumocoque, polyosidique non conjuguée, sérotype 3 | VAL185, VAL185 | |
| VAC0780 | VAXNEUVANCE | ||
| VAC0030 | REVAXIS | ||
| VAC0163 | Vaccin Coqueluche entier inactivé, sans précision | ||
| VAC0296 | MENPOVAX 4 A+C+Y+W135 | ||
| VAC0078 | RUDI-ROUVAX | ||
| VAL071 | Valence typhoïde, inactivée, entière | VAL014, VAL014 | |
| VAC0827 | Vaccin ROR-V - Rougeole-Oreillons-Rubéole-Varicelle, sans précision | ||
| VAC0911 | Vaccin Hépatite A, monovalent, dose pédiatrique, sans précision | ||
| VAC1361 | HEPAMUNE B 20 µg | ||
| VAC1010 | TRIAMER | ||
| VAC1143 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus codant la protéine de pointe du SARS-CoV-2, sans précision | ||
| VAC1058 | SPIKEVAX XBB.1.5 0,1 mg/mL dose 50 µg MODERNA | ||
| VAC1276 | DTP BIOMED | ||
| VAC0382 | Vaccin Diph-T - Diphtérie-Tétanos, sans précision | ||
| VAC0031 | ROTATEQ | ||
| VAC0164 | INTANZA 9 µg | ||
| VAC0297 | MENPOVAX A+C | ||
| VAC0079 | ENCEPUR | ||
| VAL072 | Valence méningocoque B, contenant la fHbp des sous-familles A et B | VAL161, VAL161 | |
| VAL290 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 30 microgrammes | VAL303, VAL303 | |
| VAC0828 | Vaccin Rotavirus pentavalent, sans précision | ||
| VAC1011 | DITEKIBOOSTER | ||
| VAC0912 | Vaccin Hépatite A, dose pédiatrique, sans précision | ||
| VAC1362 | SK TD | ||
| VAC1059 | SPIKEVAX XBB.1.5 0,1 mg/mL dose 25 µg MODERNA | ||
| DIS080 | Méningocoque X | ||
| VAC1144 | Vaccin Covid 19 à sous-unité protéique, protéine de pointe du SARS-CoV-2 recombinante, S-2P et CpG1018, sans précision | ||
| VAC1277 | Vaccin contre le chikungunya, sans précision | ||
| VAC0161 | ZOSTAVAX | ||
| VAC0294 | MENCEVAX A | ||
| VAC0076 | DTVax | ||
| VAC0958 | ADIUGRIP | ||
| VAC1274 | d BIOMED | ||
| VAC0957 | VACCINO BCG BERNA | ||
| VAC0824 | Vaccin Hépatite A virosomal, sans précision | ||
| VAC1141 | Vaccin contre la grippe aviaire H5N8, sans précision | ||
| VAC1056 | R21/MATRIX-M | ||
| VAC1189 | Vaccin Covid 19 à vecteur non réplicatif, vaccine Ankara modifiée codant la protéine de pointe du SARS-CoV-2, sans précision | ||
| VAC0162 | Vaccin Brucellose, sans précision | ||
| VAC0295 | MENOMUNE-A/C/Y/W-135 | ||
| VAC0077 | IMOVAX OREILLONS | ||
| VAC0959 | STREPTOPUR | ||
| VAL070 | Valence covid 19, vecteur viral non réplicatif, adénovirus codant la protéine de pointe du SARS-CoV-2, sans précision | VAL397, VAL397 | VAL027, VAL050, VAL292 |
| VAC0826 | MEASLES AND RUBELLA VACCINE SII | ||
| VAC1142 | Vaccin Covid 19 à vecteur viral non replicatif avec cellules présentant l'antigène, sans précision | ||
| VAC0910 | Vaccin Hépatite A, entier inactivé, dose adulte, sans précision | ||
| VAC1275 | D BIOMED | ||
| VAC1360 | HEPAMUNE B 10 µg | ||
| VAC0825 | Vaccin Hépatites A et B combiné, sans précision | ||
| VAC1057 | ENGERIX B JUNIOR | ||
| VAC0380 | Vaccin TP - Tétanos-Poliomyélite, sans précision | ||
| VAC0252 | VAXIGRIP ENFANTS | ||
| VAC0385 | TELVACLPTAP | ||
| VAC0034 | SPIROLEPT | ||
| VAL075 | Valence Leptospira icterohaemorrhagiae, inactivée, entière | ||
| VAL293 | Valence charbon, immunoglobuline | ||
| VAL160 | Valence zona, sans précision | VAL020, VAL159 | |
| VAC0916 | Vaccin Hépatite B, monovalent pour les patients dialysés, sans précision | ||
| VAC1365 | COMVAC5 | ||
| VAC1014 | PROVARIVAX | ||
| VAC1147 | Anticorps monoclonal humain VRS, nirsevimab, sans précision | ||
| VAC1232 | Vaccin Coqueluche acellulaire, dose réduite, sans précision | ||
| VAC0470 | QUINVAXEM | ||
| VAC0120 | VACCIN VARICELLE MERIEUX | ||
| VAC0253 | VAXIRAB N | ||
| VAC0386 | TETAMYN | ||
| VAC0168 | AMBIRIX | ||
| VAC0035 | STAMARIL | ||
| VAL294 | Valence variole, première génération, vivant atténué | VAL022, VAL022 | |
| VAL161 | Valence méningocoque B, multicomposée, sans précision | VAL118, VAL118 | VAL098, VAL072 |
| VAC0917 | Vaccin Hépatite E, sans précision | ||
| VAC1015 | COMBIVAX | ||
| VAC1100 | BOTULISM ANTITOXIN BEHRING | ||
| VAL076 | Valence covid 19, entier inactivé, sans précision | VAL164, VAL164 | VAL265, VAL264 |
| VAC1233 | Vaccin Pneumocoque conjugué 10-valent, sans précision | ||
| VAC1366 | HILLCHOL | ||
| VAC1148 | Vaccin Haemophilus influenzae type b, polyosidique non conjugué, sans précision | ||
| VAC0471 | HEPAVAX-GENE B 20 µg | ||
| VAC0383 | ANATOXAL TE | ||
| VAC0032 | ROUVAX | ||
| VAC0165 | VAQTA 25 U/0,5 mL | ||
| VAC0298 | MERUVAX | ||
| VAL073 | Valence covid 19, vecteur viral replicatif avec cellules présentant l'antigène | VAL162, VAL162 | |
| VAL291 | Valence hépatite B, recombinante, trois antigènes (HbS, pré-S1 et pré-S2) | VAL068, VAL068 | |
| VAC0914 | Vaccin Hépatite B, monovalent, dose pédiatrique, sans précision | ||
| VAC0829 | Vaccin Rubéole et Oreillons, sans précision | ||
| VAC1230 | Vaccin Méningocoque C et Haemophilus influenzae type b, conjugué à l'anatoxine tétanique, sans précision | ||
| VAC0913 | BIMERVAX | ||
| VAC1363 | HEPAVAX-GENE B 10 µg | ||
| VAC1278 | WALRINVAX | ||
| VAC1012 | PICOVAX | ||
| VAC1145 | Vaccin Hépatite B recombinant, trois antigènes, sans précision | ||
| VAC0251 | HUMOTET-ANTI TETANUS | ||
| VAC0384 | TE/VAC/PTAP | ||
| VAC0166 | VAQTA 50 U | ||
| VAC0033 | RUDIVAX | ||
| VAC0299 | MERUVAX II | ||
| VAL074 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, haute dose | VAL064, VAL064 | |
| VAL292 | Valence covid 19, vecteur viral non réplicatif, adénovirus 26 codant la protéine de pointe du SARS-CoV-2, en essai clinique | VAL070, VAL070 | |
| VAC0915 | Vaccin Hépatite B, monovalent, dose adulte, sans précision | ||
| VAC1231 | Vaccin pentavalent DTCaHibHepB- Diphtérie-Tétanos-Coqueluche-Hib PRP-Hepatite B 10μg, sans précision | ||
| VAC1146 | Vaccin Grippe quadrivalent, inactivé, haute dose, sans précision | ||
| VAC1279 | Vaccin contre le charbon adsorbé, avec adjuvant | ||
| VAC1364 | BIOHIB | ||
| VAC1013 | FLUBLOK TRIVALENT | ||
| VAL031 | Valence encéphalite à tiques, sans précision | VAL313, VAL312 | |
| VAL382 | Valence covid 19, sous-variant Omicron JN.1, sous-unité protéique, protéine de pointe recombinante dans des nanoparticules | VAL107, VAL107 | |
| VAC1292 | BIO-TCV | ||
| VAC0539 | DENGVAXIA | ||
| DIS041 | Brucellose | ||
| DIS003 | Coqueluche | ||
| VAC0624 | M-M-Vax | ||
| VAC0757 | NBP 2001 | ||
| VAC1074 | CYFENDUS | ||
| VAL079 | Valence rubéole, vivante atténuée | ||
| VAC0975 | PERTURIX | ||
| VAL164 | Valence covid 19, non vivant, sans précision | VAL157, VAL157 | VAL035, VAL053, VAL039, VAL076, VAL168 |
| VAC0842 | NEORABIS | ||
| VAL297 | Valence méningocoque A, sans précision | VAL037, VAL041 | |
| VAC0094 | VACCIN SABIN POLIOVAC MERIEUX | ||
| VAC0095 | VACCIN TAB PASTEUR | ||
| VAL250 | Valence encéphalite japonaise, inactivée, entière, préparée sur tissu cérébral murin | VAL089, VAL089 | |
| VAL383 | Valence VRS, ARNm simple brin coiffé en 5' codant pour la glycoprotéine F, stabilisé dans la conformation de préfusion | VAL318, VAL318 | |
| VAC1160 | Vaccin Variole vivant de 2ème génération, sans précision | ||
| VAC1293 | VAKSIN BCG KERING | ||
| VAC0408 | TRIPLE ANTIGEN | ||
| DIS040 | Paludisme | ||
| VAC0407 | TRIPLE | ||
| VAC0758 | SPFN COVID 19 VACCINE + AFLQ | ||
| DIS004 | Poliomyélite | ||
| VAC0976 | VACCINO ANTICOLERICO ISI | ||
| VAC1075 | Vaccin Charbon acellulaire, sans précision | ||
| VAC0625 | MORATEN | ||
| VAC0710 | COVID-19 mRNA VACCINE BNT162b2 | ||
| VAL298 | Valence méningocoque C, sans précision | VAL137, VAL057 | |
| VAL165 | Valence covid 19, vivant, sans précision | VAL157, VAL157 | VAL162, VAL163, VAL086 |
| VAC0843 | NOVIRAB | ||
| VAL032 | Valence typhoïde, non conjuguée, antigène capsulaire polyosidique Vi | VAL014, VAL014 | |
| VAC0180 | ACTACEL | ||
| VAL162 | Valence covid 19, vecteur viral réplicatif, sans précision | VAL165, VAL165 | VAL073, VAL398 |
| VAL295 | Valence variole, deuxième génération, vivant atténué | VAL022, VAL022 | |
| VAL380 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2, 10 microgrammes | VAL395, VAL395 | |
| VAC1072 | Vaccin Covid 19 à ARNm, virus originel, 25 µg, sans précision | ||
| VAC1290 | MOPV1 BIO FARMA | ||
| VAC0319 | OMNIHIB | ||
| DIS005 | Haemophilus influenzae b | ||
| VAC0888 | QUATTVAXEM | ||
| VAC0404 | TRIPACEL | ||
| VAC0622 | EOLARIX | ||
| VAC0973 | VIROFLU | ||
| VAC0755 | ADJUVANTED INACTIVATED VACCINE AGAINST SARS-CoV-2 | ||
| VAC0840 | ADDIGRIP | ||
| VAL077 | Valence oreillons, vivant atténué | VAL183, VAL183 | |
| VAC0092 | VACCIN CHOLERIQUE PASTEUR | ||
| VAL163 | Valence covid 19, vecteur viral non replicatif, sans précision | VAL165, VAL165 | VAL167, VAL397 |
| VAL030 | Valence Borrelia burgdorferi, recombinante, protéine de surface externe A (OspA) | VAL339, VAL339 | |
| VAL381 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2, 3 microgrammes | VAL395, VAL395 | |
| VAC1073 | Vaccin Maladie de Lyme (anti-Borrelia burgdorferi), sans précision | ||
| VAC1291 | MOPV2 BIO FARMA | ||
| VAC0889 | MONO OPV3 | ||
| VAC0538 | VACCIN BCG SYNTHAVERSE | ||
| VAC0405 | TRIPEDIA | ||
| VAC0756 | MV-014-212 | ||
| VAC0841 | INFLUVAC 0,25 mL | ||
| VAL078 | Valence méningocoque Y, polyoside conjugué | VAL299, VAL299 | VAL277, VAL276, VAL275 |
| VAC0623 | Vaccin Rougeole et Oreillons, sans précision | ||
| VAL296 | Valence variole, troisième génération, non réplicatif, Virus modifié de la vaccine d'Ankara, | VAL028, VAL028 | |
| VAC0974 | MENCEVAX AC | ||
| DIS006 | Hépatite B | ||
| VAC0093 | VACCIN DT TAB PASTEUR | ||
| VAC0183 | AIMMUGEN | ||
| VAC0098 | HEXAVAC | ||
| VAC1381 | MEASLES AND RUBELLA VACCINE ZYDUS | ||
| VAC1296 | DTP BIO FARMA | ||
| VAC0979 | VACCINO ANTITETANICO ISI | ||
| VAC0713 | Vaccin Typhoïde polyosidique, sans précision | ||
| VAL168 | Valence covid 19, ARN, sans précision | VAL164, VAL164 | VAL043 |
| VAC0846 | VACCIN POLIOMYELITIQUE ORAL BIVALENT TYPES 1 et 3 | ||
| VAC1030 | GEMCOVAC-19 | ||
| VAC1163 | Vaccin Pneumocoque conjugué 20-valent, sans précision | ||
| VAL035 | Valence covid 19, ADN plasmidique codant la protéine de pointe du SARS-CoV-2 | VAL164, VAL164 | |
| VAL386 | Valence grippe aviaire, A(H5), sans précision | VAL051, VAL385 | |
| VAC0931 | FLUBLOK QUADRIVALENT | ||
| VAL253 | Valence rage, immunoglobuline, origine équine | VAL016, VAL016 | |
| VAL120 | Valence méningocoque, polyvalent, polyoside non conjugué | VAL234, VAL234 | |
| VAC1078 | ENVACGEN | ||
| VAC0050 | HAVRIX 720 U/0,5 mL | ||
| VAC0051 | INFANRIXTETRA | ||
| VAC0184 | ALDIANA | ||
| VAC0099 | MENINVACT | ||
| VAC0848 | VACCIN BCG INSTITUT MERIEUX | ||
| VAC0714 | VACCIN CONTRE LA COVID-19 (INACTIVE, AVEC ADJUVANT) VALNEVA | ||
| VAC1164 | Vaccin quadrivalent DTCaHib- Diphtérie-Tétanos-Coqueluche-Hib PRP, sans précision | ||
| VAC0932 | Vaccin Grippe quadrivalent recombinant, sans précision | ||
| VAC1297 | TT BIO FARMA | ||
| VAC1382 | SKYTYPHOID | ||
| VAC0847 | VACCIN PNEUMOCOCCIQUE SARBACH | ||
| VAL169 | Valence covid 19, ARNm auto-amplifiant (AAA) | VAL303, VAL303 | |
| VAC1031 | SPIKEVAX 50 µg MONODOSE MODERNA | ||
| VAL036 | Valence papillomavirus, VLP, nonavalent, types 6, 11, 16, 18, 31, 33, 45, 52 et 58 | VAL237, VAL237 | |
| VAL254 | Valence rage, inactivée, entière, type Semple, préparée sur tissu cérébral de chèvre ou de mouton infecté par le virus de la rage, inactivé par du phénol ou de la ß-propiolactone, contient de la myéline | VAL256, VAL256 | |
| VAL387 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2, 25 microgrammes | VAL395, VAL395 | |
| VAL121 | Valence poliomyélite, trivalente, inactivée, entière, orale | VAL042, VAL042 | |
| VAC1079 | VAX-SPIRAL | ||
| VAC0096 | VACCIN GRIPPAL RONCHESE (VGR) | ||
| VAL251 | Valence encéphalite japonaise, inactivée, dérivée de cellules Vero | VAL089, VAL089 | VAL402, VAL401 |
| DIS001 | Diphtérie | ||
| VAC1161 | Vaccin quadrivalent DTCeP - Diphtérie-Tétanos-Coqueluche-Hib PRP, sans précision | ||
| VAC0409 | TRIPLE SABIN | ||
| VAC0977 | ENTEROVACCINO ISI | ||
| VAC0626 | MoRu Viraten | ||
| VAC0759 | EUCORVAC-19 | ||
| VAC0844 | VERORABVAX | ||
| VAC1076 | UROMUNE (MV 140) | ||
| VAC1294 | BIO-TD | ||
| VAL166 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, dose pédiatrique | VAL122, VAL122 | |
| VAC0711 | Vaccin Typhoïde conjugué, sans précision | ||
| VAL299 | Valence méningocoque Y, sans précision | VAL078, VAL139 | |
| VAL033 | Valence poliomyélite, vivante atténuée, orale, monovalente type 2 | VAL133, VAL133 | |
| VAL384 | Valence lèpre, sans précision | ||
| VAC0097 | VACCIN LEPTOSPIRES ICTEROHEMORRAGIAE PASTEUR | ||
| VAC0628 | Immravax | ||
| VAC1380 | ZYVAC TCV | ||
| VAC0845 | VACCIN POLIOMYELITIQUE ORAL PRODUIT SUR CELLULES VERO MERIEUX | ||
| VAC1077 | ENVAX-A71 | ||
| VAC0627 | MORUMAN | ||
| VAC0712 | Vaccin Typhoïde et Hépatite A, sans précision | ||
| VAC1162 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.1, 15 microgrammes, sans précision | ||
| DIS002 | Tétanos | ||
| VAC0978 | VAC.DIFTO TETANO ISI | ||
| VAC1295 | DT BIO FARMA | ||
| VAL167 | Valence covid 19, vecteur viral non replicatif avec cellules présentant l'antigène | VAL163, VAL163 | |
| VAL034 | Valence diphtérique, anatoxine, dose réduite | VAL083, VAL083 | |
| VAL252 | Valence rage, immunoglobuline, origine humaine | VAL016, VAL016 | |
| VAC0930 | AD5-NCOV COVID-19 INHALATION VACCINE | ||
| VAL385 | Valence grippe aviaire, A(H5N8) | VAL386, VAL386 | |
| VAC0182 | ADACEL | ||
| VAC0313 | MUMPS inactivated | ||
| VAC0228 | ERVEVAX RA 27/3 | ||
| VAL039 | Valence covid 19, VLP, protéine de pointe recombinante | VAL164, VAL164 | |
| VAL124 | Valence choléra, vivante atténuée, sans précision | VAL081, VAL081 | VAL357 |
| VAL257 | Valence rage, inactivée, entière, préparée sur culture cellulaire, sans précision | VAL080, VAL080 | VAL259, VAL260, VAL258, VAL261 |
| VAC0579 | CLAIRYG 50 mg/mL | ||
| VAL342 | Valence Klebsiella pneumoniæ, sans précision | VAL345, VAL345 | |
| VAC0446 | VCDT | ||
| VAC0664 | GX-19-DNA-Covid | ||
| VAC0797 | Vaccin Diphtérie, Tétanos et Coqueluche, sans précision | ||
| VAC0531 | TETANOS ADSORBE MERIEUX | ||
| VAC1426 | Vaccin bivalent recombinant contre le papillomavirus humain (types 16 et 18) (Pichia pastoris) | ||
| VAC0882 | CANDID 1 | ||
| VAC1208 | Vaccin quadrivalent DTCeHepB - Diphtérie-Tétanos-Coqueluche-HépatiteB 10µg, sans précision | ||
| VAC0229 | FLU SHIELD | ||
| VAL258 | Valence rage, inactivée, entière, préparée sur culture de cellules diploïdes humaines (HDCV) MRC-5, inactivation par la ß-propiolactone | VAL257, VAL257 | |
| VAL125 | Valence hépatite A, inactivée, entière, sans précision | VAL288, VAL288 | VAL283, VAL130, VAL284 |
| VAC0447 | VDA VACCIN DIFTERIC ADSORBIT | ||
| VAC0798 | Vaccin Haemophilus influenzae b et Méningocoque C, sans précision | ||
| VAL210 | Valence pneumocoque, polyosidique non conjuguée, sérotype 5 | VAL185, VAL185 | |
| VAL343 | Valence Enterococcus fæcalis, sans précision | VAL345, VAL345 | |
| VAC0532 | TETANUS VACCIN | ||
| VAC0665 | COVAXIN BHARAT BIOTECH COVID-19 VACCINE | ||
| VAC0883 | ENTEROVACCINO TIFICO SCLAVO | ||
| VAC1209 | Vaccin Rougeole, entier inactivé, sans précision | ||
| VAC1427 | Vaccin entier inactivé contre l'encéphalite japonaise, préparé sur cellules Vero, 6 microgrammes | ||
| VAC0311 | MUMATEN BERNA PRODUCTSNA | ||
| DIS048 | Méningocoques | ||
| VAC0226 | Diptheria, Tetanus and Acellular Pertussis Combined Walvax vaccine | ||
| VAC0359 | RIMEVAX | ||
| VAC0008 | GRIPGUARD | ||
| VAL037 | Valence méningocoque A, polyoside non conjugué | VAL297, VAL297 | |
| VAL388 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2, 50 microgrammes | VAL395, VAL395 | |
| VAL255 | Valence rage, inactivée, entière, type Fuenzalida, préparée sur tissu cérébral de souriceau à la mamelle infecté par le virus de la rage, teneur moindre en myéline | VAL256, VAL256 | |
| VAL122 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, sans adjuvant | VAL231, VAL231 | VAL015, VAL166, VAL094 |
| VAC0577 | TRIPACEL HYBRID | ||
| VAL340 | Valence charbon, sans précision | VAL111 | |
| VAC0444 | VAXEM-HIB | ||
| VAC0662 | OSAKA-DNA-COVID / AG0301-COVID19 | ||
| VAC1424 | Vaccin pneumococcique polyosidique conjugué, 10-valent, séroptypes 1, 5, 6A, 6B, 7F, 9V, 14, 19A, 19F et 23F | ||
| VAC0880 | Vaccin pentavalent DTCoqHibP - Diphtérie-Tétanos-Coqueluche-Hib-Polio, sans précision | ||
| VAC0795 | Vaccin Coqueluche acellulaire, sans précision | ||
| VAC1206 | Vaccin Covid 19 à ARNm auto-amplifiant, sans précision | ||
| VAC1339 | BIMERVAX XBB.1.16 | ||
| VAC0312 | MUMPS LIVE | ||
| VAC0227 | EPAXAL | ||
| VAC0009 | HBVAXPRO 10 µg | ||
| DIS047 | Méningocoque Y | ||
| VAL038 | Valence covid 19, vecteur viral réplicatif, virus de la rougeole codant la protéine de pointe du SARS-CoV-2 | VAL398, VAL398 | |
| VAL256 | Valence rage, inactivée, entière, préparée sur tissu cérébral animal infecté par le virus de la rage, sans précision | VAL080, VAL080 | VAL254, VAL255 |
| VAL389 | Valence Pseudomonas aeruginosa, 7 immunotypes | ||
| VAL123 | Valence rotavirus, vivant atténué, pentavalent | VAL106, VAL106 | |
| VAC0578 | INFANRIX-HIB | ||
| VAC0796 | Vaccin Coqueluche, sans précision | ||
| VAC0445 | VAXIPAR | ||
| VAL341 | Valence Escherichia coli, sans précision | VAL345, VAL345 | |
| VAC0881 | Vaccin Encéphalite Japonaise vivant atténué, sans précision | ||
| VAC0663 | CADILA-DNA-COVID | ||
| VAC0530 | TETANOL PUR | ||
| VAC1425 | Vaccin typhoïdique, antigène Vi conjugué à la protéine CRM197 | ||
| VAC1207 | Vaccin Covid 19 à vecteur viral réplicatif, virus de la maladie de Newcastle codant la protéine de pointe du SARS-CoV-2, sans précision | ||
| VAC0317 | NABI-HB | ||
| DIS046 | Méningocoque W | ||
| VAC1070 | FLUZONE HIGH-DOSE QUADRIVALENT SOUTHERN HEMISPHERE | ||
| VAL346 | Valence entérovirus A71 | ||
| VAL213 | Valence pneumocoque, polyosidique non conjuguée, sérotype 8 | VAL185, VAL185 | |
| VAC0668 | KENTUCKY-RBD-COVID | ||
| VAC0535 | VAXELIS | ||
| VAC0620 | IXCHIQ | ||
| VAC0753 | INACTIVATED SARS-COV-2 VACCINE FAKHRAVAC (MIVAC) | ||
| VAC0886 | MONO OPV1 | ||
| VAC0971 | VACCINO ANTIVAIOLOSO LANCY | ||
| VAC0090 | VACCIN BRUCELLIQUE P.I. à usage humain | ||
| VAL128 | Valence grippe, sans précision | VAL140, VAL364, VAL366 | |
| DIS045 | Méningocoque B | ||
| VAC0318 | NOTHAV | ||
| VAC1071 | Anticorps ou vaccin VRS, sans précision | ||
| VAL214 | Valence pneumocoque, polyosidique non conjuguée, sérotype 9N | VAL185, VAL185 | |
| VAL347 | Valence Leptospira canicola, inactivée, entière | ||
| VAC0669 | ARCTURUS-RNA-COVID | ||
| VAC0754 | INACTIVATED KOCAK-19 INAKTIF ADJUVANT COVID-19 VACCINE | ||
| VAC0403 | TRINIVAC | ||
| VAC0972 | VIROFLUSOMA | ||
| DIS008 | Rougeole | ||
| VAC0887 | POLIORAL | ||
| VAC0621 | MENC VACCINE FUNED | ||
| VAC0091 | VACCIN CCB PASTEUR | ||
| VAL129 | Valence herpes simplex, sans précision | ||
| VAC0315 | MUMPSVAX | ||
| DIS044 | Méningocoque A | ||
| VAL259 | Valence rage, inactivée, entière, purifiée et préparée sur culture de cellules d’embryon de poulet (PCECV), souche fixe du virus de la rage Flury LEP-25 multipliée sur cultures primaires de fibroblastes de poulet, virus inactivé par la ß-propiolactone | VAL257, VAL257 | |
| VAL126 | Valence Ebola, sans précision | VAL108, VAL109, VAL007 | |
| VAL344 | Valence Proteus vulgaris, sans précision | VAL345, VAL345 | |
| VAC0448 | VICPS (TYPHIM VI) | ||
| DIS043 | Méningocoque C | ||
| VAC0666 | JCOVDEN | ||
| DIS009 | Oreillons | ||
| VAL211 | Valence pneumocoque, polyosidique non conjuguée, sérotype 6B | VAL185, VAL185 | |
| VAC0884 | DIF PER TET ALL | ||
| VAC0799 | Vaccin DTHib - Diphtérie-Tétanos-Hib, sans précision | ||
| VAC0400 | TRIACELLUVAX | ||
| VAC1428 | Vaccin anti-covid 19 à sous-unité protéique, protéine RBD recombinante homodimérique, variant Omicron XBB.1.16, avec adjuvant (SQBA) | ||
| VAL127 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée | VAL230, VAL230 | VAL064, VAL350 |
| VAC0449 | VIRELON T 20 | ||
| DIS042 | Typhus exanthématique | ||
| VAL212 | Valence pneumocoque, polyosidique non conjuguée, sérotype 7F | VAL185, VAL185 | |
| VAL345 | Valence infections urinaires, sans précision | VAL344, VAL343, VAL341, VAL342 | |
| VAC0885 | INFLUPOZZI ZONALE | ||
| VAC0534 | MENJUGATE 10 µg | ||
| VAC0667 | NUVAXOVID | ||
| VAC0401 | TRIHIBIT | ||
| VAC0752 | COVISHIELD | ||
| VAC0970 | TETATOX | ||
| VAC1429 | TETANEA | ||
| VAC0220 | DT MERIEUX | ||
| VAC0353 | R-VAC | ||
| VAC0135 | Vaccin Poliomyélite, sans précision | ||
| VAC0002 | AGRIPPAL | ||
| VAC0268 | IPOL | ||
| VAL302 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 50 microgrammes | VAL303, VAL303 | |
| VAC1333 | COMIRNATY KP.2 10 µg | ||
| VAC1200 | Vaccin Grippe quadrivalent, sur culture cellulaire, sans précision | ||
| VAC0486 | NIMENRIX | ||
| VAC1115 | Vaccin pentavalent DTCaHibP - Diphtérie-Tétanos-Coqueluche-Hib PRP-Polio, sans précision | ||
| VAC1248 | Vaccin Grippe/Covid 19, à ARNm, sans précision | ||
| VAL217 | Valence pneumocoque, polyosidique non conjuguée, sérotype 11A | VAL185, VAL185 | |
| VAC0003 | AVAXIM 160 U | ||
| VAC0354 | RA27/3 | ||
| VAC0136 | Vaccin DTCe - Diphtérie-Tétanos-Coqueluche, sans précision | ||
| VAL303 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL043, VAL043 | VAL135, VAL181, VAL289, VAL180, VAL290, VAL169, VAL302, VAL306, VAL304, VAL310, VAL327 |
| VAC1201 | Vaccin Dengue tétravalent, vivant atténué recombinant chimérique basé sur le vaccin fièvre jaune 17D, sans précision | ||
| VAC1334 | COMIRNATY KP.2 30 µg | ||
| VAC0487 | MENHIBRIX | ||
| VAC1249 | Vaccin Grippe, inactivé trivalent, haute dose, voie intradermique, sans précision | ||
| VAC1116 | Vaccin Rage, entier inactivé, préparé sur culture de cellules Vero, sans précision | ||
| VAC0790 | Vaccin DTHepB - Diphtérie-Tétanos-Hépatite B, sans précision | ||
| VAL218 | Valence pneumocoque, polyosidique non conjuguée, sérotype 12F | VAL185, VAL185 | |
| VAC0351 | QUINTUPLE | ||
| VAC0133 | Vaccin Variole, sans précision | ||
| VAC0266 | INFLUENZA HA VACCINE KOVAX | ||
| VAC0399 | TRIACEL | ||
| VAC0048 | GENHEVAC B PASTEUR | ||
| VAL215 | Valence pneumocoque, polyosidique non conjuguée, sérotype 9V | VAL185, VAL185 | |
| VAL300 | Valence méningocoque W, sans précision | VAL136, VAL138 | |
| VAC1113 | Vaccin Covid 19 à sous-unité protéique, protéine de pointe recombinante, sans précision | ||
| VAC1246 | VACCIN COVID-GRIPPE ARN MRNA-1083 | ||
| VAC1331 | CELLDEMIC | ||
| VAC1379 | ZYVAC MMR | ||
| VAC1028 | RECOMBIVAX HB DIALYSÉ | ||
| VAC0484 | RABIVAX-S | ||
| VAL348 | Valence Leptospira pomona, inactivée, entière | ||
| VAC0352 | R-HB VACCINE | ||
| VAC0001 | ACT-HIB | ||
| VAC0134 | Vaccin BCG, sans précision | ||
| VAC0267 | IPAD TP | ||
| VAC0049 | HAVRIX 1440 U/1mL | ||
| VAL301 | Valence grippe, trivalente, recombinante | VAL361, VAL361 | |
| VAC1114 | Vaccin Typhoïde et Hépatite A, antigène capsulaire polyosidique, sans précision | ||
| VAC1332 | COMIRNATY KP.2 3 µg | ||
| VAC1029 | QUINTANRIX | ||
| VAC0485 | TETAGAM P (immunoglobuline) | ||
| VAC1247 | Vaccin Hépatite A, sans précision | ||
| VAC0570 | HIBERIX | ||
| VAL216 | Valence pneumocoque, polyosidique non conjuguée, sérotype 10A | VAL185, VAL185 | |
| VAL349 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, adjuvant | VAL231, VAL231 | |
| VAC0224 | ECOLARIX | ||
| VAC0357 | RESPIGAM, RSV-IVIG | ||
| VAC0139 | PENT-HIBEST | ||
| VAC0006 | FLUVIRINE | ||
| VAC1422 | Vaccin anti-covid 19 à sous-unité protéique, protéine N recombinante | ||
| VAC0575 | FSME-IMMUN | ||
| VAC1337 | CONVACELL | ||
| VAC0442 | VARICELLON | ||
| VAC0660 | CHINESE-IMB-INACTIVATED-COVID | ||
| VAC0793 | TETADIF | ||
| VAC1204 | Vaccin Covid 19 à sous-unité protéique, protéine de pointe recombinante, avec adjuvant, sans précision | ||
| VAL306 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 3 microgrammes | VAL303, VAL303 | |
| VAC1119 | Vaccin Covid 19 à virus entier inactivé, autorisé, sans précision | ||
| VAC0310 | MOVIVAC | ||
| VAC0225 | EIPV | ||
| VAC0007 | GARDASIL | ||
| VAC0358 | Immunoglobuline Rage origine humaine, sans précision | ||
| VAL080 | Valence rage, inactivée, entière, sans précision | VAL262, VAL257, VAL256 | |
| VAC0576 | FLUVIRAL | ||
| VAC0443 | SEVAC VARIE | ||
| VAC0794 | Vaccin Tétanos avec Ig T, sans précision | ||
| VAC1205 | Vaccin Ebola, vecteur viral vivant non réplicatif recombinant Ad26.ZEBOV, sans précision | ||
| VAC1338 | ZOONOTIC | ||
| VAC1423 | Vaccin contre la grippe pandémique à virus influenza A(H1N1)pdm09 vivant atténué | ||
| VAC0661 | INOVIO-DNA-COVID | ||
| VAL307 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2, 15 microgrammes | VAL394, VAL394 | |
| VAC0222 | TRIPVAC | ||
| VAC0355 | RABAVERT | ||
| VAC0137 | Vaccin Diphtérie et Tétanos, sans précision | ||
| VAC0004 | D.T. POLIO MERIEUX | ||
| VAC1420 | ARNm simple brin coiffé en 5' codant la glycoprotéine F du virus respiratoire syncytial stabilisé dans la conformation de préfusion | ||
| VAC1202 | Vaccin Covid 19 à virus vivant atténué, sans précision | ||
| VAC0488 | PENTAXIM | ||
| VAC1117 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.4/5, 5 microgrammes, sans précision | ||
| VAC0573 | AGRIFLU | ||
| VAC1335 | INCELLIPAN | ||
| VAL219 | Valence pneumocoque, polyosidique non conjuguée, sérotype 14 | VAL185, VAL185 | |
| VAC0791 | Vaccin hexavalent DTPCoqHibHepB - Diphtérie-Tétanos-Coqueluche-Polio-Hib-Hépatite B, sans précision | ||
| VAL304 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 15 microgrammes | VAL303, VAL303 | |
| VAC0223 | DUAL ANTIGEN SII | ||
| VAC0356 | RECOMBIVAX HB PÉDIATRIQUE | ||
| VAC0005 | DUKORAL | ||
| VAC0138 | Vaccin DiphTPCoq - Diphtérie-Tétanos-Coqueluche-Polio, sans précision | ||
| VAC0489 | TRIMOVAX | ||
| VAC1421 | Vaccin anti-covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, virus originel | ||
| VAC0574 | Td POLIO ADSORBED | ||
| VAC1118 | Vaccin Entérovirus A71, sans précision | ||
| VAC0792 | Vaccin pentavalent DTCoqPHepB - Diphtérie-Tétanos-Coqueluche-Polio-Hépatite B, sans précision | ||
| VAC0441 | SKYVARICELLA INJ | ||
| VAC1203 | Vaccin Brucellose, protéique (antigène P.I.), sans précision | ||
| VAC1336 | KOSTAIVE | ||
| VAL305 | Valence covid 19, variant Omicron BA.1, ARNm codant la protéine de pointe du SARS-CoV-2, 15 microgrammes | VAL393, VAL393 | |
| VAC0260 | IMOVAX Rabies I.D. | ||
| VAC0393 | TICE BCG | ||
| VAC0175 | A.D.T. BOOSTER | ||
| VAC0042 | VACCIN BCG SSI | ||
| VAL083 | Valence diphtérique, anatoxine, dose non précisée | VAL414, VAL414 | VAL097, VAL034 |
| VAC0706 | FLUZONE QUADRIVALENT | ||
| VAC0839 | Vaccin Brucellose entier inactivé, sans précision | ||
| VAC1022 | COMIRNATY 3 µg 6 MOIS-4 ANS BIONTECH-PFIZER | ||
| VAC0923 | Anticorps monoclonal VRS, sans précision | ||
| VAC1240 | Vaccin Méningocoque B à 4 composants, sans précision | ||
| VAC1373 | ROTAVAC 5D | ||
| VAC1155 | Vaccin Hépatite B plasmatique, sans précision | ||
| VAC1288 | VAKSIN POLIOMYELITIS BIO FARMA | ||
| VAC0261 | IMOVAX RAGE | ||
| VAC0394 | TIG | ||
| VAC0043 | BOOSTRIXTETRA | ||
| VAC0176 | A.K.D.S. | ||
| VAL084 | Valence covid 19, vecteur viral réplicatif, virus de la stomatite vésiculaire codant la protéine de pointe du SARS-CoV-2 | VAL398, VAL398 | |
| VAC0707 | CORONAVIRUS SARS-CoV-2 INACTIVÉ | ||
| VAC0925 | Vaccin Grippe trivalent inactivé, sans précision | ||
| VAC1241 | Vaccin Zona, glycoprotéine E (gE) de surface du virus varicelle-zona (VZV), sans précision | ||
| VAC0924 | FLUZONE INTRADERMAL | ||
| VAC1374 | TYPBAR-TCV | ||
| VAC1289 | VAKSIN POLIOMYELITIS BIVALEN BIO FARMA | ||
| VAC1023 | COMIRNATY ORIGINAL/OMICRON BA.4-5 (15/15 µg) BIONTECH-PFIZER | ||
| VAC1156 | Immunoglobuline Botulisme, sans précision | ||
| VAC0040 | TYAVAX | ||
| VAC0173 | FLUENZ | ||
| VAC0088 | Vaccin DTP - Diphtérie-Tétanos-Polio, sans précision | ||
| VAL081 | Valence choléra, sans précision | VAL124, VAL359 | |
| VAC0837 | COVOVAX SII | ||
| VAC0703 | ADJUVANTED PROTEIN SUBUNIT (RBD) | ||
| VAC1153 | Vaccin Méningocoque ACWY quadrivalent, conjugué à l'anatoxine diphtérique, sans précision | ||
| VAC0921 | Vaccin Encéphalite Japonaise, sans précision | ||
| VAC1286 | VAKSIN COVID-19 BIO FARMA | ||
| VAC1371 | REVAC-B MCF | ||
| VAC0836 | FLUAD TETRA | ||
| VAC1020 | VACCIN HEPATITE A AVENTIS PASTEUR MSD | ||
| VAC1068 | Vaccin Fièvre de la vallée du Rift, sans précision | ||
| VAL308 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2, 25 microgrammes | VAL394, VAL394 | |
| VAC0391 | TETRAMUNE | ||
| VAC0392 | TETRAVAX | ||
| VAC0041 | TYPHIM VI | ||
| VAC0174 | PROQUAD | ||
| VAL082 | Valence papillomavirus, types non précisés | VAL237, VAL236 | |
| VAC0838 | COVOVAX NOVAVAX | ||
| VAC0705 | INFLUSPLIT TETRA | ||
| VAC0922 | Vaccin Adénovirus, type 4 et type 7, vivant atténué, voie orale, sans précision | ||
| VAC1372 | ROTAVAC | ||
| VAC1021 | COMIRNATY ORIGINAL/OMICRON BA.1 (15/15 µg) BIONTECH-PFIZER | ||
| VAC1154 | Vaccin Oreillons entier inactivé, sans précision | ||
| VAC1069 | Immunoglobuline Vaccine, sans précision | ||
| VAC1287 | VAKSIN HEPATITIS B BIO FARMA | ||
| VAL309 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2, 5 microgrammes | VAL394, VAL394 | |
| VAC0131 | Vaccin Rage, sans précision | ||
| VAC0264 | INFANRIX | ||
| VAC0397 | TRESIVAC LYOPHILIZED | ||
| VAC0046 | ENGERIX B 20 µg | ||
| VAC0179 | ACELLULAR D.P.T. KOVAX | ||
| VAL172 | Valence fièvre Q (Coxiella burnetii), sans précision | ||
| VAL390 | Valence chikungunya, sans précision | VAL060, VAL391 | |
| VAC0928 | Vaccin Hépatite A vivant atténué, sans précision | ||
| VAC1026 | SOBERANA 02 FINLAY-FR-2 COVID-19 VACCINE | ||
| VAC1111 | Vaccin Encéphalite Japonaise, entier inactivé, préparé sur cellules Vero, sans précision | ||
| VAL087 | Valence dengue, vivante atténuée, tétravalente, chimérique recombinante basée sur le vaccin contre la fièvre jaune 17D | VAL150, VAL150 | |
| VAC1244 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, variant Omicron XBB.1.5, 30 microgrammes, sans précision | ||
| VAC1377 | VAXIFLU-4 | ||
| VAC1159 | Vaccin Grippe trivalent, recombinant, sans précision | ||
| VAC0482 | VEPACEL | ||
| VAC0350 | QUATRO-VIRELON | ||
| VAC0265 | INFLU-KOVAX | ||
| VAC0132 | Vaccin Tétanos, sans précision | ||
| VAC0398 | TRI-IMMUNOL | ||
| VAC0047 | FLUARIX | ||
| VAC0929 | Vaccin Grippe quadrivalent inactivé, dose pédiatrique, sans précision | ||
| VAL173 | Valence fièvre hémorragique d'Argentine, vivant atténué, virus Junin | VAL421, VAL421 | |
| VAL040 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, sans adjuvant, dose normale | VAL064, VAL064 | |
| VAL391 | Valence chikungunya, VLP | VAL390, VAL390 | |
| VAC1330 | FLU-M TETRA | ||
| VAC1245 | Vaccin Méningocoque ABCWY, sans précision | ||
| VAL088 | Valence varicelle, immunoglobuline | ||
| VAC1378 | VACTYPH | ||
| VAC1112 | Vaccin Grippe quadrivalent, vivant atténué, sans précision | ||
| VAC1027 | KOVIVAC CHUMAKOV COVID-19 VACCINE | ||
| VAC0483 | FLUAD PAEDIATRICS | ||
| VAC0262 | IMOVAX RUBEOLA | ||
| VAC0395 | TITIFICA | ||
| VAC0044 | CERVARIX | ||
| VAC0177 | AC VAX | ||
| VAL085 | Valence poliomyélite, vivante atténuée, orale, monovalente type 3 | VAL133, VAL133 | |
| VAL170 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), 5 microgrammes | VAL090, VAL090 | |
| VAC0926 | FLUCELVAX TRIVALENT | ||
| VAC0708 | CORVAX12 | ||
| VAC1242 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, variant Omicron XBB.1.5, 25 microgrammes, sans précision | ||
| VAC1157 | Vaccin Variole de 3ème génération, virus modifié de la vaccine d'Ankara, sans précision | ||
| VAC1375 | TWINRAB | ||
| VAC1024 | SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (50 µg/50 µg)/mL MODERNA | ||
| VAC0480 | FENDRIX | ||
| VAC0263 | IMOVAX SARAMPION | ||
| VAC0130 | Vaccin ROR, sans précision | ||
| VAC0045 | ENGERIX B 10 µg | ||
| VAC0396 | BIOPOLIO | ||
| VAC0178 | ACEL-IMUNE | ||
| VAL086 | Valence covid 19, vivant atténué, sans précision | VAL165, VAL165 | |
| VAC0709 | COVI-VAC | ||
| VAL171 | Valence encéphalite équine vénézuélienne, sans précision | ||
| VAC0927 | Vaccin Covid 19 à ARNm, dose pédiatrique, sans précision | ||
| VAC1110 | Vaccin Méningocoque C non conjugué, sans précision | ||
| VAC1376 | ZYCOV-D | ||
| VAC1025 | CORBEVAX | ||
| VAC1158 | Vaccin Covid 19 à ARNm contre le variant Omicron XBB.1.5, 3 microgrammes, sans précision | ||
| VAC1243 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, variant Omicron XBB.1.5, 50 microgrammes, sans précision | ||
| VAC0481 | TRIVIVAX | ||
| VAL261 | Valence rage, inactivée, entière, préparée en culture primaire de cellules rénales de hamster (PHKCV), souche Beijing, inactivation par le formol | VAL257, VAL257 | |
| VAL394 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL149, VAL149 | VAL307, VAL308, VAL309, VAL326, VAL411 |
| VAC1171 | Vaccin Grippe trivalent, inactivé, haute dose, sans précision | ||
| VAC0419 | SHANTT | ||
| VAC0769 | SC-Ad6-1 | ||
| VAC0418 | TRIVIVAC Y | ||
| VAC0987 | TANRIX | ||
| DIS053 | Maladie de Lyme | ||
| VAC1086 | PNEUMUNE | ||
| VAC0503 | Immunoglobuline Rage origine équine, sans précision | ||
| VAC0636 | FLUMIST QUADRIVALENT | ||
| VAC0721 | ADIMRSC-2F | ||
| VAL176 | Valence virus parainfluenza humains, sans précision | ||
| VAC0854 | Vaccin Poliomyélite oral monovalent type 3 - mOPV3, sans précision | ||
| VAL043 | Valence covid 19, ARNm codant la protéine de pointe du SARS-CoV-2, autorisé | VAL168, VAL168 | VAL149, VAL303 |
| VAC0191 | ARILVAX | ||
| VAL262 | Valence rage, inactivée, entière, préparée sur oeufs embryonnés (VOE), sans précision | VAL080, VAL080 | VAL263 |
| VAC1390 | HEALIVE | ||
| VAC1172 | Anatoxine Diphtérie, dose réduite, sans précision | ||
| VAC0988 | VACCINO MENINGOCOCCICO POLISACCARIDICO TETRAVALENTE GSK | ||
| VAC0637 | IPAD DT | ||
| VAC0855 | Vaccin DiphTP - Diphtérie-Tétanos-Polio, sans précision | ||
| DIS052 | Botulisme | ||
| VAC1087 | HYPERTET | ||
| VAC0504 | INFANRIX POLIO HIB NOURRISSONS | ||
| VAC0940 | SPUTNIK-LIGHT | ||
| VAC0722 | COVIGENIX VAX-001 | ||
| VAL177 | Valence Haemophilus influenzae type b, sans précision | VAL103, VAL049 | |
| VAL044 | Valence varicelle, sans précision | ||
| VAL395 | Valence covid 19, variant Omicron JN.1, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL417, VAL417 | VAL379, VAL381, VAL380, VAL388, VAL387, VAL406 |
| VAC0192 | ATTENUVAX | ||
| VAL174 | Valence Hantavirus, sans précision | ||
| VAL041 | Valence méningocoque A, polyoside conjugué | VAL297, VAL297 | VAL271, VAL269, VAL270 |
| VAL392 | Valence grippe aviaire, A(H5N1), ARNm | VAL051, VAL051 | |
| VAC1084 | BAYTET | ||
| DIS051 | Charbon | ||
| VAC0549 | Vaccin dTP - Diphtérie-Tétanos-Polio, dose réduite, sans précision | ||
| VAC0416 | TRIVIRATEN | ||
| VAC0767 | ChAdV68 SAM-LNP rS-TCE GRITSTONE ONCOLOGY COVID-19 VACCINE | ||
| VAC0852 | Vaccin Poliomyélite oral monovalent type 2 - mOPV2, sans précision | ||
| VAL089 | Valence encéphalite japonaise, inactivée, sans précision | VAL249, VAL249 | VAL251, VAL250 |
| VAC0634 | MVABEA | ||
| VAC0501 | EQUIRAB (immunoglobuline) | ||
| VAC0985 | VACCINO TAB TE ISI | ||
| VAL042 | Valence poliomyélite, sans précision | VAL056, VAL133, VAL121 | |
| VAL393 | Valence covid 19, variant Omicron BA.1, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL149, VAL149 | VAL178, VAL305, VAL412 |
| VAL260 | Valence rage, inactivée, entière, préparée sur culture de cellules Vero (PVRV), souche Wistar, inactivation par la ß-propiolactone | VAL257, VAL257 | |
| VAC1170 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus de chimpanzé ChadOx1 codant la protéine de pointe du SARS-CoV-2, sans précision | ||
| VAC0417 | TRIVIVAC SEVAC | ||
| VAC0635 | PREFLUCEL | ||
| VAC0768 | COVIVAC | ||
| VAC1085 | MYCOBAX | ||
| VAC0502 | Immunoglobuline Rage, sans précision | ||
| VAC0986 | H ATETAL ISI | ||
| VAL175 | Valence leishmaniose, sans précision | ||
| DIS050 | Grippe aviaire | ||
| VAC0853 | Vaccin Poliomyélite oral monovalent type 1 - mOPV1, sans précision | ||
| VAC0720 | S-268019 | ||
| VAC0190 | ANATETALL | ||
| VAC0195 | BEGRIVAC | ||
| VAC0062 | VAXIGRIP | ||
| VAL350 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, adjuvant, dose normale | VAL127, VAL127 | |
| VAC0859 | Vaccin HPV quadrivalent, sans précision | ||
| VAC1260 | COMIRNATY JN.1 3 µg | ||
| VAC0508 | JEEV 3 µg | ||
| VAC0725 | COH04S1 | ||
| VAC1175 | Vaccin Grippe trivalent, inactivé culture cellulaire, dose normale, sans précision | ||
| VAC0943 | Vaccin Rage cellules diploïdes, sans précision | ||
| VAC1393 | PROVARIX | ||
| VAC0858 | Vaccin HPV bivalent, sans précision | ||
| VAC1042 | Vaccin Covid 19 à vecteur viral non replicatif, sans précision | ||
| VAL047 | Valence hépatite B, immunoglobuline | ||
| VAL265 | Valence covid 19, entier inactivé, en essai clinique | VAL076, VAL076 | |
| VAL398 | Valence covid 19, vecteur viral réplicatif, virus codant la protéine de pointe du SARS-CoV-2 | VAL162, VAL162 | VAL084, VAL038, VAL066, VAL095 |
| VAL132 | Valence poliomyélite, vivante atténuée, orale, monovalente type 1 | VAL133, VAL133 | |
| VAC0810 | Vaccin Méningocoque polyosidique polyvalent, sans précision | ||
| VAC0280 | MUMPS-MEASLES VACCINE MICROGEN | ||
| VAC0063 | TETRACOQ | ||
| VAC0196 | BIAVAX | ||
| VAC0509 | BIKEN | ||
| VAC0727 | ADCLD-COV19 | ||
| VAC0944 | Vaccin Choléra entier inactivé, voie orale, sans précision | ||
| VAC1394 | POLIO SINOVAC VACCINE | ||
| VAC0726 | ADCOVID | ||
| VAC0811 | Vaccin Méningocoque B, sans précision | ||
| VAC1043 | Vaccin Covid 19 à sous-unité protéique, sans précision | ||
| VAC1176 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus 5 codant les protéines S et N du SARS-CoV-2, sans précision | ||
| VAL048 | Valence oreillons, inactivée, entière | VAL183, VAL183 | |
| VAC1261 | NUVAXOVID JN.1 | ||
| VAL399 | Valence typhoïde, antigène Vi conjugué à l’anatoxine tétanique | VAL002, VAL002 | |
| VAL133 | Valence poliomyélite, vivante atténuée, orale, monovalente, sans précision | VAL042, VAL042 | VAL033, VAL085, VAL132 |
| VAL266 | Valence méningocoque C, polyoside conjugué à l'anatoxine tétanique | VAL057, VAL057 | |
| VAL351 | Valence grippe, trivalente, virosomale, sans précision | VAL362, VAL362 | |
| VAC0281 | LM - 3 RIT | ||
| VAL130 | Valence hépatite A, virosome | VAL125, VAL125 | |
| VAC1040 | AREXVY | ||
| VAC0639 | ADACEL POLIO | ||
| VAC1391 | BILIVE | ||
| VAC0856 | Vaccin DTCaHib - Diphtérie-Tétanos-Coqueluche-Hib, sans précision | ||
| VAC1088 | HYPERRAB | ||
| VAC0638 | IPAD POLIO | ||
| VAC0505 | HIBEST | ||
| VAC0723 | GLS-5310 | ||
| VAC1173 | Vaccin Covid 19 à vecteur viral réplicatif, virus influenza codant la protéine de pointe du SARS-CoV-2, sans précision | ||
| VAC0989 | HANTAVAX | ||
| VAL178 | Valence covid 19, variant Omicron BA.1, ARNm codant la protéine de pointe du SARS-CoV-2, 25 microgrammes | VAL393, VAL393 | |
| VAL045 | Valence paratyphoïde, inactivée, entière | VAL014, VAL014 | |
| VAL263 | Valence rage, inactivée, entière, préparée sur cellules d’embryon de canard, inactivation par la ß-propiolactone | VAL262, VAL262 | |
| VAC0941 | Immunoglobuline Charbon, sans précision | ||
| VAL396 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL417, VAL417 | VAL323, VAL324, VAL325, VAL330, VAL329 |
| VAC0193 | AVAC-1, AVA | ||
| VAC0060 | VARILRIX | ||
| VAC0194 | B-CAPSA | ||
| VAC1392 | 23-VALENT SINOVAC | ||
| VAC0507 | HEXACIMA | ||
| VAC0506 | Vaccin pentavalent DTCaHibP - Diphtérie-Tétanos-Coqueluche-Hib-Polio, sans précision | ||
| VAC0857 | Vaccin DTCoqHepB - Diphtérie-Tétanos-Coqueluche-Hépatite B, sans précision | ||
| VAL179 | Valence méningocoque, monovalent, polyosidique conjugué | VAL234, VAL234 | |
| VAC0724 | CHULACOV19 | ||
| VAC1041 | Vaccin Covid 19 à ARN, sans précision | ||
| VAC1174 | Vaccin pentavalent DTCaPHepB - Diphtérie-Tétanos-Coqueluche-Polio-Hépatite B 10µg, sans précision | ||
| VAL046 | Valence Typhus | ||
| VAL397 | Valence covid 19, vecteur viral non réplicatif codant la protéine de pointe du SARS-CoV-2, sans précision | VAL163, VAL163 | VAL070, VAL101, VAL069, VAL054, VAL319 |
| VAC0942 | Vaccin Rage embryon de poulet, sans précision | ||
| VAL264 | Valence covid 19, entier inactivé, autorisé | VAL076, VAL076 | |
| VAL131 | Valence peste, inactivée, entière | VAL422, VAL422 | |
| VAC1089 | HYPERHEP B | ||
| VAC0061 | VARIVAX | ||
| VAC0325 | PEDIARIX | ||
| VAC0107 | CELVAPAN | ||
| DIS014 | Tuberculose | ||
| VAL269 | Valence méningocoque A, polyoside conjugué à la protéine CRM197 | VAL041, VAL041 | |
| VAL136 | Valence méningocoque W, polyoside conjugué | VAL300, VAL300 | VAL272, VAL273, VAL274 |
| VAL003 | Valence coqueluche, sans précision | VAL117, VAL010 | |
| VAL221 | Valence pneumocoque, polyosidique non conjuguée, sérotype 15F | VAL185, VAL185 | |
| VAC0458 | ZAANTIDE antitoxin | ||
| VAL354 | Valence pneumocoque, polyosidique conjuguée, sérotype 9N | VAL184, VAL184 | |
| VAC0543 | HEXAXIM | ||
| VAC0676 | CUREVAC-RNA-COVID | ||
| VAC0410 | TRIPLE VIRAL | ||
| VAC0761 | V-01 | ||
| VAC1305 | MRBEV | ||
| VAC0894 | Vaccin Adénovirus, sans précision | ||
| VAC1438 | Vaccin grippe, trivalent, inactivé, fractionné ou sous-unité, adjuvant | ||
| VAC0326 | PEDVAXHIB | ||
| VAC0108 | PANDEMRIX | ||
| VAL137 | Valence méningocoque C, polyoside non conjugué | VAL298, VAL298 | |
| VAL004 | Valence choléra, inactivée, entière, injectable | VAL359, VAL359 | |
| VAL355 | Valence pneumocoque, polyosidique conjuguée, sérotype 17F | VAL184, VAL184 | |
| VAC0459 | ZAANTITE | ||
| VAC0677 | CHINESE-PLA-ARN-Covid | ||
| VAL222 | Valence pneumocoque, polyosidique non conjuguée, sérotype 17F | VAL185, VAL185 | |
| VAC0895 | Vaccin Encéphalite équine vénézuélienne, sans précision | ||
| VAC0544 | TETRAXIM | ||
| VAC0411 | TRIVACUNA LETI | ||
| VAC0980 | VAC.DPT ISI | ||
| VAC0762 | COV2 SAM (LNP) VACCINE | ||
| VAC1439 | Vaccin méningocoque, polyvalent, polyosidique conjugué | ||
| VAC1306 | TYPHIBEV | ||
| VAC0323 | PAVIVAC-SEVAC | ||
| VAC0105 | PANENZA | ||
| VAC0238 | FUNED-CEME | ||
| VAL049 | Valence Haemophilus influenzae type b, polyoside non conjuguée | VAL177, VAL177 | |
| VAL267 | Valence méningocoque C, polyoside conjugué à l'anatoxine diphtérique | VAL057, VAL057 | |
| VAL134 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, voie intradermique, sans précision | VAL230, VAL230 | |
| VAL001 | Valence grippe, trivalente, vivante atténuée, dose normale | VAL140, VAL140 | |
| VAC0456 | WELLTRIVAX TRIVALENTE | ||
| VAL352 | Valence grippe, quadrivalente, virosomale, sans précision | VAL362, VAL362 | |
| VAC0892 | POLIOVAX-IN | ||
| VAC0541 | BOOSTRIX | ||
| VAC0674 | PASTEUR-MSD MEASLES VECTOR COVID | ||
| VAC1303 | VLA15 | ||
| VAC1436 | Vaccin rage, inactivé, entier, préparé sur tissu cérébral animal infecté par le virus de la rage, sans précision | ||
| VAC1218 | Vaccin Méningocoque A polyosidique conjugué à l'anatoxine tétanique, sans précision | ||
| DIS059 | Peste | ||
| VAC0324 | Vaccin Pneumocoque conjugué 7-valent, sans précision | ||
| VAC0106 | Q-Pan H1N1 | ||
| DIS011 | Varicelle | ||
| VAL135 | Valence covid 19, ARNm codant la protéine de pointe du SARS-CoV-2, en essai clinique | VAL303, VAL303 | |
| DIS010 | Rubéole | ||
| VAL268 | Valence méningocoque C, polyoside conjugué à la protéine CRM197 | VAL057, VAL057 | |
| VAL002 | Valence typhoïde, conjuguée, antigène capsulaire polyosidique Vi lié à une protéine porteuse | VAL014, VAL014 | VAL399, VAL400 |
| VAL353 | Valence pneumocoque, polyosidique conjuguée, sérotype 2 | VAL184, VAL184 | |
| VAC0457 | YF-VAX | ||
| VAC0675 | IMPERIAL-COLLEGE-RNA-COVID | ||
| VAL220 | Valence pneumocoque, polyosidique non conjuguée, sérotype 15B | VAL185, VAL185 | |
| VAC0542 | Vaccin D.T.P. Pasteur | ||
| VAC1304 | BERAB | ||
| VAC1437 | Vaccin méningocoque, monovalent, polyosidique conjugué | ||
| VAC0893 | VACCINO ANTICOLERICO SCLAVO | ||
| VAC0760 | RECOV | ||
| VAC1219 | Vaccin hexavalent DTCeHibMCV-A-C-T - Diphtérie-Tétanos-Coqueluche-Hib PRP-Méningocoque A et C, conjugué à l'anatoxine tétanique, sans précision | ||
| VAC1082 | BAYHEP B | ||
| DIS058 | Virus Respiratoire Syncytial | ||
| VAL225 | Valence pneumocoque, polyosidique non conjuguée, sérotype 19F | VAL185, VAL185 | |
| VAL358 | Valence botulisme, immunoglobuline | VAL420, VAL420 | |
| VAC0414 | TRIVAX-HIB | ||
| VAC0765 | DS-5670a | ||
| VAC0983 | VACCINO ANTIPOL ISI | ||
| VAL310 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 5 microgrammes | VAL303, VAL303 | |
| VAC0898 | Vaccin Leishmaniose, sans précision | ||
| VAC0632 | OPVERO | ||
| VAC0850 | NEISVAC-C | ||
| VAC1309 | NOVEL ORAL (nOPV) TYPE 2 BIOLOGICAL E. LTD | ||
| VAL007 | Valence Ebola, vecteur réplicatif virus de la stomatite vésiculaire recombinant (rVSV) - glycoprotéine GP d'EBOV | VAL126, VAL126 | |
| VAC1083 | BAYRAB | ||
| DIS057 | Covid 19 | ||
| VAL226 | Valence pneumocoque, polyosidique non conjuguée, sérotype 20 | VAL185, VAL185 | |
| VAC0899 | Vaccin Virus Parainfluenza humains, sans précision | ||
| VAL311 | Valence paludisme, pré-érythrocytaire R21/Matrix-M | VAL025, VAL025 | |
| VAC0415 | TRIVB | ||
| VAC0633 | ZABDENO | ||
| VAC0984 | VACCINO ANTIVAIOLOSO ISI | ||
| VAC0851 | POLIO SABIN MONO TWO (ORAL) GSK | ||
| VAC0766 | HDT-301 | ||
| VAC0500 | FAVIRAB | ||
| VAL008 | Valence coqueluche, acellulaire, dose standard | VAL117, VAL117 | |
| VAL359 | Valence choléra, inactivée, entière, sans précision | VAL081, VAL081 | VAL021, VAL004 |
| VAC1080 | COVAXIN | ||
| VAC0327 | PENTA | ||
| DIS056 | Chikungunya | ||
| VAC0109 | FOCETRIA (unidose) | ||
| VAL138 | Valence méningocoque W, polyoside non conjugué | VAL300, VAL300 | |
| VAL005 | Valence rougeole, vivante atténuée | VAL182, VAL182 | |
| VAL223 | Valence pneumocoque, polyosidique non conjuguée, sérotype 18C | VAL185, VAL185 | |
| VAL356 | Valence pneumocoque, polyosidique conjuguée, sérotype 20 | VAL184, VAL184 | |
| VAC0896 | Vaccin Fièvre Q, sans précision | ||
| VAC0545 | EUVAX B 20 µg | ||
| VAC0678 | Medicago-VLP-Covid | ||
| VAC0412 | TRIVAX | ||
| VAC0763 | mRNA-1273.351 | ||
| VAC0981 | VACCINO PERTOSSE ISI | ||
| VAC1307 | JEEV 6 µg | ||
| DIS055 | Ebola | ||
| VAC0328 | PENTACEL | ||
| VAC1081 | BAYGAM | ||
| VAL006 | Valence brucellose, sans précision | VAL146, VAL147 | |
| VAL357 | Valence choléra, vivante atténuée, orale | VAL124, VAL124 | |
| VAC0679 | MEDIGEN-S-2P-CpH1018-COVID | ||
| VAL224 | Valence pneumocoque, polyosidique non conjuguée, sérotype 19A | VAL185, VAL185 | |
| DIS054 | Hépatite E | ||
| VAC0546 | DULTAVAX | ||
| VAC0413 | TRIVAX-AD | ||
| VAC0631 | MENINVACTKIT | ||
| VAC0764 | MRT5500 | ||
| VAC0897 | Vaccin Hantavirus, sans précision | ||
| VAC0982 | VACCINO TIFICO ISI | ||
| VAC1308 | DT BIOLOGICAL E LTD | ||
| VAL139 | Valence méningocoque Y, polyoside non conjugué | VAL299, VAL299 | |
| VAC0232 | FLULAVAL | ||
| VAC0014 | INFANRIX HEXA | ||
| VAC0365 | RUBELLA VACCINE MICROGEN | ||
| VAC0147 | Vaccin Grippe A(H1N1)2009, sans précision | ||
| VAL314 | Valence encéphalite à tiques, inactivée, entière, souche Neudörfl, dose adulte | VAL313, VAL313 | |
| VAC1212 | Vaccin Poliomyélite, trivalent, entier inactivé oral, sans précision | ||
| VAC1345 | ZEROTYPH | ||
| VAC1430 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.4/5, 25 microgrammes, sans précision | ||
| VAC0498 | IMOGAM RAGE | ||
| VAC1127 | Immunoglobuline Hépatite A, Rougeole, Varicelle et Rubéole, sans précision | ||
| VAL229 | Valence pneumocoque, polyosidique non conjuguée, sérotype 33F | VAL185, VAL185 | |
| VAC0450 | VIROVAC MASSLING, PEROTID, RUBELLA | ||
| VAC0233 | FLUMIST | ||
| VAC0366 | RUBELLA-KOVAX | ||
| VAC0148 | Vaccin Leptospirose, sans précision | ||
| VAC0015 | INFANRIXQUINTA | ||
| VAL400 | Valence typhoïde, antigène Vi conjugué à la protéine CRM197 | VAL002, VAL002 | |
| VAC1431 | Vaccin VRS, sans précision | ||
| VAC1213 | Vaccin Choléra contenant la sous-unité B recombinante de la toxine cholérique et des bactéries V. cholerae O1 entières inactivées, sans précision | ||
| VAC0499 | BENIRAB (immunoglobuline) | ||
| VAC1128 | Vaccin Covid 19 à ADN plasmidique, sans précision | ||
| VAC1346 | FLU QUADRIVALENT MCV | ||
| VAC0451 | VIVOTIF | ||
| VAL315 | Valence encéphalite à tiques, entière inactivée, souche Neudörfl, dose pédiatrique | VAL313, VAL313 | |
| VAC0230 | FLUAD | ||
| VAC0012 | IMMUGRIP | ||
| VAC0363 | ROTASHIELD | ||
| VAC0145 | Vaccin Encéphalite à tiques, sans précision | ||
| VAC0278 | LIRUGEN | ||
| VAC0809 | Vaccin Méningocoque polyosidique monovalent, sans précision | ||
| VAL312 | Valence encéphalite à tiques, inactivée, entière, souche K23 | VAL031, VAL031 | |
| VAC1125 | Vaccin Hépatite B, sans précision | ||
| VAC1210 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, virus original, 100 microgrammes, sans précision | ||
| VAC1343 | BORYUNG CELL CULTURE-DERIVED JAPANESE ENCEPHALITIS VACCINE | ||
| VAC0496 | GAMMATETANOS (immunoglobuline) | ||
| VAC1258 | COMIRNATY JN.1 30 µg | ||
| VAL009 | Valence paludisme, protéine de surface du sporozoïte | VAL025, VAL025 | |
| VAL227 | Valence pneumocoque, polyosidique non conjuguée, sérotype 22F | VAL185, VAL185 | |
| VAC0231 | FLUKOVAX | ||
| VAC0364 | RUBEATEN BERNA PRODUCTS | ||
| VAC0146 | Vaccin Encéphalite Japonaise vivant atténué 14-14-2, sans précision | ||
| VAC0013 | IMOVAX POLIO | ||
| VAL313 | Valence encéphalite à tiques, inactivée, entière, souche Neudörfl, dose non précisée | VAL031, VAL031 | VAL314, VAL315 |
| VAC1344 | BORYUNG JAPANESE ENCEPHALITIS VACCINE | ||
| VAC1211 | Vaccin Méningocoque C polyosidique conjugué à la protéine CRM197, sans précision | ||
| VAC0497 | Immunoglobuline Tétanos, sans précision | ||
| VAC1126 | Vaccin pentavalent DTCeHibP - Diphtérie-Tétanos-Coqueluche-Hib PRP-Polio, sans précision | ||
| VAC1259 | COMIRNATY JN.1 10 µg | ||
| VAC0582 | TRUMENBA | ||
| VAL228 | Valence pneumocoque, polyosidique non conjuguée, sérotype 23F | VAL185, VAL185 | |
| VAC0321 | ORIMUNE | ||
| VAC0103 | MENACTRA | ||
| VAC0236 | FLUZONE HIGH-DOSE | ||
| VAC0018 | MENCEVAX ACWY | ||
| VAC0369 | RUBEOVAX | ||
| DIS018 | Typhoïde | ||
| VAL091 | Valence typhoïde, vivante atténuée, souche Ty21a, orale | VAL014, VAL014 | |
| VAC1301 | BE Td | ||
| VAC0454 | VVR CANTACUZINO | ||
| VAC1216 | Vaccin quadrivalent DTCaHepB - Diphtérie-Tétanos-Coqueluche-Hépatite B 10µg, sans précision | ||
| VAC1349 | TY BIOMED | ||
| VAC1434 | Vaccin méningocoque A, sans précision | ||
| VAC0672 | VAXINE-SPIKE-COVID | ||
| VAL318 | Valence VRS, vaccin, sans précision | VAL338, VAL338 | VAL316, VAL322, VAL383 |
| VAC0890 | NEOTYF | ||
| VAL403 | Valence méningocoque X, sans précision | VAL404 | |
| VAC0322 | PARIORIX | ||
| VAC0104 | HUMENZA | ||
| DIS017 | Fièvre jaune | ||
| VAC0019 | MENINGITEC | ||
| VAL092 | Valence fièvre jaune | ||
| VAC0673 | QUEENSLAND-SPIKE-MF59-COVID | ||
| VAC1435 | Vaccin rage, inactivé, entier, préparé sur culture cellulaire, sans précision | ||
| VAC0891 | PNEUMOPUR | ||
| VAC1217 | Vaccin Hépatite B et Haemophilus influenzae type b, sans précision | ||
| VAC0540 | IPAD T | ||
| VAL319 | Valence covid 19, vecteur viral non réplicatif, adénovirus codant la protéine de pointe du SARS-CoV-2, par inhalation | VAL397, VAL397 | |
| VAC1302 | COMBE FIVE | ||
| VAL404 | Valence méningocoque X, polyoside conjugué | VAL403, VAL403 | |
| VAC0234 | FLUOGEN | ||
| VAC0101 | Vaccin Hépatite B, recombinant, sans précision | ||
| VAC0367 | RUBELLOVAC | ||
| VAC0016 | INFLUVAC | ||
| DIS016 | Hépatite A | ||
| VAC0149 | Vaccin Méningocoque B:14:P1.7,16, sans précision | ||
| VAL401 | Valence encéphalite japonaise, inactivée, dérivée de cellules Vero, 3 microgrammes | VAL251, VAL251 | |
| VAC1432 | Vaccin Fièvre hémorragique d'Argentine, virus Junin, sans précision | ||
| VAC0585 | Vaccin dTcaP - Diphtérie-Tétanos-Coqueluche-Polio, dose réduite, sans précision | ||
| VAC1129 | Vaccin Covid 19 à sous-unité protéique, protéine de pointe recombinante dans des nanoparticules, sans précision | ||
| VAC0452 | VT (VACINA TRIPLICE) | ||
| VAC1214 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, contre le variant Omicron XBB.1.5, 10µg, sans précision | ||
| VAC1347 | EFLUELDA TIV-HD | ||
| VAC0670 | SPOUTNIK V | ||
| VAL316 | Valence VRS, recombinante, antigène RSVPreF3 dérivé de la protéine F | VAL318, VAL318 | |
| VAC0320 | Vaccin Poliomyélite oral trivalent, sans précision | ||
| VAC0102 | Vaccin Hépatite A inactivé, sans précision | ||
| VAC0235 | FLUVIRIN | ||
| DIS015 | Grippe saisonnière | ||
| VAC0368 | RUBELOGEN | ||
| VAC0017 | M-M-RVAXPRO | ||
| VAL090 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), sans précision | VAL068, VAL068 | VAL115, VAL114, VAL012, VAL170, VAL378 |
| VAL402 | Valence encéphalite japonaise, inactivée, dérivée de cellules Vero, 6 microgrammes | VAL251, VAL251 | |
| VAC1300 | BEVAC 20 µg | ||
| VAC1433 | Vaccin peste, sans précision | ||
| VAC0586 | ERVEBO | ||
| VAC1348 | TETANA | ||
| VAC0453 | VTV (VACINA TRIPLICE VIRAL) | ||
| VAC0671 | CLOVER-SPIKE-SCB-2019-COVID | ||
| VAC1215 | Vaccin hexavalent DTCaHibPHepB - Diphtérie-Tétanos-Coqueluche-Hib OMP-Polio-Hépatite B 10µg, sans précision | ||
| VAL317 | Valence VRS, anticorps, sans précision | VAL338, VAL338 | VAL148, VAL320 |
| VAC0490 | KINRIX | ||
| VAC0272 | KAKSOISROKOTE DUBBELVACCIN | ||
| VAC0054 | VACCIN RABIQUE PASTEUR | ||
| VAC0187 | AMARIL | ||
| VAL095 | Valence covid 19, vecteur viral réplicatif, virus de la maladie de Newcastle codant la protéine de pointe du SARS-CoV-2 | VAL398, VAL398 | |
| VAC0718 | CIGB-66 | ||
| VAC0936 | VACCIN PNEUMOCOCCIQUE POLYOSIDIQUE AVENTIS PASTEUR MSD | ||
| VAL180 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 100 microgrammes | VAL303, VAL303 | |
| VAC1252 | JE-CV | ||
| VAC0935 | VACCIN RABIQUE INACTIVE MERIEUX | ||
| VAC1385 | GC FLU QUADRIVALENT | ||
| VAC0802 | Vaccin Poliomyélite monovalent oral - type non connu, sans précision | ||
| VAC1034 | HEBERBIOVAC B 10 µg | ||
| VAC1167 | Vaccin Coqueluche acellulaire, dose standard, sans précision | ||
| VAL407 | Valence covid 19, variant Omicron KP.2, ARNm codant la protéine de pointe du SARS-CoV-2, 3 microgrammes | VAL406, VAL406 | |
| VAC0140 | INTANZA | ||
| VAC0273 | KIKHOSTE-VAKSINE | ||
| VAC0188 | QUIMI-HIB | ||
| VAL096 | Valence BCG | ||
| VAL181 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 25 microgrammes | VAL303, VAL303 | |
| VAC0937 | Vaccin Botulisme, sans précision | ||
| VAC0804 | Vaccin Charbon, sans précision | ||
| VAC0719 | NANOCOVAX | ||
| VAC1120 | Vaccin Leptospirose, trivalent, sans précision | ||
| VAC1253 | CHIMERIVAX-JE | ||
| VAC0803 | Polio Sabin One and Three GSK | ||
| VAC1168 | Vaccin quadrivalent DTCeHib- Diphtérie-Tétanos-Coqueluche-Hib OC, sans précision | ||
| VAC1386 | GCFLU | ||
| VAC1035 | HEBERBIOVAC HB 20 µg | ||
| VAL408 | Valence covid 19, variant Omicron KP.2, ARNm codant la protéine de pointe du SARS-CoV-2, 10 microgrammes | VAL406, VAL406 | |
| VAC0491 | TENIVAC | ||
| VAC0052 | VACCIN MENINGOCOCCIQUE A+C | ||
| VAC0185 | ALDITEANA | ||
| VAL093 | Valence rougeole, inactivée, entière | VAL182, VAL182 | |
| VAC0849 | Vaccin Tularémie, sans précision | ||
| VAC0716 | SARS-COV-2-RBD-FC FUSION PROTEIN | ||
| VAC0933 | TICOVAC 2,7µg | ||
| VAC1383 | CYVAC | ||
| VAC0800 | Vaccin DTCoqHib - Diphtérie-Tétanos-Coqueluche-Hib, sans précision | ||
| VAC0715 | ERUCOV-VAC | ||
| VAC1032 | SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.1 (25 µg/25 µg) MODERNA | ||
| VAC1165 | Anatoxine Diphtérie, dose standard, sans précision | ||
| VAC1250 | EUVICHOL-S | ||
| VAC1298 | BETT | ||
| VAL405 | Valence grippe pandémique H1N1 2009, vivante atténuée | VAL058, VAL058 | |
| VAC0270 | Vaccin Poliomyélite inactivé, sans précision | ||
| VAC0271 | ISTIVAC | ||
| VAC0186 | ALDITERPERA | ||
| VAC0053 | PRIORIX | ||
| VAL094 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, sans adjuvant, haute dose | VAL122, VAL122 | |
| VAC0717 | CIGB-669 | ||
| VAC0801 | Vaccin Hépatite B et Haemophilus influenzae b, sans précision | ||
| VAC1033 | COMIRNATY ORIGINAL/OMICRON BA.4-5 (5/5 µg) BIONTECH-PFIZER | ||
| VAC0934 | VACCIN OREILLONS AVENTIS PASTEUR MSD | ||
| VAC1251 | EUVICHOL-PLUS | ||
| VAC1384 | BARYCELA | ||
| VAC1166 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, en cours d'essai clinique, sans précision | ||
| VAC1299 | BEVAC 10 µg | ||
| VAL406 | Valence covid 19, variant Omicron KP.2, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL395, VAL395 | VAL408, VAL407, VAL409 |
| VAC0361 | RIT - LM-2 | ||
| VAC0010 | HBVAXPRO 40 µg | ||
| VAC0276 | LIOVAX | ||
| VAC0143 | Vaccin Haemophilus influenzae B, sans précision | ||
| VAC0058 | TWINRIX 10 µg | ||
| VAL184 | Valence pneumocoque, polyosidique conjugué, sans précision | VAL105, VAL105 | VAL186, VAL201, VAL194, VAL192, VAL187, VAL204, VAL202, VAL200, VAL198, VAL190, VAL188, VAL191, VAL189, VAL199, VAL203, VAL195, VAL196, VAL205, VAL193, VAL197, VAL355, VAL353, VAL354, VAL356, VAL373, VAL369, VAL377, VAL372, VAL376, VAL371, VAL375, VAL370, VAL374 |
| VAL051 | Valence grippe aviaire, A(H5N1) | VAL386, VAL386 | VAL392 |
| VAC0807 | Vaccin Choléra et Typhoïde inactivé, sans précision | ||
| VAC1341 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, variant Omicron XBB.1.5, dose non précisée | ||
| VAC1256 | Vaccin hexavalent DTCeHibPHepB - Diphtérie-Tétanos-Coqueluche-Hib-Polio-Hépatite B 15µg, sans précision | ||
| VAL099 | Valence grippe pandémique H1N1 2009, inactivée | VAL058, VAL058 | |
| VAC1389 | INLIVE | ||
| VAC1123 | Vaccin Grippe trivalent, vivant atténué, sans précision | ||
| VAC1038 | Vaccin Encéphalite à tiques, souche Neudörfl, dose adulte, sans précision | ||
| VAC0494 | TRITANRIX HepB | ||
| VAC0362 | RIT - LM-3 | ||
| VAC0144 | Vaccin Choléra, sans précision | ||
| VAC0011 | HBVAXPRO 5 µg | ||
| VAC0277 | LIRUBEL | ||
| VAL185 | Valence pneumocoque, polyosidique non conjuguée, sans précision | VAL105, VAL105 | VAL226, VAL221, VAL209, VAL224, VAL212, VAL229, VAL217, VAL220, VAL208, VAL223, VAL211, VAL228, VAL214, VAL216, VAL219, VAL207, VAL222, VAL210, VAL225, VAL227, VAL213, VAL215, VAL218, VAL206, VAL232, VAL233 |
| VAC0808 | Vaccin Haemophilus influenzae b et Ménigocoque CY, sans précision | ||
| VAC0059 | TYPHERIX | ||
| VAL052 | Valence papillomavirus, VLP, quadrivalente, types 6, 11, 16 et 18 | VAL237, VAL237 | |
| VAL270 | Valence méningocoque A, polyoside conjugué à l'anatoxine diphtérique | VAL041, VAL041 | |
| VAC1124 | Vaccin Covid 19 à virus entier inactivé, en essai clinique, sans précision | ||
| VAC1257 | Vaccin Choléra, entier inactivé oral, bivalent contenant les bactéries V. cholerae O1 et O139 entières inactivées, sans précision | ||
| VAC1342 | IPVAX | ||
| VAC1039 | Vaccin Covid 19 à ARNm, virus originel, 50 µg, sans précision | ||
| VAC0495 | BEXSERO | ||
| VAC0580 | CLAIRYG | ||
| VAC0141 | MENVEO | ||
| VAC0274 | LANCY VAXINA | ||
| VAC0056 | VACCIN TETANIQUE PASTEUR | ||
| VAC0189 | ANADIFTERALL | ||
| VAL097 | Valence diphtérique, anatoxine, dose standard | VAL083, VAL083 | |
| VAL182 | Valence rougeole, sans précision | VAL005, VAL093 | |
| VAC0805 | Vaccin Choléra, entier inactivé, injectable, sans précision | ||
| VAC0938 | Vaccin Grippe quadrivalent, sans précision | ||
| VAC1121 | Vaccin hexavalent DTCaHibPHepB - Diphtérie-Tétanos-Coqueluche-Hib-Polio-Hépatite B 10µg, sans précision | ||
| VAC1387 | SINSAVAC | ||
| VAC1036 | SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 25 µg/25 µg MODERNA | ||
| VAC1169 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.4/5, 15 microgrammes, sans précision | ||
| VAC1254 | CAPVAXIVE | ||
| VAL409 | Valence covid 19, variant Omicron KP.2, ARNm codant la protéine de pointe du SARS-CoV-2, 30 microgrammes | VAL406, VAL406 | |
| VAC0492 | AFLURIA | ||
| VAC0360 | RIMPARIX | ||
| VAC0275 | LAVANTUU TIROKOTE | ||
| VAC0057 | TWINRIX 20 µg | ||
| VAL183 | Valence oreillons, sans précision | VAL048, VAL077 | |
| VAL050 | Valence covid 19, vecteur viral non réplicatif, adénovirus 5 codant la protéine de pointe du SARS-CoV-2, sans précision | VAL070, VAL070 | |
| VAC0939 | PREHEVBRIO | ||
| VAC0806 | Vaccin Choléra, vivant atténué, sans précision | ||
| VAC1340 | SPIKEVAX BA.1 0,1 mg/mL dose 50 µg | ||
| VAC1037 | Vaccin Encéphalite à tiques, souche Neudörfl, dose pédiatrique, sans précision | ||
| VAC1122 | Vaccin Variole vivant de 1ère génération, sans précision | ||
| VAL098 | Valence méningocoque B, 4 composants | VAL161, VAL161 | |
| VAC1255 | HEXASIIL | ||
| VAC1388 | BIVAC POLIO | ||
| VAL273 | Valence méningocoque W, polyoside conjugué à l'anatoxine diphtérique | VAL136, VAL136 | |
| VAL140 | Valence grippe, vivant atténué, sans précision | VAL128, VAL128 | VAL059, VAL001 |
| DIS066 | Hantavirus | ||
| VAC1050 | BEYFORTUS 100 mg (nirsevimab) | ||
| VAC1183 | Vaccin Ebola à vecteur viral non réplicatif, sans précision | ||
| VAC0648 | Vaccin Covid 19, sans précision | ||
| VAC0999 | WETVAX APSV | ||
| VAC0866 | Vaccin Méningocoque A conjugué, sans précision | ||
| VAC1098 | XANAFLU | ||
| VAC0515 | INFANRIX-POLIO | ||
| DIS065 | Fièvre Q | ||
| VAC0951 | IMOVAX POLIO ORALE | ||
| VAC0600 | Vaccin Poliomyélite bivalent OPV 1-3, sans précision | ||
| VAL188 | Valence pneumocoque, polyosidique conjuguée, sérotype 4 | VAL184, VAL184 | |
| VAC0733 | HEPLISAV-B | ||
| VAL055 | Valence rougeole, immunoglobuline | ||
| VAC0070 | DT BIS | ||
| VAL141 | Valence rotavirus, vivant atténué, monovalent RIX4414 | VAL106, VAL106 | |
| VAC1051 | PFIZER COMIRNATY-30 XBB.1.5 | ||
| VAC0867 | Antitoxine Diphtérie, sans précision | ||
| VAC1099 | BABYBIG | ||
| VAC0649 | EFLUELDA QIV-HD | ||
| VAC0516 | ABHAYRAB | ||
| VAC0734 | POLIO BOOSTRIX | ||
| DIS064 | Encéphalite équine vénézuélienne | ||
| VAC1184 | Vaccin Méningocoque C polyosidique conjugué à l'anatoxine tétanique, sans précision | ||
| VAL189 | Valence pneumocoque, polyosidique conjuguée, sérotype 5 | VAL184, VAL184 | |
| VAL056 | Valence poliomyélite, trivalente, inactivée, entière, injectable | VAL042, VAL042 | |
| VAC0601 | Vaccin DTC - Diphtérie-Tétanos-Coqueluche, sans précision | ||
| VAL274 | Valence méningocoque W, polyoside conjugué à la protéine CRM197 | VAL136, VAL136 | |
| VAC0952 | IMOVAX COLERA | ||
| VAC0071 | D.T. BIS - RUDIVAX | ||
| VAC1409 | Vaccin à ARNm contre la covid 19 , subvariant Omicron JN.1, 50 microgrammes par dose, flacon multidose | ||
| VAL053 | Valence covid 19, sous-unité protéique, sans précision | VAL164, VAL164 | VAL104, VAL410 |
| VAL271 | Valence méningocoque A, polyoside conjugué à l'anatoxine tétanique | VAL041, VAL041 | |
| VAC1181 | Vaccin pentavalent DTCeHibHepB - Diphtérie-Tétanos-Coqueluche-Hib PRP-HépatiteB 10µg, sans précision | ||
| VAC0428 | VA-MENGOC-BC | ||
| DIS063 | Adénovirus | ||
| VAC0646 | CECOLIN | ||
| VAC0779 | BATREVAC | ||
| VAC1096 | MORCVAX | ||
| VAC0513 | HEPATYRIX | ||
| VAC0997 | Vaccin Pneumocoque conjugué 13-valent, sans précision | ||
| VAL186 | Valence pneumocoque, polyosidique conjuguée, sérotype 1 | VAL184, VAL184 | |
| VAC0864 | Immunoglobuline Varicelle, sans précision | ||
| VAC0731 | DITANRIX | ||
| VAC1408 | ENIVACHB | ||
| VAL272 | Valence méningocoque W, polyoside conjugué à l'anatoxine tétanique | VAL136, VAL136 | |
| VAC1182 | Vaccin Méningocoque ACWY polyosidique conjugué à l'anatoxine tétanique, sans précision | ||
| VAC0429 | VACCIN COMBINAT DIFTERO-TETANIC | ||
| DIS062 | Fièvre hémorragique d'Argentine | ||
| VAC0998 | LC16 | ||
| VAC1097 | CYTOGAM | ||
| VAC0647 | ROTASIIL | ||
| VAC0514 | ROTARIX | ||
| VAC0732 | COVAC-1 - COVAC-2 | ||
| VAC0950 | IMOVAX DTP | ||
| VAL187 | Valence pneumocoque, polyosidique conjuguée, sérotype 3 | VAL184, VAL184 | |
| VAC0865 | Vaccin Méningocoque A non conjugué, sans précision | ||
| VAL054 | Valence covid 19, vecteur non réplicatif, vaccine Ankara modifiée codant la protéine de pointe du SARS-CoV-2 | VAL397, VAL397 | |
| VAC0074 | D.T. COQ MERIEUX | ||
| VAC0955 | PULMOVAX | ||
| VAC0737 | GBP510 | ||
| VAC0822 | Vaccin Grippe vivant atténué, sans précision | ||
| VAC1054 | COMIRNATY ORIGINAL/OMICRON BA.4-5 (1,5/1,5 µg) | ||
| VAC1187 | Vaccin Covid 19 à vecteur viral réplicatif, virus de la rougeole codant la protéine de pointe du SARS-CoV-2, sans précision | ||
| VAL059 | Valence grippe, quadrivalente, vivante atténuée, dose normale | VAL140, VAL140 | |
| VAC1272 | PSEUDOVAC | ||
| VAL277 | Valence méningocoque Y, polyoside conjugué à l'anatoxine diphtérique | VAL078, VAL078 | |
| VAL144 | Valence hépatite A, inactivée, entière, monovalente, dose adulte | VAL284, VAL284 | |
| VAL011 | Valence covid 19, sous-unité protéique, protéine de pointe recombinante (domaine RBD) | VAL104, VAL104 | VAL413 |
| VAL362 | Valence grippe, virosomal, sans précision | VAL364, VAL364 | VAL352, VAL351 |
| DIS061 | Tularémie | ||
| VAC0292 | MEASLES VACCINE DK3 | ||
| VAC0293 | MENAFRIVAC | ||
| VAC0739 | RAZI COV PARS | ||
| VAC0823 | Vaccin Grippe VLP, sans précision | ||
| VAC1055 | NUVAXOVID XBB.1.5 | ||
| VAL278 | Valence Adénovirus, vivant atténué, voie orale, sans précision | ||
| VAC1140 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.4/5, 25 microgrammes, sans précision | ||
| VAC0956 | VACCINO COLERICO BERNA | ||
| VAC1273 | DT BIOMED | ||
| VAL145 | Valence hépatite A, inactivée, entière, bivalent (hépatites A et B), dose adulte | VAL284, VAL284 | |
| VAL012 | Valence hépatite B, antigène de surface recombinante du virus de l'hépatite B (Ag HBs), 40 microgrammes (dose pour patient dialysé) | VAL090, VAL090 | |
| VAL230 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, sans précision | VAL058, VAL058 | VAL127, VAL134 |
| DIS060 | Herpès | ||
| VAC1188 | Vaccin Covid 19 à ARNm codant la protéine de pointe du SARS-CoV-2, virus originel, 3 microgrammes, sans précision | ||
| VAL363 | Valence grippe, trivalente, VLP, sans précision | VAL029, VAL029 | |
| VAC0160 | Vaccin Zona vivant atténué, sans précision | ||
| VAL360 | Valence grippe, inactivée, obtenue sur culture cellulaire, fractionnée ou sous-unité, dose normale, sans précision | VAL364, VAL364 | VAL285, VAL112 |
| VAC1270 | SPIKEVAX JN.1 0,1 mg/mL dose 50 µg | ||
| VAC0518 | STAMARIL (multidose) | ||
| VAC0517 | FLUARIXTETRA | ||
| VAC0602 | Vaccin DTCa - Diphtérie-Tétanos-Coqueluche, dose standard, sans précision | ||
| VAC0735 | POLIOINFANRIX | ||
| VAC0868 | MENPOVAX A | ||
| VAC1052 | PFIZER COMIRNATY-10 XBB.1.5 | ||
| VAC1185 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus 26 codant la protéine de pointe du SARS-CoV-2, sans précision | ||
| VAL057 | Valence méningocoque C, polyoside conjugué | VAL298, VAL298 | VAL268, VAL266, VAL267 |
| VAC0953 | PROCOMVAX | ||
| VAL142 | Valence hépatite A, inactivée, entière, monovalente, dose pédiatrique | VAL283, VAL283 | |
| VAC0820 | Vaccin Grippe entier inactivé, sans précision | ||
| VAL275 | Valence méningocoque Y, polyoside conjugué à la protéine CRM197 | VAL078, VAL078 | |
| VAC0290 | MASERN-IMPFSTOFF SSW | ||
| VAC0072 | JE-VAX | ||
| VAC0073 | IXIARO | ||
| VAL361 | Valence grippe, recombinante, sans précision | VAL364, VAL364 | VAL287, VAL301 |
| VAC1271 | TYT BIOMED | ||
| VAC0736 | TRIAXIS POLIO | ||
| VAC1186 | Vaccin Covid 19 à vecteur viral replicatif avec cellules présentant l'antigène, sans précision | ||
| VAC0954 | JAPANESE ENCEPHALITIS VACCINE | ||
| VAC0869 | MENPOVAX C | ||
| VAC1053 | PFIZER COMIRNATY-3 XBB.1.5 | ||
| VAL058 | Valence grippe, inactivée, fractionnée ou sous-unité, sans précision | VAL365, VAL365 | VAL230, VAL099, VAL024, VAL405 |
| VAC0603 | COMVAC3 | ||
| VAL276 | Valence méningocoque Y, polyoside conjugué à l'anatoxine tétanique | VAL078, VAL078 | |
| VAL143 | Valence hépatite A, inactivée, entière, bivalent (hépatites A et B), dose pédiatrique | VAL283, VAL283 | |
| VAC0821 | Vaccin Grippe inactivé, fractionné ou sous-unité, sans précision | ||
| VAL010 | Valence coqueluche, inactivée, entière | VAL003, VAL003 | |
| VAC0291 | MEASLES VACCINE AIK-C STRAIN POLYVAC | ||
| VAC1090 | MENZB | ||
| VAC0204 | CAM-KOVAX | ||
| VAC0337 | PNU-IMUNE 23 | ||
| VAL148 | Valence VRS, immunoglobuline | VAL317, VAL317 | |
| VAL015 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, sans adjuvant, dose normale | VAL122, VAL122 | |
| VAL366 | Valence grippe, ARN, sans précision | VAL128, VAL128 | |
| VAC0688 | INTRANASAL FLU-BASED RBD DelNS1-2019-nCoV-RBD-OPT1 COVID-19 Vaccine | ||
| VAL100 | Valence encéphalite japonaise, vivant atténué, souche 14-14-2 | VAL248, VAL248 | |
| VAL233 | Valence pneumocoque, polyosidique non conjuguée, sérotype 25 | VAL185, VAL185 | |
| VAC0555 | COMBACT-HIB | ||
| VAC0991 | FLULAVAL QUADRIVALENT | ||
| VAC0640 | TRITANRIX HepB+Hib | ||
| VAC1402 | EASYSIX | ||
| VAC0773 | ABNCoV2 | ||
| VAC1317 | CERVAVAC | ||
| VAC1091 | VARIZIG | ||
| VAC0205 | CD.JEVAX | ||
| VAC0338 | POLIACEL | ||
| DIS025 | Pneumocoque | ||
| VAL149 | Valence covid 19, variant omicron, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL043, VAL043 | VAL394, VAL393, VAL417 |
| VAL016 | Valence rage, immunoglobuline, sans précision | VAL253, VAL252 | |
| VAL234 | Valence méningocoque, sans précision | VAL235, VAL119, VAL179, VAL120 | |
| VAL367 | Valence choléra, V. cholerae O1, entière inactivée, orale | VAL021, VAL021 | |
| VAL101 | Valence covid 19, vecteur non réplicatif, virus de la maladie de Newcastle codant la protéine de pointe du SARS-CoV-2 | VAL397, VAL397 | |
| VAC0556 | MENITORIX | ||
| VAC0689 | CHINESE-RECOMBINANT-Sf9-COVID | ||
| VAC0774 | FSME-IMMUN 0,25 mL | ||
| VAC0423 | TWINRIX JUNIOR | ||
| VAC0641 | GLOBORIX | ||
| VAC0992 | AFLURIA QUADRIVALENT | ||
| VAC1403 | EASYFIVE-TT | ||
| VAC1318 | DIPHTHERIA, TETANUS, PERTUSSIS AND HEPATITIS B SII | ||
| VAC0202 | BVAC | ||
| VAC0335 | PLUSERIX | ||
| VAL146 | Valence brucellose, inactivée, entière | VAL006, VAL006 | |
| VAL279 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, dose pédiatrique | VAL064, VAL064 | |
| VAL013 | Valence zona, glycoprotéine E (gE) de surface du virus varicelle-zona (VZV) | VAL159, VAL159 | |
| VAL364 | Valence grippe, non vivante, sans précision | VAL128, VAL128 | VAL029, VAL360, VAL365, VAL362, VAL361 |
| VAC0468 | ZATRIBAVAX | ||
| VAC0686 | MULTI-PEPTIDE-pVAC-COVID | ||
| VAC1400 | SHANIPV | ||
| VAL231 | Valence grippe, trivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée | VAL024, VAL024 | VAL122, VAL349 |
| VAC0553 | Vaccin pentavalent DTCeHibP - Diphtérie-Tétanos-Coqueluche-Hib-Polio, sans précision | ||
| VAC1315 | MUMPS SII | ||
| VAC0420 | BIO-TT | ||
| VAC0771 | VBI-2902a | ||
| VAC0203 | C.D.T. | ||
| VAC0336 | PNEUMOVAX | ||
| VAL147 | Valence brucellose, antigène protéique P.I. (phénol-insoluble) | VAL006, VAL006 | |
| VAL014 | Valence typhoïde, sans précision | VAL045, VAL032, VAL071, VAL002, VAL091 | |
| VAC0469 | ZATRIVAX | ||
| VAL232 | Valence pneumocoque, polyosidique non conjuguée, sérotype 6A | VAL185, VAL185 | |
| VAL365 | Valence grippe, non vivante, obtenue sur culture d'œufs, sans précision | VAL364, VAL364 | VAL058, VAL152 |
| VAC0554 | PEDIACEL | ||
| VAC0687 | UB-612 COVID-19 Vaccine | ||
| VAC0421 | TUSSITRUPIN FORTE | ||
| VAC0772 | SARS-CoV-2 VLP Vaccine | ||
| VAC0990 | ALPHARIX | ||
| VAC1316 | RUBELLA SII | ||
| VAC1401 | 9-VALENT HPV VACCINE INNOVAX | ||
| VAC1094 | OROCHOL | ||
| VAC0208 | CERTIVA | ||
| VAL237 | Valence papillomavirus, VLP, polyvalent | VAL082, VAL082 | VAL036, VAL113, VAL052 |
| VAL104 | Valence covid 19, sous-unité protéique, protéine de pointe recombinante | VAL053, VAL053 | VAL011, VAL107, VAL061, VAL416 |
| VAL322 | Valence VRS, recombinante, glycoprotéines F des sous-types A et B | VAL318, VAL318 | |
| VAC0426 | TYPHOID VACCINE WYETH | ||
| VAC0644 | QDENGA | ||
| VAC0995 | IMVAMUNE | ||
| VAC0862 | Immunoglobuline Rougeole, sans précision | ||
| VAC0777 | ADJUPANRIX | ||
| VAC0511 | SILGARD | ||
| VAC1406 | SPUTNIK V | ||
| VAL019 | Valence diphtérique, antitoxine | VAL414, VAL414 | |
| VAC1095 | MVA85A | ||
| VAC1180 | Vaccin Maladie de Lyme, recombinant, sans précision | ||
| VAC0209 | COMVAX | ||
| VAL105 | Valence pneumocoque, sans précision | VAL185, VAL184 | |
| VAC0778 | VAXCHORA | ||
| VAC0427 | TYPHOID-KOVAX | ||
| VAL323 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2, 30 microgrammes | VAL396, VAL396 | |
| VAC0863 | Immunoglobuline Hépatite B, sans précision | ||
| VAC0512 | Vaccin Typhus, sans précision | ||
| VAC0645 | IMMU ORR | ||
| VAC0730 | DENDRITIC CELL AV-COVID-19 VACCINE | ||
| VAC0996 | ACAM2000 | ||
| VAL238 | Valence papillomavirus, VLP, type 6 | VAL236, VAL236 | |
| VAC1407 | NOVOHIB | ||
| VAC0206 | CELLUVAX | ||
| VAC0339 | Vaccin Pneumocoque non conjugué 23-valent, sans précision | ||
| DIS068 | Virus parainfluenza humains | ||
| VAC1092 | KAMRAB | ||
| VAL017 | Valence coqueluche, acellulaire, dose réduite | VAL117, VAL117 | |
| VAL368 | Valence choléra, V. cholerae O139, inactivée, entière, orale | VAL021, VAL021 | |
| VAL235 | Valence méningocoque, polyvalent, polyosidique conjugué | VAL234, VAL234 | |
| VAL102 | Valence hépatite E, recombinante, peptidique | ||
| VAL320 | Valence VRS, anticorps monoclonal, sans précision | VAL317, VAL317 | VAL116, VAL321 |
| VAC0424 | Vaccin Typhoïde oral vivant atténué, sans précision | ||
| VAC0642 | FLUZONE HIGH-DOSE QUADRIVALENT | ||
| VAC0775 | Vaccin DTCeHib - Diphtérie-Tétanos-Coqueluche-Hib, sans précision | ||
| VAC0993 | TD ADSORBED | ||
| VAC1404 | EASYFOUR-TT | ||
| VAC0860 | Vaccin HPV nonavalent, sans précision | ||
| VAC1319 | DIPHTHERIA, TETANUS, PERTUSSIS AND HAEMOPHILUS INFLUENZAE B SII | ||
| VAC0207 | CENDEVAX | ||
| DIS067 | Leishmaniose | ||
| VAC1093 | HEPAGAM | ||
| VAL236 | Valence papillomavirus, VLP, monovalent | VAL082, VAL082 | VAL239, VAL245, VAL243, VAL241, VAL246, VAL238, VAL244, VAL242, VAL240 |
| VAL369 | Valence pneumocoque, polyosidique conjuguée, sérotype 15A | VAL184, VAL184 | |
| VAL103 | Valence Haemophilus influenzae type b, conjuguée, sans précision | VAL177, VAL177 | VAL156, VAL155, VAL154, VAL153 |
| VAC0776 | TETRABIK | ||
| VAC0425 | TYNE | ||
| VAC0994 | VARIVAX II | ||
| VAL321 | Valence VRS, anticorps monoclonal, nirsévimab | VAL320, VAL320 | |
| VAC0510 | HEXYON | ||
| VAC0643 | Vaccin Méningocoques ACWY conjugué, sans précision | ||
| VAC0861 | Vaccin Méningocoque B multicomposé, sans précision | ||
| VAC1405 | EASYFOURPOL | ||
| VAL018 | Valence variole, troisième génération, virus de la vaccine à réplication minimale | VAL028, VAL028 | |
| VAC0111 | Vaccin Fièvre jaune, sans précision | ||
| VAC0244 | HEPRECOMB | ||
| VAC0377 | TRIPLE ANTIGEN SII | ||
| VAC0908 | Vaccin Adénovirus de type 7, sans précision | ||
| VAC0159 | Vaccin Varicelle, sans précision | ||
| VAC0026 | PREVIGRIP | ||
| VAL411 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2, 50 microgrammes | VAL394, VAL394 | |
| VAC1442 | Vaccin grippe, quadrivalent, virosomale, sans précision | ||
| VAC1224 | Vaccin VRS, recombinant, glycoprotéines F (préfusion) des sous-types A et B du VRS, sans précision | ||
| VAC1139 | Vaccin Covid 19 à vecteur non réplicatif, virus de la maladie de Newcastle codant la protéine de pointe du SARS-CoV-2, sans précision | ||
| VAC0595 | FLUCELVAX TETRA | ||
| VAC1006 | SHANVAC B | ||
| VAC1357 | EUPOLIO | ||
| VAC0462 | ZAMEVAX A+C | ||
| VAC0680 | COVILO SINOPHARM COVID-19 VACCINE | ||
| VAL108 | Valence Ebola, vecteur viral vivant non réplicatif recombinant Ad26.ZEBOV | VAL126, VAL126 | |
| VAL326 | Valence covid 19, variant Omicron BA.4/BA.5, ARNm codant la protéine de pointe du SARS-CoV-2, 1,5 microgrammes | VAL394, VAL394 | |
| VAC0330 | PENTACT-HIB | ||
| VAC0245 | HEPTAVAX B | ||
| VAC0112 | Vaccin Typhoïde, sans précision | ||
| VAC0027 | R.O.R. VAX | ||
| VAC0378 | SYNAGIS (PALIZIVUMAB) | ||
| VAC0909 | Antitoxine Botulisme, sans précision | ||
| VAL412 | Valence covid 19, variant Omicron BA.1, ARNm codant la protéine de pointe du SARS-CoV-2, 50 microgrammes | VAL393, VAL393 | |
| VAC1310 | SII TD-VAC | ||
| VAC1443 | Vaccin grippe, trivalent, virosomal, sans précision | ||
| VAC0596 | Vaccin pentavalent DTCaHibHepB - Diphtérie-Tétanos-Coqueluche-Hib-Hépatite B, sans précision | ||
| VAC1007 | ISTIVAC4 | ||
| VAC0463 | ZAMOVAX | ||
| VAC1225 | Vaccin Diphtérie, Tétanos, Typhoïde et Paratyphoïde A et B, sans précision | ||
| VAC1358 | SKYCELLFLU QUADRIVALENT | ||
| VAL109 | Valence Ebola, vecteur viral non réplicatif, Vaccine Ankara modifiée | VAL126, VAL126 | |
| VAC0681 | GRAD-COV2 COVID-19 VACCINE REITHERA | ||
| VAL327 | Valence covid 19, virus originel, ARNm codant la protéine de pointe du SARS-CoV-2, 1,5 microgrammes | VAL303, VAL303 | |
| VAC0242 | HBY | ||
| VAC0375 | SEROBACTERIN | ||
| VAC0157 | Vaccin Pneumocoque, sans précision | ||
| VAC0024 | PNEUMO 23 | ||
| VAC0906 | Vaccin Zona, sans précision | ||
| VAL324 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2, 10 microgrammes | VAL396, VAL396 | |
| VAC1440 | Vaccin grippe, quadrivalent, inactivé, fractionné ou sous-unité, adjuvant, dose normale | ||
| VAC1004 | TEDIVAX | ||
| VAC1355 | EUPENTA | ||
| VAC1222 | Anticorps monoclonal humain VRS, palivizumab, sans précision | ||
| VAC1137 | Vaccin Encéphalite à tiques, entier inactivé, souche K23, sans précision | ||
| VAC0593 | VERORAB | ||
| VAC0460 | ZADITEADVAX | ||
| VAL239 | Valence papillomavirus, VLP, type 11 | VAL236, VAL236 | |
| VAL106 | Valence rotavirus, vivant atténué, sans précision | VAL123, VAL141 | |
| VAC0110 | Vaccin Grippe, sans précision | ||
| VAC0243 | HEPA-B INJECTION | ||
| VAC0025 | PREVENAR | ||
| VAC0376 | SHANCHOL | ||
| VAC0907 | Vaccin Adénovirus de type 4, sans précision | ||
| VAC0158 | Vaccin Rotavirus, sans précision | ||
| VAL325 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2, 3 microgrammes | VAL396, VAL396 | |
| VAL410 | Valence covid 19, sous-unité protéique, protéine N recombinante | VAL053, VAL053 | |
| VAC1223 | Immunoglobuline VRS, sans précision | ||
| VAC1356 | EUVAX B 10 µg | ||
| VAC1441 | Vaccin grippe, quadrivalent, inactivé, fractionné ou sous-unité, voie intradermique, sans précision | ||
| VAC0594 | MENQUADFI | ||
| VAC1005 | REVAC-B PLUS ADULT VACCINE | ||
| VAC1138 | Vaccin Covid 19 à sous-unité protéique recombinante | ||
| VAC0461 | ZADITEVAX | ||
| VAL107 | Valence covid 19, sous-unité protéique, protéine de pointe recombinante dans des nanoparticules | VAL104, VAL104 | VAL328, VAL382 |
| VAC0200 | BIOTHRAX | ||
| VAC0333 | PFIZER VAX-MEASLES K INACTIVATED | ||
| VAC0115 | AVAXIM 80 U PEDIATRIQUE | ||
| VAC0248 | HINKUYS KAROKOE | ||
| VAC0599 | Vaccin pentavalent DTCoqHibHepB - Diphtérie-Tétanos-Coqueluche-Hib-Hépatite B, sans précision | ||
| VAC0466 | ZATETRAVAX | ||
| VAC0684 | QAZVAC | ||
| VAC1446 | Vaccin encéphalite japonaise, inactivé, dérivé de cellules Vero, 3 microgrammes | ||
| VAC1228 | Vaccin VRS, recombinant, antigène RSVPreF3 dérivé de la protéine F, sans précision | ||
| VAC0551 | Vaccin DTCaP - Diphtérie-Tétanos-Coqueluche-Polio, sans précision | ||
| VAC1313 | BCG SII | ||
| VAL415 | Valence charbon, acellulaire, absorbé, adjuvant | VAL111, VAL111 | |
| VAC0201 | BIVIRATEN BERNA | ||
| VAC0334 | PFIZER VAX-MEASLES L | ||
| VAC0249 | RUBELLA VACCINE HPV-77 | ||
| DIS029 | Variole-Mpox | ||
| VAC0116 | R.O.R SANOFI PASTEUR | ||
| VAC0467 | ZATEVAX | ||
| VAC0552 | Vaccin hexavalent DTPCaHibHepB - Diphtérie-Tétanos-Polio-Coqueluche acellulaire -Hib-Hépatite B, sans précision | ||
| VAC0685 | VIDPREVTYN BETA | ||
| VAC0770 | NDV-HXP-S | ||
| VAC1314 | MEASLES SII | ||
| VAL416 | Valence covid 19, sous-unité protéique, adjuvant, protéine de pointe recombinante | VAL104, VAL104 | |
| VAC1229 | Vaccin Méningocoque B (à protéines de vésicules de membrane externe) et C, sans précision | ||
| VAC0113 | Vaccin rubéole, vivant atténué, sans précision | ||
| VAC0246 | HIBERNA PRODUCTSIX | ||
| VAC0379 | T-IMMUN | ||
| DIS028 | Encéphalite japonaise | ||
| VAC0028 | RABIPUR | ||
| VAL413 | Valence covid 19, sous-variant Omicron XBB.1.16 , sous-unité protéique, protéine de pointe recombinante (domaine RBD) | VAL011, VAL011 | |
| VAC1311 | Vaccin Méningocoques ACWXY conjugué, sans précision | ||
| VAC1444 | Vaccin grippe, trivalent, VLP, sans précision | ||
| VAC1008 | DITEMER | ||
| VAC1359 | SKYCELLFLU TRIVALENT | ||
| VAC0464 | ZAMRUVAX | ||
| VAC0682 | FLUQUADRI | ||
| VAC1226 | Vaccin Hépatites A et B, dose pédiatrique, sans précision | ||
| VAL328 | Valence covid 19, sous-variant Omicron XBB.1.5, sous-unité protéique, protéine de pointe recombinante dans des nanoparticules | VAL107, VAL107 | |
| VAC0332 | PENTAVALENTE | ||
| VAC0114 | Vaccin Rougeole, vivant atténué, sans précision | ||
| DIS027 | Encéphalite à tiques | ||
| VAC0247 | HIBTITER | ||
| VAC0029 | REPEVAX | ||
| VAC1312 | TT SII | ||
| VAC0598 | Vaccin pentavalent DTCeHibHepB - Diphtérie-Tétanos-Coqueluche-Hib-Hépatite B, sans précision | ||
| VAC0465 | ZARUVAX | ||
| VAC1227 | Vaccin Hépatite B, dose pédiatrique, sans précision | ||
| VAC1445 | Vaccin grippe aviaire, A(H5N1), ARNm | ||
| VAC0550 | Vaccin RR - Rougeole-Rubéole, sans précision | ||
| VAC0683 | EpiVacCorona | ||
| VAL329 | Valence covid 19, variant Omicron XBB.1.5, ARNm codant la protéine de pointe du SARS-CoV-2, 50 microgrammes | VAL396, VAL396 | |
| VAL414 | Valence diphtérique, sans précision | VAL083, VAL019 | |
| VAC1009 | TETAMER | ||
| VAC0151 | Vaccin Méningocoques A + C, sans précision | ||
| VAC0284 | LYOVAC ATTENUVAX | ||
| VAC0066 | DTCP PASTEUR | ||
| VAC0199 | BIMMUGEN | ||
| VAL192 | Valence pneumocoque, polyosidique conjuguée, sérotype 7F | VAL184, VAL184 | |
| VAC0948 | BACITHRAX | ||
| VAC0815 | Vaccin Pneumocoque et Haemophilus influenzae b, sans précision | ||
| VAC1131 | Vaccin Pneumocoque non conjugué 17-valent, sans précision | ||
| VAC1264 | Vaccin A(H5) contre la grippe aviaire, sans précision | ||
| VAC0814 | Vaccin Pneumocoque conjugué, sans précision | ||
| VAC1179 | Vaccin Choléra et Typhoïde, injectable, sans précision | ||
| VAC1397 | PANFLU | ||
| VAC1046 | BEYFORTUS 50 mg (nirsevimab) | ||
| VAL419 | Valence botulisme, produits d'immunisation active ou passive | VAL280, VAL420 | |
| VAC0370 | RVA RABIES VACCINE ABSORBED BIOPORT | ||
| VAC0152 | Vaccin Méningocoques ACWY non conjugué, sans précision | ||
| VAC0285 | LYOVAC MERUVAX | ||
| VAC0067 | HAVRIX 360 U | ||
| VAL193 | Valence pneumocoque, polyosidique conjuguée, sérotype 8 | VAL184, VAL184 | |
| VAL060 | Valence chikungunya, vivant atténué | VAL390, VAL390 | |
| VAC0816 | PEDATYPH | ||
| VAC0949 | IMOVAX BCG | ||
| VAC0900 | PREVENAR 20 | ||
| VAC1132 | Vaccin Covid 19 bivalent à ARNm contre le virus originel et le variant Omicron BA.4/5, 1,5 microgrammes, sans précision | ||
| VAC1350 | T SIS BIOMED | ||
| VAC1398 | PANFLU.1 | ||
| VAC1047 | ABRYSVO | ||
| VAC1265 | CLODIVAC | ||
| VAC0282 | LTEANAS IMUNA | ||
| VAC0064 | PENTACOQ | ||
| VAC0197 | BIAVAX II | ||
| VAL190 | Valence pneumocoque, polyosidique conjuguée, sérotype 6A | VAL184, VAL184 | |
| VAC0728 | aAPC COVID-19 VACCINE | ||
| VAC0812 | Vaccin Peste entier inactivé, sans précision | ||
| VAC1044 | Vaccin Covid 19 à virus entier inactivé, sans précision | ||
| VAC0945 | Vaccin Méningocoque sérogroupe inconnu, sans précision | ||
| VAC1262 | MRESVIA | ||
| VAC1395 | MUMPS SINOVAC VACCINE | ||
| VAC1177 | Vaccin Variole de 3ème génération, virus de la vaccine vivant à réplication minimale, sans précision | ||
| VAL417 | Valence covid 19, variant Omicron BA.2, ARNm codant la protéine de pointe du SARS-CoV-2 | VAL149, VAL149 | VAL396, VAL395 |
| VAC0283 | LYMERIX | ||
| VAC0150 | Vaccin Méningocoque C conjugué, sans précision | ||
| VAC0198 | BIKEN-HB | ||
| VAC0729 | LV-SMENP-DC vaccine | ||
| VAL191 | Valence pneumocoque, polyosidique conjuguée, sérotype 6B | VAL184, VAL184 | |
| VAC0947 | IMMU-PHILUS | ||
| VAC1263 | Vaccin covid à ARNm codant la protéine de pointe du SARS-COV-2, autorisé | ||
| VAC0946 | TYPHIDRALL | ||
| VAC1396 | ANFLU | ||
| VAC0813 | Vaccin Pneumocoque non conjugué, sans précision | ||
| VAC1130 | Vaccin Grippe saisonnière trivalent inactivé et anatoxine tétanique, sans précision | ||
| VAC1045 | INFANRIX-IPV/HIB | ||
| VAC1178 | Vaccin Dengue tétravalent, vivant atténué recombinant chimérique, sans précision | ||
| VAL418 | Valence variole, produits d'immunisation active ou passive | VAL022, VAL337 | |
| VAC0240 | GUNEVAX | ||
| VAC0373 | SALK | ||
| VAC0155 | Vaccin Dengue, sans précision | ||
| VAC0022 | NEISVAC | ||
| VAC0288 | M-R VAX II | ||
| VAL196 | Valence pneumocoque, polyosidique conjuguée, sérotype 11A | VAL184, VAL184 | |
| VAC0819 | Vaccin Encéphalite Japonaise entier inactivé, sans précision | ||
| VAL063 | Valence botulisme, antitoxine | VAL420, VAL420 | |
| VAL281 | Valence Adénovirus de type 7, vivant atténué, voie orale, sans précision | ||
| VAC0904 | Vaccin Rage préparé sur embryon de canard, sans précision | ||
| VAC1220 | Vaccin Méningocoque CY et Haemophilus influenzae type b, conjugué à l'anatoxine tétanique, sans précision | ||
| VAC1135 | Vaccin Covid 19 à vecteur viral non réplicatif, adénovirus codant la protéine de pointe du SARS-CoV-2, par inhalation, sans précision | ||
| VAC1268 | SPIKEVAX JN.1 50 µg | ||
| VAC1002 | Q-VAX | ||
| VAC1353 | IL-YANG FLU VACCINE | ||
| VAC0591 | VIVAXIM | ||
| VAC0241 | HAEMOPHILUS INFLUENZAE B CONJUGATE VACCINE - SERUM INSTITUTE OF INDIA | ||
| VAC0023 | PENTAVAC | ||
| VAC0374 | SANDOVAC | ||
| VAC0156 | Vaccin HPV, sans précision | ||
| VAC0289 | M-VAX PFIZER | ||
| VAL064 | Valence grippe, quadrivalente, inactivée, fractionnée ou sous-unité, voie intramusculaire ou sous-cutanée, sans adjuvant | VAL127, VAL127 | VAL040, VAL074, VAL279 |
| VAL282 | Valence Adénovirus de type 4, vivant atténué, voie orale, sans précision | ||
| VAC0905 | Vaccin Rage PHKCV, sans précision | ||
| VAC1003 | TEDIVAX PRO ADULTO | ||
| VAC1136 | Vaccin Pneumocoque conjugué 23-valent, sans précision | ||
| VAC1221 | Vaccin trivalent Diphtérie, Tétanos et Rubéole, sans précision | ||
| VAL197 | Valence pneumocoque, polyosidique conjuguée, sérotype 12F | VAL184, VAL184 | |
| VAC1354 | EUFORVAC | ||
| VAC1269 | SPIKEVAX JN.1 0,1 mg/mL dose 25 µg | ||
| VAC0592 | SPEEDA | ||
| VAC0371 | POLIO SABIN GSK | ||
| VAC0153 | Vaccin Oreillons, sans précision | ||
| VAC0020 | MENJUGATEKIT 10 µg | ||
| VAC0286 | M-M-R II | ||
| VAC0068 | MONOVAX | ||
| VAL194 | Valence pneumocoque, polyosidique conjuguée, sérotype 9V | VAL184, VAL184 | |
| VAL061 | Valence covid 19, sous-unité protéique, protéine de pointe du SARS-CoV-2 recombinante, S-2P et CpG1018 | VAL104, VAL104 | |
| VAC0817 | Vaccin Typhoïde entier inactivé, sans précision | ||
| VAC1000 | VACV VACCINIA VIRUS LISTER ELSTREE | ||
| VAC1351 | TETANA PRO | ||
| VAC0901 | MENCEVAX ACW | ||
| VAC1048 | DECAVAC | ||
| VAC1133 | Vaccin Méningocoque ACWY polyosidique conjugué, sans précision | ||
| VAC1266 | PENMENVY | ||
| VAC1399 | TERTRANFLU | ||
| VAC0021 | MUTAGRIP | ||
| VAC0372 | SAHIA | ||
| VAC0287 | M-R VAX | ||
| VAC0154 | Vaccin Paludisme, sans précision | ||
| VAC0069 | MENOMUNE | ||
| VAL195 | Valence pneumocoque, polyosidique conjuguée, sérotype 10A | VAL184, VAL184 | |
| VAL062 | Valence choléra, sous-unité, recombinante de la toxine cholérique B (rCTB) | VAL021, VAL021 | |
| VAC0903 | Vaccin Rage type Fuenzalida, sans précision | ||
| VAL280 | Valence botulisme, anatoxine | VAL419, VAL419 | |
| VAC0818 | Vaccin Typhoïde et Paratyphoïde, sans précision | ||
| VAC1352 | TERATECT | ||
| VAC0902 | Vaccin Rage type Semple, sans précision | ||
| VAC1267 | VIMKUNYA | ||
| VAC1001 | V4020 VEEV VACCINE | ||
| VAC1134 | Vaccin Fièvre hémorragique d'Argentine, vivant atténué, virus Junin, sans précision | ||
| VAC1049 | TDVAX | ||
| VAC0590 | VACCIN BCG AJVACCINES |
Affichages en langues supplémentaires
| Code | Deutsch (German, de) | English (English, en) | French (fr) | gr | lv | Polskie (Polish, pl) | Portuguese (pt) |
| VAL152 | Inf-I | INF-I | Inf-I | Inf-I | Inf-I | Inf-I | Inf-I |
| VAL370 | PCV-15C | VPC-15C | |||||
| VAC1062 | CMV-Immunglobulin | CMV immune globulin | CMV ανοσοσφαιρίνη | CMV imūnglobulīns | Immunoglobulina CMV | Imunoglobulina CMV | |
| DIS078 | Lepra | Leprosy | Λέπρα | Lēproze | Trąd | Lepra | |
| VAC1280 | 21-valent pneumococcal conjugate vaccine, unspecified | ||||||
| VAC0878 | |||||||
| VAC0527 | |||||||
| VAC0745 | |||||||
| VAC1195 | COVID-19 vaccine with non-replicating viral vector, adenovirus 26 encoding the spike protein of SARS-CoV-2, in clinical trial, unspecified | ||||||
| VAC0830 | Subunit shingles vaccine, unspecified | Subunit shingles vaccine, unspecified | Subunit shingles vaccine, unspecified | Subunit shingles vaccine, unspecified | Subunit shingles vaccine, unspecified | Subunit shingles vaccine, unspecified | |
| VAL067 | T | T | T | T | T | T | T |
| VAC0612 | |||||||
| VAL285 | Trivalente inaktivierte Influenza-Valenz aus Zellkultur, spalt- oder untereinheitlich, normale Dosis | INF-CC3 | Inf-CC3 | Τρισθενής αδρανοποιημένη βαλεντία της γρίπης που προέρχεται από κυτταροκαλλιέργεια, κλασματοποιημένη ή υπομονάδα, κανονική δόση | Trivalenta inaktivēta gripas valence, iegūta no šūnu kultūras, frakcionēta vai apakšvienība, normāla deva | Trójwalentna inaktywowana wartość przeciwko grypie uzyskana z hodowli komórkowej, dzielona lub podjednostkowa, normalna dawka | alência vacinal trivalente inativada da gripe obtida por cultura celular, fracionada ou de subunidade, dose normal |
| VAC0963 | |||||||
| VAC0082 | |||||||
| VAL020 | Shingles-L | Shingles-LA | Zona-V | Shingles-L | Shingles-L | Shingles-L | Shingles-L |
| VAL371 | PCV-16F | VPC-16F | |||||
| DIS077 | Enterovirus | ||||||
| VAC1281 | |||||||
| VAC0529 | |||||||
| VAC0528 | |||||||
| VAC0613 | |||||||
| VAC0879 | |||||||
| VAC1063 | Hepatitis-C-Impfstoff, nicht näher bezeichnet | Hepatitis C vaccine, unspecified | Εμβόλιο ηπατίτιδας C, απροσδιόριστο | C hepatīta vakcīna, neprecizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu C, nieokreślona | Vacina contra hepatite C, não especificada | |
| DIS076 | Harnwegsinfektion | Urinary infection | Ουρολοίμωξη | Urīnceļu infekcija | Infekcja dróg moczowych | Infecção urinária | |
| VAC1196 | Japanese encephalitis vaccine, whole inactivated prepared from murine brain tissue, unspecified | ||||||
| VAL068 | HepB | HepB | HepB | HepB | HepB | HepB | HepB |
| VAC0964 | |||||||
| VAL153 | PRP-D | PRP-D | PRP-D | PRP-D | PRP-D | PRP-D | PRP-D |
| VAC0831 | Ebola vaccine, unspecified | Ebola vaccine, unspecified | Ebola vaccine, unspecified | Ebola vaccine, unspecified | Ebola vaccine, unspecified | Ebola vaccine, unspecified | |
| VAL286 | HepA-LAV | HepA-LA | HepA-VVA | HepA-LAV | HepA-LAV | HepA-LAV | HepA-LAV |
| VAC0083 | |||||||
| VAL283 | HepA-PED | HepA-PED | HepA-PED | HepA-PED | HepA-PED | HepA-PED | HepA-PED |
| VAL150 | Den | Den | Den | Den | Den | Den | Den |
| VAC1193 | Japanese encephalitis vaccine, live recombinant attenuated, unspecified | ||||||
| VAC0307 | |||||||
| VAC1060 | |||||||
| DIS075 | Rift-Valley-Fieber | Rift Valley fever | Πυρετός της κοιλάδας Rift | Rifta ielejas drudzis | Gorączka Doliny Rift | Febre do Vale do Rift | |
| VAC0525 | |||||||
| VAC0658 | |||||||
| VAC0743 | |||||||
| VAC0961 | |||||||
| VAL198 | PCV-14 | PCV-14 | VPC-14 | PCV-14 | PCV-14 | PCV-14 | PCV-14 |
| VAC0876 | |||||||
| VAC0610 | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | Tdap - Diphtheria-Tetanus-Pertussis vaccine, low dose, unspecified | |
| VAL065 | RC-TDV | RC-TDV | RC-TDV | RC-TDV | RC-TDV | RC-TDV | RC-TDV |
| VAC0080 | |||||||
| VAL284 | HepA-ADU | HepA-ADU | HepA-ADU | HepA-ADU | HepA-ADU | HepA-ADU | HepA-ADU |
| VAL151 | Tular | Tular | Tular | Tular | Tular | Tular | Tular |
| VAC1061 | |||||||
| VAC1194 | Tetanus, typhoid and paratypoid A and B vaccines, unspecified | ||||||
| VAC0308 | |||||||
| VAC0309 | |||||||
| VAC0659 | |||||||
| VAC0877 | |||||||
| DIS074 | Streptococcus pyogenes | Streptococcus pyogenes | Streptococcus pyogenes | Streptococcus pyogenes | Streptococcus pyogenes | Streptococcus pyogenes | |
| VAC0526 | |||||||
| VAC0611 | |||||||
| VAC0962 | |||||||
| VAL199 | PCV-15B | PCV-15B | VPC-15B | PCV-15B | PCV-15B | PCV-15B | PCV-15B |
| VAC0744 | |||||||
| VAL066 | COVID-VVr-S-Influ | COVID-VVr-S-Influ | Covid-VVr-S-Influ | COVID-VVr-S-Influ | COVID-VVr-S-Influ | COVID-VVr-S-Influ | COVID-VVr-S-Influ |
| VAC0086 | |||||||
| DIS073 | Melanom | Melanoma | Μελάνωμα | Melanoma | Czerniak | Melanoma | |
| VAC1066 | Melanom-Impfstoff, nicht näher bezeichnet | Melanoma vaccine, unspecified | Εμβόλιο μελανώματος, απροσδιόριστο | Melanomas vakcīna, neprecizēta | Szczepionka na czerniaka, nieokreślona | Vacina contra melanoma, não especificada | |
| VAL289 | COVID-mRNA-S-10 | COVID-mRNA-S-ORI-10 | Covid-ARNm-S-ORI-10 | COVID-mRNA-S-ORI-10 | COVID-mRNA-S-ORI-10 | COVID-mRNA-S-ORI-10 | COVID-mRNA-S-ORI-10 |
| VAC0701 | |||||||
| VAC1151 | Quadrivalent DTPeP vaccine - Diphtheria-Tetanus-Pertussis-Polio, unspecified | ||||||
| VAC0967 | |||||||
| VAC1284 | |||||||
| VAL156 | PRP-T | PRP-T | PRP-T | PRP-T | PRP-T | PRP-T | PRP-T |
| VAL023 | INF-SUid3 | Inf-SUid3 | |||||
| VAL241 | HVP-18 | HPV-18 | VPH-18 | HVP-18 | HVP-18 | HVP-18 | HVP-18 |
| VAC1199 | Recombinant vesicular stomatitis replicative viral vector Ebola vaccine (rVSV) - EBOV GP glycoprotein, unspecified | ||||||
| VAL374 | PCV-23B | VPC-23B | |||||
| VAC0171 | |||||||
| VAC0172 | |||||||
| VAC0087 | |||||||
| VAC0969 | |||||||
| VAC1370 | |||||||
| VAC1285 | |||||||
| VAC0968 | |||||||
| VAC0835 | |||||||
| VAL157 | COVID | COVID | Covid | COVID | COVID | COVID | COVID |
| VAC0702 | |||||||
| VAC1152 | Meningococcal B vaccine containing fHbp of subfamilies A and B, unspecified | ||||||
| VAL024 | Trivalente inaktivierte Influenza-Valenz, Spalt- oder Untereinheit, ohne Spezifikation | INF-SU3 | Inf-SU3 | Τρισθενής αδρανοποιημένη βαλεντία της γρίπης, κλασματοποιημένη ή υπομονάδα, χωρίς διευκρίνιση | Trivalenta inaktivēta gripas valence, frakcionēta vai apakšvienība, bez precizējuma | Trójwalentna inaktywowana wartość przeciwko grypie, dzielona lub podjednostkowa, bez określenia | Valência vacinal trivalente inativada da gripe, fracionada ou de subunidade, sem especificação |
| VAL375 | PCV-24F | VPC-24F | |||||
| VAC0920 | Diphtherie-Tetanus-Td-Impfstoff, nicht näher bezeichnet | Diphtheria-tetanus Td vaccine, unspecified | Εμβόλιο διφθερίτιδας-τετάνου Td, απροσδιόριστο | Difterijas-stingumkrampju Td vakcīna, neprecizēta | Szczepionka przeciw błonicy i tężcowi Td, nieokreślona | Vacina difteria-tétano Td, não especificada | |
| VAL242 | HVP-31 | HPV-31 | VPH-31 | HVP-31 | HVP-31 | HVP-31 | HVP-31 |
| DIS072 | HIV infektion | HIV infection | HIV λοίμωξη | HIV infekcija | Zakażenie wirusem HIV | Infecção pelo VIH | |
| VAC1067 | Impfstoff gegen Streptococcus pyogenes, nicht näher bezeichnet | Streptococcus pyogenes vaccine, unspecified | Εμβόλιο Streptococcus pyogenes, απροσδιόριστο | Streptococcus pyogenes vakcīna, neprecizēta | Szczepionka Streptococcus pyogenes, nieokreślona | Vacina contra Streptococcus pyogenes, não especificada | |
| VAC0390 | |||||||
| VAC0084 | H5N1 pre-pandemic influenza vaccine, unspecified | H5N1 pre-pandemic influenza vaccine, unspecified | H5N1 pre-pandemic influenza vaccine, unspecified | H5N1 pre-pandemic influenza vaccine, unspecified | H5N1 pre-pandemic influenza vaccine, unspecified | H5N1 pre-pandemic influenza vaccine, unspecified | |
| VAL372 | PCV-20A | VPC-20A | |||||
| VAC1282 | |||||||
| VAC1197 | COVID-19 vaccine with chimpanzee adenovirus and self-amplifying mRNA, unspecified | ||||||
| VAC0965 | |||||||
| VAC1064 | HIV-Impfstoff, nicht näher bezeichnet | HIV vaccine, unspecified | Εμβόλιο HIV, απροσδιόριστο | HIV vakcīna, neprecizēta | Szczepionka przeciwko wirusowi HIV, nieokreślona | Vacina contra HIV, não especificada | |
| VAL069 | COVID-VVnr-S-ChAdOx1 | COVID-VVnr-S-ChAdOx1 | Covid-VVnr-S-ChAdOx1 | COVID-VVnr-S-ChAdOx1 | COVID-VVnr-S-ChAdOx1 | COVID-VVnr-S-ChAdOx1 | COVID-VVnr-S-ChAdOx1 |
| VAC0614 | |||||||
| VAL287 | Quadrivalente rekombinante Influenza-Valenz | INF-R4 | Inf-R4 | Tετρασθενής ανασυνδυασμένη βαλεντία της γρίπης | Četrvalenta rekombinanta gripas valence | Czterowalentna rekombinowana wartość przeciwko grypie | Valência vacinal tetravalente recombinante contra a gripe |
| VAC0832 | Herpes Simplex vaccine, unspecified | Herpes Simplex vaccine, unspecified | Herpes Simplex vaccine, unspecified | Herpes Simplex vaccine, unspecified | Herpes Simplex vaccine, unspecified | Herpes Simplex vaccine, unspecified | |
| VAL154 | HbOC | HbOC | HbOC | HbOC | HbOC | HbOC | HbOC |
| DIS071 | Hepatitis C | Hepatitis C | Ηπατίτιδα Γ | C hepatīts | Wirusowe zapalenie wątroby typu C | Hepatite C | |
| VAL021 | O-Chol-I | CHOL-I-O | O-Chol-I | O-Chol-I | O-Chol-I | O-Chol-I | O-Chol-I |
| VAC0085 | |||||||
| VAL240 | HVP-16 | HPV-16 | VPH-16 | HVP-16 | HVP-16 | HVP-16 | HVP-16 |
| VAC1150 | COVID-19 mRNA vaccine encoding the spike protein of SARS-CoV-2, original virus, 30 micrograms, unspecified | ||||||
| VAC0966 | |||||||
| VAC0615 | |||||||
| VAC0833 | |||||||
| VAC1065 | Leprosy vaccine | Leprosy vaccine | Leprosy vaccine | Leprosy vaccine | Leprosy vaccine | Leprosy vaccine | |
| VAC1198 | Chinkungunya vaccine, live attenuated, unspecified | ||||||
| VAC1283 | |||||||
| VAL155 | PRP-OMP | PRP-OMP | PRP-OMP | PRP-OMP | PRP-OMP | PRP-OMP | PRP-OMP |
| VAL288 | HepA | HepA | HepA | HepA | HepA | HepA | HepA |
| DIS070 | Cytomegalovirus | Cytomegalovirus | κυτταρομεγαλοϊός | Citomegalovīruss | Wirus cytomegalii | Citomegalovírus | |
| VAL022 | Smallpox-L | POX-LA | POX-V | Smallpox-L | Smallpox-L | Smallpox-L | Smallpox-L |
| VAL373 | PCV-23A | VPC-23A | |||||
| VAC0170 | |||||||
| VAC0301 | |||||||
| DIS038 | Humane Papillomviren | Papillomavirus | Ιός θηλώματος | Cilvēka papilomas vīrusa infekcija | Wirus brodawczaka ludzkiego | Vírus do papiloma humano | |
| VAC0216 | |||||||
| VAC0349 | |||||||
| VAL027 | COVID-VVnr-S-Ad26 | COVID-VVnr-S-Ad26 | Covid-VVnr-S-Ad26 | COVID-VVnr-S-Ad26 | COVID-VVnr-S-Ad26 | COVID-VVnr-S-Ad26 | COVID-VVnr-S-Ad26 |
| VAL245 | HVP-52 | HPV-52 | VPH-52 | HVP-52 | HVP-52 | HVP-52 | HVP-52 |
| VAL378 | rHBsAg-15 | rAgHBs-15 | |||||
| VAL112 | Quadrivalente inaktivierte Influenza-Valenz aus Zellkultur, spalt- oder untereinheitlich, normale Dosis | INF-CC4 | Inf-CC4 | Τετρασθενής αδρανοποιημένη βαλεντία της γρίπης που προέρχεται από κυτταροκαλλιέργεια, κλασματοποιημένη ή υπομονάδα, κανονική δόση | Četrvalenta inaktivēta gripas valence, iegūta no šūnu kultūras, frakcionēta vai apakšvienība, normāla deva | Czterowalentna inaktywowana wartość przeciwko grypie uzyskana z hodowli komórkowej, dzielona lub podjednostkowa, normalna dawka | Valência vacinal tetravalente inativada da gripe obtida por cultura celular, fracionada ou de subunidade, dose normal |
| VAC0567 | |||||||
| VAC0434 | |||||||
| VAC0785 | |||||||
| VAL330 | COVID-mRNA-S-OMI-XBB.1.5-25 | Covid-ARNm-S-OMI-XBB.1.5-25 | COVID-mRNA-S-OMI-XBB.1.5-25 | ||||
| VAC0870 | |||||||
| VAC0652 | |||||||
| VAC1414 | COVID-19 vaccine, protein subunit, recombinant spike protein nanoparticles, with adjuvant (Matrix M), Omicron JN.1 subvariant | ||||||
| VAC1329 | |||||||
| VAC0217 | |||||||
| VAL028 | POX-3G | POX-3G | POX-3G | POX-3G | POX-3G | POX-3G | POX-3G |
| VAL379 | COVID-mRNA-S-OMI-JN.1-30 | Covid-ARNm-S-OMI-JN.1-30 | |||||
| VAL246 | HVP-45 | HPV-45 | VPH-45 | HVP-45 | HVP-45 | HVP-45 | HVP-45 |
| VAL113 | HPV-02-valent | HPV-02-valent | VPH-02-valent | HPV-02-valent | HPV-02-valent | HPV-02-valent | HPV-02-valent |
| VAC0568 | |||||||
| VAL331 | CMV-Ig | CMV-Ig | CMV-Ig | CMV-Ig | CMV-Ig | CMV-Ig | CMV-Ig |
| VAC0435 | |||||||
| VAC0653 | Hepatitis A + Hepatitis B vaccine Child, unspecified | Hepatitis A + Hepatitis B vaccine Child, unspecified | Hepatitis A + Hepatitis B vaccine Child, unspecified | Hepatitis A + Hepatitis B vaccine Child, unspecified | Hepatitis A + Hepatitis B vaccine Child, unspecified | Hepatitis A + Hepatitis B vaccine Child, unspecified | |
| VAC0786 | |||||||
| VAC0520 | |||||||
| VAC1415 | Polyvalent vaccine against pus bacterium Pseudomonas aeruginosa | ||||||
| VAC0871 | |||||||
| VAC0214 | |||||||
| VAC0347 | |||||||
| VAC0129 | |||||||
| DIS036 | Cholera | Cholera | Χολέρα | Holera | Cholera | Cólera | |
| VAL158 | pHBsAg | pHBsAg | pAgHBs | pHBsAg | pHBsAg | pHBsAg | pHBsAg |
| VAL025 | Mala | Mala | Palu | Mala | Mala | Mala | Mala |
| VAL243 | HPV-33 | HPV-33 | VPH-33 | HPV-33 | HPV-33 | HPV-33 | HPV-33 |
| VAL376 | PCV-31 | VPC-31 | |||||
| VAL110 | T-Ig | T-Ig | T-Ig | T-Ig | T-Ig | T-Ig | T-Ig |
| VAC0698 | |||||||
| VAC0783 | |||||||
| VAC0432 | |||||||
| VAC1327 | |||||||
| VAC1412 | COVID-19 mRNA vaccine, subvariant Omicron JN.1, 10 micrograms, paediatric dose (5-11 years) | ||||||
| VAC0650 | |||||||
| VAC1109 | ACW unconjugated meningococcal vaccine, unspecified | ||||||
| VAC0300 | |||||||
| VAC0348 | |||||||
| VAL159 | Shingles-SU | Shingles-SU | Zona-SU | Shingles-SU | Shingles-SU | Shingles-SU | Shingles-SU |
| VAL026 | MenB-OMP | MenB-OMP | MenB-OMP | MenB-OMP | MenB-OMP | MenB-OMP | MenB-OMP |
| VAL377 | PCV-35B | VPC-35B | |||||
| VAC0699 | |||||||
| VAL244 | HVP-58 | HPV-58 | VPH-58 | HVP-58 | HVP-58 | HVP-58 | HVP-58 |
| VAL111 | Bant | Bant | Bant | Bant | Bant | Bant | Bant |
| VAC0566 | |||||||
| VAC0433 | |||||||
| VAC0651 | |||||||
| VAC1413 | COVID-19 mRNA vaccine, subvariant Omicron JN.1, 3 micrograms, dose (6 months-4 years) | ||||||
| VAC0784 | |||||||
| VAC1328 | |||||||
| VAC0305 | |||||||
| DIS034 | Leptospirose | Leptospirosis | Λεπτοσπείρωση | Leptospiroze | Leptospirozy | Leptospirose | |
| VAC1191 | Vaccine for the prevention of urinary infections in women, unspecified | ||||||
| VAL116 | RSV-mAb-pal | RSV-mAb-pal | VRS-mAb-pal | RSV-mAb-pal | RSV-mAb-pal | RSV-mAb-pal | RSV-mAb-pal |
| VAC0438 | |||||||
| VAC0789 | |||||||
| VAL201 | PCV-19A | PCV-19A | VPC-19A | PCV-19A | PCV-19A | PCV-19A | PCV-19A |
| VAL334 | MEL | MEL | |||||
| VAC0874 | |||||||
| VAC0523 | |||||||
| VAC0656 | |||||||
| VAC0741 | |||||||
| VAL249 | JE | JE | EJ | JE | JE | JE | JE |
| VAC1418 | COVID-19 mRNA vaccine, subvariant Omicron KP.2, 30 micrograms, adult (+ 12 years) | ||||||
| DIS033 | Herpes Zoster | Shingles | ζώνη | Jostas roze | Półpasiec | Herpes zoster | |
| VAC0306 | |||||||
| VAC1192 | Pentavalent vaccine DTPePHibHepB - Diphtheria-Tetanus-Pertussis-Hib OC-HepatitisB 10µg, unspecified | ||||||
| VAL335 | SPYO | SPYO | |||||
| VAC0439 | |||||||
| VAL202 | PCV-19F | PCV-19F | VPC-19F | PCV-19F | PCV-19F | PCV-19F | PCV-19F |
| VAC0657 | |||||||
| DIS032 | Rotavirus | Rotavirus | Ροταϊός | Rotavīruss | Rotawirusy | Rotavírus | |
| VAC0524 | |||||||
| VAL420 | BOT-passive | BOT-passive | |||||
| VAC0875 | |||||||
| VAC0742 | |||||||
| VAC0960 | |||||||
| VAC1419 | Chikungunya VLP vaccine (recombinant, adsorbed) | ||||||
| VAL117 | Acel | Acel | Acel | Acel | Acel | Acel | Acel |
| VAC0303 | |||||||
| VAC0218 | |||||||
| VAL247 | JE-LAR | JE-LAR | EJ-VRA | JE-LAR | JE-LAR | JE-LAR | JE-LAR |
| VAL114 | rHBsAg-10 | rHBsAg-10 | rAgHBs-10 | rHBsAg-10 | rHBsAg-10 | rHBsAg-10 | rHBsAg-10 |
| DIS031 | Denguefieber | Dengue fever | Δάγκειος πυρετός | Tropu drudzis | Denga | Dengue | |
| VAC0569 | |||||||
| VAC0787 | Diphtheria-Tetanus-Rubella, unspecified | Diphtheria-Tetanus-Rubella, unspecified | Diphtheria-Tetanus-Rubella, unspecified | Diphtheria-Tetanus-Rubella, unspecified | Diphtheria-Tetanus-Rubella, unspecified | Diphtheria-Tetanus-Rubella, unspecified | |
| VAC0436 | |||||||
| VAL332 | Hepatitis-C-Valenz, ohne Spezifikation | HepC | HepC | Βαλεντία της ηπατίτιδας C, χωρίς διευκρίνιση | C hepatīta valence, bez precizējuma | Wartość przeciwko wirusowemu zapaleniu wątroby typu C, bez określenia | Valência vacinal da hepatite C, sem especificação |
| VAC0654 | Hepatitis A + Hepatitis B vaccine Adult, unspecified | Hepatitis A + Hepatitis B vaccine Adult, unspecified | Hepatitis A + Hepatitis B vaccine Adult, unspecified | Hepatitis A + Hepatitis B vaccine Adult, unspecified | Hepatitis A + Hepatitis B vaccine Adult, unspecified | Hepatitis A + Hepatitis B vaccine Adult, unspecified | |
| VAC0521 | |||||||
| VAC0872 | |||||||
| VAC1416 | COVID-19 mRNA vaccine, subvariant Omicron KP.2, 3 micrograms, paediatric dose (6 months-4 years) | ||||||
| VAL029 | Inf-VLP | INF-VLP | Inf-VLP | Inf-VLP | Inf-VLP | Inf-VLP | Inf-VLP |
| VAC1190 | COVID-19 vaccine with replicative viral vector, vesicular stomatitis virus encoding the SARS-CoV-2 spike protein, unspecified | ||||||
| VAC0304 | |||||||
| VAC0219 | |||||||
| DIS079 | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Pseudomonas aeruginosa | |
| VAL115 | Hepatitis-B-Impfstoff, rekombinantes Hepatitis-B-Virus-Oberflächenantigen (HBsAg), 20 Mikrogramm | rHBsAg-20 | rAgHBs-20 | Εμβόλιο ηπατίτιδας Β, ανασυνδυασμένο αντιγόνο επιφανείας του ιού της ηπατίτιδας Β (HBsAg), 20 μικρογραμμάρια | Hepatīta B vakcīna, rekombinants hepatīta B vīrusa virsmas antigēns (HBsAg), 20 mikrogrami | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu B, rekombinowany antygen powierzchniowy wirusa zapalenia wątroby typu B (HBsAg), 20 mikrogramów | Vacina contra a hepatite B, antigénio de superfície recombinante do vírus da hepatite B (HBsAg), 20 microgramas |
| VAL248 | JE-LAV | JE-LA | EJ-VVA | JE-LAV | JE-LAV | JE-LAV | JE-LAV |
| DIS030 | Tollwut | Rabies | Οργή | Trakumsērga | Wścieklizna | Raiva | |
| VAL333 | HIV | VIH | |||||
| VAC0437 | |||||||
| VAL200 | PCV-18C | PCV-18C | VPC-18C | PCV-18C | PCV-18C | PCV-18C | PCV-18C |
| VAC0655 | Diphtheria vaccine, unspecified | Diphtheria vaccine, unspecified | Diphtheria vaccine, unspecified | Diphtheria vaccine, unspecified | Diphtheria vaccine, unspecified | Diphtheria vaccine, unspecified | |
| VAC0788 | Hib-IPV, unspecified | Hib-IPV, unspecified | Hib-IPV, unspecified | Hib-IPV, unspecified | Hib-IPV, unspecified | Hib-IPV, unspecified | |
| VAC0873 | |||||||
| VAC0740 | |||||||
| VAC1417 | COVID-19 mRNA vaccine, subvariant Omicron KP.2, 10 micrograms, paediatric dose (5-11 years) | ||||||
| VAC0341 | |||||||
| VAC0123 | |||||||
| VAC0256 | |||||||
| VAC0038 | |||||||
| VAC0389 | |||||||
| VAC1103 | |||||||
| VAC1321 | |||||||
| VAC1369 | |||||||
| VAC1018 | |||||||
| VAC0474 | |||||||
| VAC1236 | COVID-19 protein subunit vaccine, recombinant spike protein in nanoparticles, Omicron subvariant XBB.1.5, unspecified | ||||||
| VAC0692 | |||||||
| VAL205 | PCV-33F | PCV-33F | VPC-33F | PCV-33F | PCV-33F | PCV-33F | PCV-33F |
| VAL338 | RSV | RSV | VRS | RSV | RSV | RSV | RSV |
| VAC0124 | |||||||
| VAC0257 | |||||||
| VAC0039 | |||||||
| VAC1322 | |||||||
| VAC1019 | |||||||
| VAC0475 | |||||||
| VAC0693 | |||||||
| VAC1104 | |||||||
| VAC1237 | Pre-erythrocytic malaria vaccine, unspecified | ||||||
| VAC0560 | |||||||
| VAL339 | Lyme | Lyme | |||||
| VAL206 | PPSV-01 | PPSV-01 | VPP-01 | PPSV-01 | PPSV-01 | PPSV-01 | PPSV-01 |
| VAC0254 | |||||||
| VAC0121 | |||||||
| VAC0036 | |||||||
| VAC0387 | |||||||
| VAC0169 | |||||||
| VAC0918 | PRP-D-Hib-Impfstoff, nicht spezifiziert | PRP-D Hib vaccine, unspecified | Εμβόλιο PRP-D Hib, απροσδιόριστο | PRP-D Hib vakcīna, neprecizēta | Szczepionka PRP-D Hib, nieokreślona | Vacina PRP-D Hib, não especificada | |
| VAL203 | PCV-22F | PCV-22F | VPC-22F | PCV-22F | PCV-22F | PCV-22F | PCV-22F |
| VAL336 | RVF | RVF | FVR | RVF | RVF | RVF | FVR |
| VAL421 | Junin | Junin | |||||
| VAC1234 | 15-valent unconjugated pneumococcal vaccine, unspecified | ||||||
| VAC1367 | |||||||
| VAC1101 | |||||||
| VAC1016 | |||||||
| VAC1149 | Oral live attenuated cholera vaccine, unspecified | ||||||
| VAC0472 | |||||||
| VAL118 | MenB | MenB | MenB | MenB | MenB | MenB | MenB |
| VAC0690 | |||||||
| VAC0255 | |||||||
| VAC0388 | |||||||
| VAC0919 | Hib-hbOC-Impfstoff, nicht spezifiziert | Hib hbOC vaccine, unspecified | Εμβόλιο Hib hbOC, απροσδιόριστο | Hib hbOC vakcīna, neprecizēta | Szczepionka Hib hbOC, nieokreślona | Vacina Hib hbOC, não especificada | |
| VAC0037 | |||||||
| VAL204 | PCV-23F | PCV-23F | VPC-23F | PCV-23F | PCV-23F | PCV-23F | PCV-23F |
| VAL422 | Yp | Yp | |||||
| VAC1102 | |||||||
| VAC1235 | RIX4414 monovalent rotavirus vaccine, unspecified | ||||||
| VAC1320 | |||||||
| VAC1368 | |||||||
| VAC1017 | |||||||
| VAC0473 | |||||||
| VAC0691 | |||||||
| VAL119 | MPV-mono | MPV-mono | MPV-mono | MPV-mono | MPV-mono | MPV-mono | MPV-mono |
| VAL337 | Pocken-Ig | POX-Ig | POX-Ig | Ευλογιά-Ig | Bakas-Ig | Ospa-Ig | Varíola-Ig |
| VAC0212 | |||||||
| VAC0345 | Hib PRP-T conjugated vaccine, unspecified | Hib PRP-T conjugated vaccine, unspecified | Hib PRP-T conjugated vaccine, unspecified | Hib PRP-T conjugated vaccine, unspecified | Hib PRP-T conjugated vaccine, unspecified | Hib PRP-T conjugated vaccine, unspecified | |
| VAC0127 | |||||||
| VAC0478 | |||||||
| VAC1410 | COVID-19 mRNA vaccine, Omicron JN.1 subvariant, 25 micrograms per dose, multidose vial | ||||||
| VAC0563 | |||||||
| VAC0696 | |||||||
| VAC1107 | Whole inactivated Cholera vaccine, unspecified | ||||||
| VAC0781 | |||||||
| VAC0430 | |||||||
| VAL209 | PPSV-04 | PPSV-04 | VPP-04 | PPSV-04 | PPSV-04 | PPSV-04 | PPSV-04 |
| VAC1325 | |||||||
| VAC0213 | |||||||
| VAC0346 | |||||||
| VAC0128 | |||||||
| VAC0479 | |||||||
| VAC0697 | |||||||
| VAC1411 | COVID-19 mRNA vaccine, subvariant Omicron JN.1, 30 micrograms, adult dose (+ 12 years) | ||||||
| VAC1326 | |||||||
| VAC0431 | |||||||
| VAC0782 | |||||||
| VAC1108 | COVID-19 bivalent mRNA vaccine, original virus + Omicron BA.1 variant, unspecified | ||||||
| VAC0210 | |||||||
| VAC0343 | |||||||
| VAC0258 | |||||||
| VAC0125 | |||||||
| VAC1323 | |||||||
| VAC0476 | |||||||
| VAC1238 | Vaccine against hepatitis B and malaria, unspecified | ||||||
| VAC0694 | |||||||
| VAC0561 | |||||||
| VAC1105 | |||||||
| VAL207 | PPSV-02 | PPSV-02 | VPP-02 | PPSV-02 | PPSV-02 | PPSV-02 | PPSV-02 |
| VAC0211 | |||||||
| VAC0344 | PRP-OMP Hib vaccine, unspecified | PRP-OMP Hib vaccine, unspecified | PRP-OMP Hib vaccine, unspecified | PRP-OMP Hib vaccine, unspecified | PRP-OMP Hib vaccine, unspecified | PRP-OMP Hib vaccine, unspecified | |
| VAC0126 | |||||||
| VAC0259 | |||||||
| VAC0477 | |||||||
| VAC0695 | |||||||
| VAC1106 | COVID-19 VLP vaccine, unspecified | ||||||
| VAC1239 | Konjugierter Pneumokokken-Impfstoff, 15-valent, nicht näher bezeichnet | 15-valent Pneumococcus conjugate vaccine, unspecified | Πνευμονιοκοκκικό 15-δύναμο συζευγμένο εμβόλιο, απροσδιόριστο | Pneimokoku 15-valenta konjugētā vakcīna, neprecizēta | 15-walentna skoniugowana szczepionka przeciw pneumokokom, nieokreślona | Vacina pneumocócica conjugada 15-valente, não especificada | |
| VAC0562 | |||||||
| VAC1324 | |||||||
| VAL208 | PPSV-03 | PPSV-03 | VPP-03 | PPSV-03 | PPSV-03 | PPSV-03 | PPSV-03 |
| VAC0780 | |||||||
| VAC0030 | |||||||
| VAC0163 | Whole-cell inactivated pertussis vaccine, unspecified | Whole-cell inactivated pertussis vaccine, unspecified | Whole-cell inactivated pertussis vaccine, unspecified | Whole-cell inactivated pertussis vaccine, unspecified | Whole-cell inactivated pertussis vaccine, unspecified | Whole-cell inactivated pertussis vaccine, unspecified | |
| VAC0296 | |||||||
| VAC0078 | |||||||
| VAL071 | Ty-I | Ty-I | Ty-I | Ty-I | Ty-I | Ty-I | Ty-I |
| VAC0827 | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | MMRV - Measles-Mumps-Rubella-Varicella vaccine, unspecified | |
| VAC0911 | Hepatitis-A-Totimpfstoff, monovalent, pädiatrische Dosis, nicht spezifiziert | Hepatitis A whole inactivated vaccine, monovalent, pediatric dose, unspecified | Ολόκληρο αδρανοποιημένο εμβόλιο ηπατίτιδας Α, μονοσθενές, παιδιατρική δόση, απροσδιόριστο | A hepatīta vesela inaktivēta vakcīna, monovalenta, pediatriskā deva, neprecizēta | Wirusowe zapalenie wątroby Szczepionka cała inaktywowana, jednoważna, dawka pediatryczna, nieokreślona | Vacina totalmente inativada contra hepatite A, monovalente, dose pediátrica, não especificada | |
| VAC1361 | |||||||
| VAC1010 | |||||||
| VAC1143 | COVID-19 vaccine with non-replicating viral vector, adenovirus encoding the spike protein of SARS-CoV-2, unspecified | ||||||
| VAC1058 | |||||||
| VAC1276 | |||||||
| VAC0382 | Tetanus diphtheria vaccine, unspecified | Tetanus diphtheria vaccine, unspecified | Tetanus diphtheria vaccine, unspecified | Tetanus diphtheria vaccine, unspecified | Tetanus diphtheria vaccine, unspecified | Tetanus diphtheria vaccine, unspecified | |
| VAC0031 | |||||||
| VAC0164 | |||||||
| VAC0297 | |||||||
| VAC0079 | |||||||
| VAL072 | MenB-fHbpAB | MenB-fHbpAB | MenB-fHbpAB | MenB-fHbpAB | MenB-fHbpAB | MenB-fHbpAB | MenB-fHbpAB |
| VAL290 | COVID-mRNA-S-30 | COVID-mRNA-S-ORI-30 | Covid-ARNm-S-ORI-30 | COVID-mRNA-S-ORI-30 | COVID-mRNA-S-ORI-30 | COVID-mRNA-S-ORI-30 | COVID-mRNA-S-ORI-30 |
| VAC0828 | Rotavirus pentavalent vaccine, unspecified | Rotavirus pentavalent vaccine, unspecified | Rotavirus pentavalent vaccine, unspecified | Rotavirus pentavalent vaccine, unspecified | Rotavirus pentavalent vaccine, unspecified | Rotavirus pentavalent vaccine, unspecified | |
| VAC1011 | |||||||
| VAC0912 | Hepatitis-A-Impfstoff, pädiatrische Dosis, nicht spezifiziert | Hepatitis A vaccine, pediatric dose, unspecified | Εμβόλιο ηπατίτιδας Α, παιδιατρική δόση, απροσδιόριστη | Vakcīna pret A hepatītu, pediatriskā deva, neprecizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu A, dawka pediatryczna, nieokreślona | Vacina contra hepatite A, dose pediátrica, não especificada | |
| VAC1362 | |||||||
| VAC1059 | |||||||
| DIS080 | Meningokokken X | Meningococcal X | Μηνιγγιτιδόκοκκος X | Meningokoks X | Meningokok X | Meningococo X | |
| VAC1144 | COVID-19 protein subunit vaccine, recombinant SARS-CoV-2 spike protein, S-2P and CpG1018, unspecified | ||||||
| VAC1277 | Impfstoff gegen Chikungunya, ohne nähere Angaben | Vaccine against chikungunya, unspecified | Εμβόλιο κατά του chikungunya, απροσδιόριστο | Vakcīna pret čikungunju, neprecizēta | Szczepionka przeciwko chikungunya, nieokreślona | ||
| VAC0161 | |||||||
| VAC0294 | |||||||
| VAC0076 | |||||||
| VAC0958 | |||||||
| VAC1274 | |||||||
| VAC0957 | |||||||
| VAC0824 | Hepatitis A virosome vaccine, unspecified | Hepatitis A virosome vaccine, unspecified | Hepatitis A virosome vaccine, unspecified | Hepatitis A virosome vaccine, unspecified | Hepatitis A virosome vaccine, unspecified | Hepatitis A virosome vaccine, unspecified | |
| VAC1141 | Bird Flu H5N8 Vaccine, unspecified | ||||||
| VAC1056 | |||||||
| VAC1189 | Non-replicating vector COVID-19 vaccine, modified Ankara vaccine encoding the SARS-CoV-2 spike protein, unspecified | ||||||
| VAC0162 | Brucellosis vaccine, unspecified | Brucellosis vaccine, unspecified | Brucellosis vaccine, unspecified | Brucellosis vaccine, unspecified | Brucellosis vaccine, unspecified | Brucellosis vaccine, unspecified | |
| VAC0295 | |||||||
| VAC0077 | |||||||
| VAC0959 | |||||||
| VAL070 | COVID-VVnr-S-Ad | COVID-VVnr-S-Ad | Covid-VVnr-S-Ad | COVID-VVnr-S-Ad | COVID-VVnr-S-Ad | COVID-VVnr-S-Ad | COVID-VVnr-S-Ad |
| VAC0826 | |||||||
| VAC1142 | COVID-19 vaccine, non-replicating vector, antigen-presenting cells, unspecified | ||||||
| VAC0910 | Inaktivierter Hepatitis-A-Impfstoff, Erwachsenendosis, nicht spezifiziert | Inactivated hepatitis A vaccine, adult dose, unspecified | Αδρανοποιημένο εμβόλιο ηπατίτιδας Α, δόση για ενήλικες, μη καθορισμένη | Inaktivēta A hepatīta vakcīna, pieaugušo deva, neprecizēta | Inaktywowana szczepionka przeciwko wirusowemu zapaleniu wątroby typu A, dawka dla dorosłych, nieokreślona | Vacina inativada contra hepatite A, dose para adultos, não especificada | |
| VAC1275 | |||||||
| VAC1360 | |||||||
| VAC0825 | Combined hepatitis A and hepatitis B vaccine, unspecified | Combined hepatitis A and hepatitis B vaccine, unspecified | Combined hepatitis A and hepatitis B vaccine, unspecified | Combined hepatitis A and hepatitis B vaccine, unspecified | Combined hepatitis A and hepatitis B vaccine, unspecified | Combined hepatitis A and hepatitis B vaccine, unspecified | |
| VAC1057 | |||||||
| VAC0380 | T.Polio, unspecified | T.Polio, unspecified | T.Polio, unspecified | T.Polio, unspecified | T.Polio, unspecified | T.Polio, unspecified | |
| VAC0252 | |||||||
| VAC0385 | |||||||
| VAC0034 | |||||||
| VAL075 | Lepto-wI | Lepto-wI | Lepto-eI | Lepto-wI | Lepto-wI | Lepto-wI | Lepto-wI |
| VAL293 | Anthrax-Ig | Anthrax-Ig | Charbon-Ig | Anthrax-Ig | Anthrax-Ig | Anthrax-Ig | Anthrax-Ig |
| VAL160 | Shingles | Shingles | Zona | Shingles | Shingles | Shingles | Shingles |
| VAC0916 | Hepatitis-B-Impfstoff, monovalent, Dosierung für Dialysepatienten, nicht spezifiziert | Hepatitis B vaccine, monovalent, dialysis patient dosage, unspecified | Εμβόλιο ηπατίτιδας Β, μονοσθενές, δοσολογία ασθενούς σε αιμοκάθαρση, απροσδιόριστη | B hepatīta vakcīna, monovalenta, dialīzes pacienta deva, neprecizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu B, monowalentna, dawka dla pacjentów dializowanych, nieokreślona | Vacina contra hepatite B, monovalente, dosagem para pacientes em diálise, não especificada | |
| VAC1365 | |||||||
| VAC1014 | |||||||
| VAC1147 | Human monoclonal antibody against respiratory syncytial virus (RSV), nirsevimab, unspecified | ||||||
| VAC1232 | Acellular pertussis vaccine, reduced dose, unspecified | ||||||
| VAC0470 | |||||||
| VAC0120 | |||||||
| VAC0253 | |||||||
| VAC0386 | |||||||
| VAC0168 | |||||||
| VAC0035 | |||||||
| VAL294 | Pox-1G | POX-1G | POX-1G | Pox-1G | Pox-1G | Pox-1G | Pox-1G |
| VAL161 | MenB-mc | MenB-mc | MenB-mc | MenB-mc | MenB-mc | MenB-mc | MenB-mc |
| VAC0917 | Hepatitis-E-Impfstoff, nicht näher bezeichnet | Hepatitis E vaccine, unspecified | Εμβόλιο ηπατίτιδας Ε, απροσδιόριστο | Vakcīna pret E hepatītu, neprecizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu E, nieokreślona | Vacina contra hepatite E, não especificada | |
| VAC1015 | |||||||
| VAC1100 | |||||||
| VAL076 | COVID-19-Impfstoff, inaktiviertes Vollvirus, nicht spezifiziert | COVID-IV | Covid-VI | Εμβόλιο COVID-19, αδρανοποιημένο με ολόκληρο τον ιό, απροσδιόριστο | COVID-19 vakcīna, inaktivēta ar veselu vīrionu, neprecizēta | Szczepionka COVID-19, inaktywowana całymi wirusami, nieokreślona | Vacina COVID-19, virião inteiro inactivado, não especificada |
| VAC1233 | 10-valenter konjugierter Pneumokokken-Impfstoff, nicht näher bezeichnet | 10-valent Pneumococcus conjugate vaccine, unspecified | Πνευμονιοκοκκικό 10-δύναμο συζευγμένο εμβόλιο, απροσδιόριστο | Pneimokoku 10-valentā konjugētā vakcīna, neprecizēta | 10-walentna skoniugowana szczepionka przeciw pneumokokom, nieokreślona | Vacina pneumocócica conjugada 10-valente, não especificada | |
| VAC1366 | |||||||
| VAC1148 | Haemophilus influenzae type b vaccine, unconjugated polysaccharide, unspecified | ||||||
| VAC0471 | |||||||
| VAC0383 | |||||||
| VAC0032 | |||||||
| VAC0165 | |||||||
| VAC0298 | |||||||
| VAL073 | COVID-VVr+APC | COVID-VVr+APC | Covid-VVr+APC | COVID-VVr+APC | COVID-VVr+APC | COVID-VVr+APC | COVID-VVr+APC |
| VAL291 | HepB-r-3Ag | HBs-r-3Ag | HBs-r-3Ag | HepB-r-3Ag | HepB-r-3Ag | HepB-r-3Ag | HepB-r-3Ag |
| VAC0914 | Hepatitis-B-Impfstoff, monovalent, pädiatrische Dosis, nicht spezifiziert | Hepatitis B vaccine, monovalent, pediatric dose, unspecified | Εμβόλιο ηπατίτιδας Β, μονοσθενές, παιδιατρική δόση, απροσδιόριστο | B hepatīta vakcīna, monovalenta, pediatriskā deva, neprecizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu B, monowalentna, dawka pediatryczna, nieokreślona | Vacina contra hepatite B, monovalente, dose pediátrica, não especificada | |
| VAC0829 | Rubella-Mumps vaccine, unspecified | Rubella-Mumps vaccine, unspecified | Rubella-Mumps vaccine, unspecified | Rubella-Mumps vaccine, unspecified | Rubella-Mumps vaccine, unspecified | Rubella-Mumps vaccine, unspecified | |
| VAC1230 | Meningococcal C and anti-Haemophilus influenzae type b vaccine, conjugated with tetanus toxoid, unspecified | ||||||
| VAC0913 | |||||||
| VAC1363 | |||||||
| VAC1278 | |||||||
| VAC1012 | |||||||
| VAC1145 | Recombinant hepatitis B vaccine, three antigens, unspecified | ||||||
| VAC0251 | |||||||
| VAC0384 | |||||||
| VAC0166 | |||||||
| VAC0033 | |||||||
| VAC0299 | |||||||
| VAL074 | Vierwertiger inaktivierter Influenza-Impfstoff, Split oder Subunit, hochdosiert | INF-SUhd4 | Inf-SUhd4 | Τετραδύναμο αδρανοποιημένο εμβόλιο γρίπης, διαιρεμένο ή υπομονάδα, υψηλής δόσης | Četrivalenta inaktivēta gripas vakcīna, sadalīta vai subvienota, lielas devas | Inaktywowana czterowalentna szczepionka przeciwko grypie, podzielona lub podjednostkowa, wysokodawkowa | Vacina quadrivalente contra a gripe inactivada, fenda ou subunidade, dose alta |
| VAL292 | Covid-VVnr-S-Ad26-CT | COVID-VVnr-S-Ad26-CT | Covid-VVnr-S-Ad26-CT | Covid-VVnr-S-Ad26-CT | Covid-VVnr-S-Ad26-CT | Covid-VVnr-S-Ad26-CT | Covid-VVnr-S-Ad26-CT |
| VAC0915 | Hepatitis-B-Impfstoff, monovalent, Dosierung für Erwachsene, nicht spezifiziert | Hepatitis B vaccine, monovalent, adult dose, unspecified | Εμβόλιο ηπατίτιδας Β, μονοσθενές, δόση για ενήλικες, απροσδιόριστο | B hepatīta vakcīna, monovalenta, pieaugušo deva, nav precizēta | Szczepionka przeciwko wirusowemu zapaleniu wątroby typu B, monowalentna, dawka dla dorosłych, nieokreślona | Vacina contra hepatite B, monovalente, dosagem para adultos, não especificada | |
| VAC1231 | Pentavalent vaccine DTPaHibHepB- Diphtheria-Tetanus-Pertussis-Hib PRP-Hepatitis B 10μg, unspecified | ||||||
| VAC1146 | Inactivated quadrivalent influenza vaccine, high dose, unspecified | ||||||
| VAC1279 | Adjuvanted adsorbed anthrax vaccine | ||||||
| VAC1364 | |||||||
| VAC1013 | |||||||
| VAL031 | TBE | TBE | TBE | TBE | TBE | TBE | TBE |
| VAL382 | COVID-PS-rSnp-JN.1 | Covid-SP-rSnp-JN.1 | |||||
| VAC1292 | |||||||
| VAC0539 | |||||||
| DIS041 | Brucellose | Brucellosis | Βρουκέλλωση | Bruceloze | Bruceloza | Brucelose | |
| DIS003 | Keuchhusten | Pertussis | Κοκκίτης | Gara klepus | Krztusiec | Tosse convulsa | |
| VAC0624 | |||||||
| VAC0757 | |||||||
| VAC1074 | |||||||
| VAL079 | Rub-LAV | Rub-LA | Rub-VVA | Rub-LAV | Rub-LAV | Rub-LAV | Rub-LAV |
| VAC0975 | |||||||
| VAL164 | COVID-non-live | COVID-non-live | Covid-non-vivant | COVID-non-live | COVID-non-live | COVID-non-live | COVID-non-live |
| VAC0842 | |||||||
| VAL297 | MenA | MenA | MenA | MenA | MenA | MenA | MenA |
| VAC0094 | |||||||
| VAC0095 | |||||||
| VAL250 | JE-I-mb | JE-I-mb | EJ-I-cm | JE-I-mb | JE-I-mb | JE-I-mb | JE-I-mb |
| VAL383 | mRSV | mRSV | mVRS | mRSV | mRSV | mRSV | mRSV |
| VAC1160 | 2nd generation live smallpox vaccine, unspecified | ||||||
| VAC1293 | |||||||
| VAC0408 | |||||||
| DIS040 | Malaria | Malaria | Ελονοσία | Malārija | Malaria | Malária | |
| VAC0407 | |||||||
| VAC0758 | |||||||
| DIS004 | Poliomyelitis | Poliomyelitis | Πολιομυελίτις | Poliomielīts | Polio / Choroba Heinego-Medina | Poliomielite | |
| VAC0976 | |||||||
| VAC1075 | Azellulärer Anthrax-Impfstoff, nicht näher bezeichnet | Acellular anthrax vaccine, unspecified | Ακυτταρικό εμβόλιο άνθρακα, απροσδιόριστο | Acelulārā Sibīrijas mēra vakcīna, neprecizēta | Bezkomórkowa szczepionka przeciwko wąglikowi, nieokreślona | Vacina acelular contra antraz, não especificada | |
| VAC0625 | |||||||
| VAC0710 | |||||||
| VAL298 | MenC | MenC | MenC | MenC | MenC | MenC | MenC |
| VAL165 | COVID-live | COVID-live | Covid-vivant | COVID-live | COVID-live | COVID-live | COVID-live |
| VAC0843 | |||||||
| VAL032 | Ty-ViPS | Ty-ViPS | Ty-ViPS | Ty-ViPS | Ty-ViPS | Ty-ViPS | Ty-ViPS |
| VAC0180 | |||||||
| VAL162 | COVID-VVr | COVID-VVr | Covid-VVr | COVID-VVr | COVID-VVr | COVID-VVr | COVID-VVr |
| VAL295 | Pox-2G | POX-2G | POX-2G | Pox-2G | Pox-2G | Pox-2G | Pox-2G |
| VAL380 | COVID-mRNA-S-OMI-JN.1-10 | Covid-ARNm-S-OMI-JN.1-10 | |||||
| VAC1072 | COVID-19-mRNA-Impfstoff, Originalvirus, 25 µg, nicht spezifiziert | COVID-19 mRNA vaccine, original virus, 25 µg, unspecified | Εμβόλιο mRNA COVID-19, αρχικός ιός, 25 μg, απροσδιόριστο | Covid-19 mRNS vakcīna, oriģināls vīruss, 25 µg, neprecizēts | Szczepionka mRNA przeciwko COVID-19, wirus oryginalny, 25 µg, nieokreślony | Vacina de mRNA contra COVID-19, vírus original, 25 µg, não especificado | |
| VAC1290 | |||||||
| VAC0319 | |||||||
| DIS005 | Haemophilus influenzae b-Infektion | Haemophilus influenzae b | Haemophilus influenzae β | Pfeifera nūjiņa | Haemophilus influenzae typu b | Haemophilus influenzae b | |
| VAC0888 | |||||||
| VAC0404 | |||||||
| VAC0622 | |||||||
| VAC0973 | |||||||
| VAC0755 | |||||||
| VAC0840 | |||||||
| VAL077 | Mumps-LAV | MUMPS-LA | Or-VVA | Mumps-LAV | Mumps-LAV | Mumps-LAV | Mumps-LAV |
| VAC0092 | |||||||
| VAL163 | COVID-VVnr | COVID-VVnr | Covid-VVnr | COVID-VVnr | COVID-VVnr | COVID-VVnr | COVID-VVnr |
| VAL030 | Lyme-OspA | Lyme-OspA | Lyme-OspA | Lyme-OspA | Lyme-OspA | Lyme-OspA | Lyme-OspA |
| VAL381 | COVID-mRNA-S-OMI-JN.1-3 | Covid-ARNm-S-OMI-JN.1-3 | |||||
| VAC1073 | Impfstoff gegen Lyme-Borreliose, nicht näher bezeichnet | Lyme disease vaccine, unspecified | Εμβόλιο για τη νόσο του Lyme, απροσδιόριστο | Vakcīna pret Laima slimību, neprecizēta | Szczepionka na boreliozę, nieokreślona | Vacina contra a doença de Lyme, não especificada | |
| VAC1291 | |||||||
| VAC0889 | |||||||
| VAC0538 | |||||||
| VAC0405 | |||||||
| VAC0756 | |||||||
| VAC0841 | |||||||
| VAL078 | MCV-Y | MCV-Y | MCV-Y | MCV-Y | MCV-Y | MCV-Y | MCV-Y |
| VAC0623 | Measles-mumps vaccine, unspecified | Measles-mumps vaccine, unspecified | Measles-mumps vaccine, unspecified | Measles-mumps vaccine, unspecified | Measles-mumps vaccine, unspecified | Measles-mumps vaccine, unspecified | |
| VAL296 | Pox-3G-MVA | POX-3G-MVA | POX-3G-MVA | Pox-3G-MVA | Pox-3G-MVA | Pox-3G-MVA | Pox-3G-MVA |
| VAC0974 | |||||||
| DIS006 | Hepatitis B | Hepatitis B | Ηπατίτιδα Β | B hepatīts | Wirusowe Zapalenie Wątroby typu B | Hepatite B | |
| VAC0093 | |||||||
| VAC0183 | |||||||
| VAC0098 | |||||||
| VAC1381 | |||||||
| VAC1296 | |||||||
| VAC0979 | |||||||
| VAC0713 | Typhoid polysaccharide vaccine, unspecified | Typhoid polysaccharide vaccine, unspecified | Typhoid polysaccharide vaccine, unspecified | Typhoid polysaccharide vaccine, unspecified | Typhoid polysaccharide vaccine, unspecified | Typhoid polysaccharide vaccine, unspecified | |
| VAL168 | COVID-RNA | COVID-mRNA | Covid-ARN | COVID-RNA | COVID-RNA | COVID-RNA | COVID-RNA |
| VAC0846 | |||||||
| VAC1030 | |||||||
| VAC1163 | 20-valenter konjugierter Pneumokokken-Impfstoff, nicht näher bezeichnet | 20-valent Pneumococcus conjugate vaccine, unspecified | 20-δύναμο πνευμονιοκοκκικό συζευγμένο εμβόλιο, απροσδιόριστο | 20-valenta pneimokoku konjugētā vakcīna, neprecizēta | 20-walentna skoniugowana szczepionka przeciw pneumokokom, nieokreślona | Vacina pneumocócica conjugada 20-valente, não especificada | |
| VAL035 | COVID-DNA-S | COVID-DNA-S | Covid-ADN-S | COVID-DNA-S | COVID-DNA-S | COVID-DNA-S | COVID-DNA-S |
| VAL386 | AH5 | AH5 | AH5 | AH5 | AH5 | AH5 | AH5 |
| VAC0931 | |||||||
| VAL253 | eRIG | eRIG | eRIG | eRIG | eRIG | eRIG | eRIG |
| VAL120 | MPV-poly | MPV-poly | MPV-poly | MPV-poly | MPV-poly | MPV-poly | MPV-poly |
| VAC1078 | |||||||
| VAC0050 | |||||||
| VAC0051 | |||||||
| VAC0184 | |||||||
| VAC0099 | |||||||
| VAC0848 | |||||||
| VAC0714 | |||||||
| VAC1164 | Quadrivalent DTPaHib- Diphtheria-Tetanus-Pertussis-Hib PRP vaccine, unspecified | ||||||
| VAC0932 | Quadrivalenter rekombinanter Influenza-Impfstoff, nicht spezifiziert | Quadrivalent recombinant influenza vaccine, unspecified | Τετραδύναμο ανασυνδυασμένο εμβόλιο γρίπης, απροσδιόριστο | Kvadrivalentā rekombinantā gripas vakcīna, neprecizēta | Czterowalentna rekombinowana szczepionka przeciw grypie, nieokreślona | Vacina quadrivalente recombinante contra influenza, não especificada | |
| VAC1297 | |||||||
| VAC1382 | |||||||
| VAC0847 | |||||||
| VAL169 | COVID-mRNA-SAM | COVID-mRNA-SAM | Covid-ARNm-AAA | COVID-mRNA-SAM | COVID-mRNA-SAM | COVID-mRNA-SAM | COVID-mRNA-SAM |
| VAC1031 | |||||||
| VAL036 | HPV-09-valent | HPV-09-valent | VPH-09-valent | HPV-09-valent | HPV-09-valent | HPV-09-valent | HPV-09-valent |
| VAL254 | Rab-I-Semple | Rab-I-Semple | Rab-I-Semple | Rab-I-Semple | Rab-I-Semple | Rab-I-Semple | Rab-I-Semple |
| VAL387 | COVID-mRNA-S-OMI-JN.1-25 | Covid-ARNm-S-OMI-JN.1-25 | Covid-ARNm-S-OMI-JN.1-25 | ||||
| VAL121 | POLIO-I-O | IPV-O | VPI-0 | POLIO-I-O | POLIO-I-O | POLIO-I-O | POLIO-I-O |
| VAC1079 | |||||||
| VAC0096 | |||||||
| VAL251 | JE-I-Vero | JE-I-Vero | EJ-I-Vero | JE-I-Vero | JE-I-Vero | JE-I-Vero | JE-I-Vero |
| DIS001 | Diphtherie | Diphtheria | Διφθερίτιδα | Difterija | Błonica | Difteria | |
| VAC1161 | Quadrivalent DTPeP vaccine - Diphtheria-Tetanus-Pertussis-Hib PRP, unspecified | ||||||
| VAC0409 | |||||||
| VAC0977 | |||||||
| VAC0626 | |||||||
| VAC0759 | |||||||
| VAC0844 | |||||||
| VAC1076 | |||||||
| VAC1294 | |||||||
| VAL166 | INF-SUped3 | Inf-SUped3 | |||||
| VAC0711 | Typhoid conjugate vaccine, unspecified | Typhoid conjugate vaccine, unspecified | Typhoid conjugate vaccine, unspecified | Typhoid conjugate vaccine, unspecified | Typhoid conjugate vaccine, unspecified | Typhoid conjugate vaccine, unspecified | |
| VAL299 | MenY | MenY | MenY | MenY | MenY | MenY | MenY |
| VAL033 | mOPV2 | mOPV2 | mVPO2 | mOPV2 | mOPV2 | mOPV2 | mOPV2 |
| VAL384 | LEP | LEP | Lep | LEP | LEP | LEP | LEP |
| VAC0097 | |||||||
| VAC0628 | |||||||
| VAC1380 | |||||||
| VAC0845 | |||||||
| VAC1077 | |||||||
| VAC0627 | |||||||
| VAC0712 | Typhoid-hepatitis A vaccine, unspecified | Typhoid-hepatitis A vaccine, unspecified | Typhoid-hepatitis A vaccine, unspecified | Typhoid-hepatitis A vaccine, unspecified | Typhoid-hepatitis A vaccine, unspecified | Typhoid-hepatitis A vaccine, unspecified | |
| VAC1162 | COVID-19 mRNA vaccine, bivalent, original virus and Omicron BA.1 variant, 15 micrograms, unspecified | ||||||
| DIS002 | Tetanus | Tetanus | Τέτανος | Stingumkrampji | Tężec | Tétano | |
| VAC0978 | |||||||
| VAC1295 | |||||||
| VAL167 | COVID-VVnr+APC | COVID-VVnr+APC | Covid-VVnr+APC | COVID-VVnr+APC | COVID-VVnr+APC | COVID-VVnr+APC | COVID-VVnr+APC |
| VAL034 | d | d | d | d | d | d | d |
| VAL252 | RIG-hu | RIG-hu | hRIG | RIG-hu | RIG-hu | RIG-hu | RIG-hu |
| VAC0930 | |||||||
| VAL385 | AH5N8 | AH5N8 | |||||
| VAC0182 | |||||||
| VAC0313 | |||||||
| VAC0228 | |||||||
| VAL039 | COVID-VLP-rS | COVID-VLP-rS | Covid-VLP-rS | COVID-VLP-rS | COVID-VLP-rS | COVID-VLP-rS | COVID-VLP-rS |
| VAL124 | Chol-L | CHOL-LA | Chol-V | Chol-L | Chol-L | Chol-L | Chol-L |
| VAL257 | Rab-I-CC | Rab-I-CC | Rab-I-CC | Rab-I-CC | Rab-I-CC | Rab-I-CC | Rab-I-CC |
| VAC0579 | |||||||
| VAL342 | Kpn | Kpn | Kpn | Kpn | Kpn | Kpn | Kpn |
| VAC0446 | |||||||
| VAC0664 | |||||||
| VAC0797 | Diph-T-aP/ap, unspecified | Diph-T-aP/ap, unspecified | Diph-T-aP/ap, unspecified | Diph-T-aP/ap, unspecified | Diph-T-aP/ap, unspecified | Diph-T-aP/ap, unspecified | |
| VAC0531 | |||||||
| VAC1426 | Bivalent recombinant vaccine against human papillomavirus (types 16 and 18) (Pichia pastoris) | ||||||
| VAC0882 | |||||||
| VAC1208 | Quadrivalent DTPeHepB vaccine - Diphtheria-Tetanus-Pertussis-HepatitisB 10µg, unspecified | ||||||
| VAC0229 | |||||||
| VAL258 | Rab-I-HDCV | Rab-I-HDCV | Rab-I-HDCV | Rab-I-HDCV | Rab-I-HDCV | Rab-I-HDCV | Rab-I-HDCV |
| VAL125 | HepA-I | HepA-I | HepA-I | HepA-I | HepA-I | HepA-I | HepA-I |
| VAC0447 | |||||||
| VAC0798 | Hib-MeningoC vaccine, unspecified | Hib-MeningoC vaccine, unspecified | Hib-MeningoC vaccine, unspecified | Hib-MeningoC vaccine, unspecified | Hib-MeningoC vaccine, unspecified | Hib-MeningoC vaccine, unspecified | |
| VAL210 | PPSV-05 | PPSV-05 | VPP-05 | PPSV-05 | PPSV-05 | PPSV-05 | PPSV-05 |
| VAL343 | Efa | Efa | Efa | Efa | Efa | Efa | Efa |
| VAC0532 | |||||||
| VAC0665 | |||||||
| VAC0883 | |||||||
| VAC1209 | Measles vaccine, whole inactivated, unspecified | ||||||
| VAC1427 | Whole inactivated Japanese encephalitis vaccine, prepared in Vero cells, 6 micrograms | ||||||
| VAC0311 | |||||||
| DIS048 | Meningokokken | Méningocoque | Μηνιγγιτιδόκοκκος | Meningokoku | Meningokok | Meningococo | |
| VAC0226 | |||||||
| VAC0359 | |||||||
| VAC0008 | |||||||
| VAL037 | MPV-A | MPV-A | MPV-A | MPV-A | MPV-A | MPV-A | MPV-A |
| VAL388 | COVID-mRNA-S-OMI-JN.1-50 | Covid-ARNm-S-OMI-JN.1-50 | Covid-ARNm-S-OMI-JN.1-50 | ||||
| VAL255 | Rab-I-Fuenzalida | Rab-I-Fuenzalida | Rab-I-Fuenzalida | Rab-I-Fuenzalida | Rab-I-Fuenzalida | Rab-I-Fuenzalida | Rab-I-Fuenzalida |
| VAL122 | INF-SUNA3 | Inf-SUNA3 | |||||
| VAC0577 | |||||||
| VAL340 | Milzbrand | Anthrax | Charbon | Άνθρακας | Sibīrijas mēris | Wąglik | Antraz |
| VAC0444 | |||||||
| VAC0662 | |||||||
| VAC1424 | 10-valent pneumococcal polysaccharide conjugate vaccine, serotypes 1, 5, 6A, 6B, 7F, 9V, 14, 19A, 19F and 23F | ||||||
| VAC0880 | Pentavalenter Diphtherie-Tetanus-Pertussis-Hib-Polio-Impfstoff (DTPerHibIPV), nicht spezifiziert | Pentavalent Diphtheria-Tetanus-Pertussis-Hib-Polio (DTPerHibIPV) vaccine, unspecified | Πενταδύναμο εμβόλιο διφθερίτιδας-τετάνου-κοκκύτη-Hib-πολυομυελίτιδας (DTPerHibIPV), μη καθορισμένο | Pentavalentā difterijas-stingumkrampju-garā klepus-Hib-polio (DTPerHibIPV) vakcīna, neprecizēta | Pentawalentna szczepionka przeciwko błonicy, tężcowi, krztuścowi, Hib-Polio (DTPerHibIPV), nieokreślona | Vacina pentavalente contra difteria-tétano-coqueluche-Hib-poliomielite (DTPerHibIPV), não especificada | |
| VAC0795 | Acellular pertussis vaccine, unspecified | Acellular pertussis vaccine, unspecified | Acellular pertussis vaccine, unspecified | Acellular pertussis vaccine, unspecified | Acellular pertussis vaccine, unspecified | Acellular pertussis vaccine, unspecified | |
| VAC1206 | COVID-19 vaccine with self-amplifying mRNA, unspecified | ||||||
| VAC1339 | |||||||
| VAC0312 | |||||||
| VAC0227 | |||||||
| VAC0009 | |||||||
| DIS047 | Meningokokken Y | Meningococcal Y | Μηνιγγιτιδόκοκκος Υ | Meningokoks Y | Meningokok Y | Meningococo Y | |
| VAL038 | COVID-VVr-S-Meas | COVID-VVr-S-Meas | Covid-VVr-S-Roug | COVID-VVr-S-Meas | COVID-VVr-S-Meas | COVID-VVr-S-Meas | COVID-VVr-S-Meas |
| VAL256 | Rab-I-NervousTissue | Rab-I-NervousTissue | Rab-I-TissuNerveux | Rab-I-NervousTissue | Rab-I-NervousTissue | Rab-I-NervousTissue | Rab-I-NervousTissue |
| VAL389 | PAER7 | PAER7 | PAER7 | PAER7 | PAER7 | PAER7 | PAER7 |
| VAL123 | Rota5-L | Rota5-L | Rota5-V | Rota5-L | Rota5-L | Rota5-L | Rota5-L |
| VAC0578 | |||||||
| VAC0796 | Pertussis vaccine, unspecified | Pertussis vaccine, unspecified | Pertussis vaccine, unspecified | Pertussis vaccine, unspecified | Pertussis vaccine, unspecified | Pertussis vaccine, unspecified | |
| VAC0445 | |||||||
| VAL341 | Eco | Eco | Eco | Eco | Eco | Eco | Eco |
| VAC0881 | Abgeschwächter Lebendimpfstoff gegen Japanische Enzephalitis, nicht näher bezeichnet | Live attenuated Japanese Encephalitis vaccine, unspecified | Ζωντανό εξασθενημένο εμβόλιο Ιαπωνικής Εγκεφαλίτιδας, απροσδιόριστο | Dzīva novājināta Japānas encefalīta vakcīna, neprecizēta | Żywa, atenuowana szczepionka przeciwko japońskiemu zapaleniu mózgu, nieokreślona | Vacina viva atenuada contra encefalite japonesa, não especificada | |
| VAC0663 | |||||||
| VAC0530 | |||||||
| VAC1425 | Typhoid vaccine, Vi antigen conjugated to CRM197 protein | ||||||
| VAC1207 | COVID-19 vaccine with replicative viral vector, Newcastle disease virus encoding the SARS-CoV-2 spike protein, unspecified | ||||||
| VAC0317 | |||||||
| DIS046 | Meningokokken W | Meningococcal W | Μηνιγγιτιδόκοκκος W | Meningokoku W | Meningokok W | Meningococo W | |
| VAC1070 | |||||||
| VAL346 | EV71 | EV71 | |||||
| VAL213 | PPSV-08 | PPSV-08 | VPP-08 | PPSV-08 | PPSV-08 | PPSV-08 | PPSV-08 |
| VAC0668 | |||||||
| VAC0535 | |||||||
| VAC0620 | |||||||
| VAC0753 | |||||||
| VAC0886 | |||||||
| VAC0971 | |||||||
| VAC0090 | |||||||
| VAL128 | Inf | INF | Inf | Inf | Inf | Inf | Inf |
| DIS045 | Meningokokken B | Meningococcal B | Μηνιγγιτιδόκοκκος Β | Meningokoks B | Meningokok B | Meningococo B | |
| VAC0318 | |||||||
| VAC1071 | RSV-antistof eller -vaccine, uspecificeret | RSV antibody or vaccine, unspecified | Αντίσωμα ή εμβόλιο RSV, απροσδιόριστο | RSV antiviela vai vakcīna, neprecizēta | Przeciwciało lub szczepionka przeciwko wirusowi RSV, nieokreślone | Anticorpo ou vacina contra RSV, não especificado | |
| VAL214 | PPSV-09N | PPSV-09N | VPP-09N | PPSV-09N | PPSV-09N | PPSV-09N | PPSV-09N |
| VAL347 | Lepto-ca | Lepto-ca | |||||
| VAC0669 | |||||||
| VAC0754 | |||||||
| VAC0403 | |||||||
| VAC0972 | |||||||
| DIS008 | Masern | Measles | Ιλαρά | Masalas | Odra | Sarampo | |
| VAC0887 | |||||||
| VAC0621 | |||||||
| VAC0091 | |||||||
| VAL129 | HSV | HSV | HSV | HSV | HSV | HSV | HSV |
| VAC0315 | |||||||
| DIS044 | Meningokokken A | Meningococcal A | Μηνιγγιτιδόκοκκος Α | Meningokoks A | Meningokok A | Meningococo A | |
| VAL259 | Rab-I-PCEC | Rab-I-PCEC | Rab-I-PCEC | Rab-I-PCEC | Rab-I-PCEC | Rab-I-PCEC | Rab-I-PCEC |
| VAL126 | Ebola | Ebola | Ebola | Ebola | Ebola | Ebola | Ebola |
| VAL344 | Pvu | Pvu | Pvu | Pvu | Pvu | Pvu | Pvu |
| VAC0448 | |||||||
| DIS043 | Meningococcus C | Meningococcal C | Μηνιγγιτιδόκοκκος C | Meningokoks C | Meningokoki C | Meningococo C | |
| VAC0666 | |||||||
| DIS009 | Mumps | Mumps | Παρωτίτιδα | Epidēmiskais parotīts | Świnka | Parotidite epidémica | |
| VAL211 | PPSV-06B | PPSV-06B | VPP-06B | PPSV-06B | PPSV-06B | PPSV-06B | PPSV-06B |
| VAC0884 | |||||||
| VAC0799 | DT-Hib vaccine, unspecified | DT-Hib vaccine, unspecified | DT-Hib vaccine, unspecified | DT-Hib vaccine, unspecified | DT-Hib vaccine, unspecified | DT-Hib vaccine, unspecified | |
| VAC0400 | |||||||
| VAC1428 | COVID-19 vaccine, protein subunit, recombinant homodimeric RBD protein, Omicron variant XBB.1.16, with adjuvant (SQBA) | ||||||
| VAL127 | INF-SUimsc4 | Inf-SUimsc4 | |||||
| VAC0449 | |||||||
| DIS042 | Exanthematischer Typhus | Exanthematous typhus | Εξανθηματώδης τύφος | Eksantēmisks tīfs | Tyfus wysypkowy | tifo exantematoso | |
| VAL212 | PPSV-07F | PPSV-07F | VPP-07F | PPSV-07F | PPSV-07F | PPSV-07F | PPSV-07F |
| VAL345 | UTI | UTI | UTI | UTI | UTI | UTI | UTI |
| VAC0885 | |||||||
| VAC0534 | |||||||
| VAC0667 | |||||||
| VAC0401 | |||||||
| VAC0752 | |||||||
| VAC0970 | |||||||
| VAC1429 | |||||||
| VAC0220 | |||||||
| VAC0353 | |||||||
| VAC0135 | Polio vaccine, unspecified | Polio vaccine, unspecified | Polio vaccine, unspecified | Polio vaccine, unspecified | Polio vaccine, unspecified | Polio vaccine, unspecified | |
| VAC0002 | |||||||
| VAC0268 | |||||||
| VAL302 | Covid-mRNA-S-50 | COVID-mRNA-S-ORI-50 | Covid-ARNm-S-ORI-50 | COVID-mRNA-S-ORI-50 | Covid-mRNA-S-50 | Covid-mRNA-S-50 | Covid-mRNA-S-50 |
| VAC1333 | |||||||
| VAC1200 | Quadrivalent influenza vaccine, on cell culture, unspecified | ||||||
| VAC0486 | |||||||
| VAC1115 | Pentavalent vaccine DTPaHibP - Diphtheria-Tetanus-Pertussis-Hib PRP-Polio, unspecified | ||||||
| VAC1248 | Influenza/Covid 19 mRNA vaccine, unspecified | ||||||
| VAL217 | PPSV-11A | PPSV-11A | VPP-11A | PPSV-11A | PPSV-11A | PPSV-11A | PPSV-11A |
| VAC0003 | |||||||
| VAC0354 | |||||||
| VAC0136 | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | DTwP - Diphtheria-Tetanus-Pertussis, unspecified | |
| VAL303 | Covid-ARNm-S-ORI | COVID-mRNA-S-ORI | Covid-ARNm-S-ORI | COVID-mRNA-S-ORI | COVID-mRNA-S-ORI | COVID-mRNA-S-ORI | COVID-mRNA-S-ORI |
| VAC1201 | Tetravalent Dengue vaccine, live attenuated chimeric recombinant based on 17D yellow fever vaccine, unspecified | ||||||
| VAC1334 | |||||||
| VAC0487 | |||||||
| VAC1249 | Flu vaccine, trivalent inactivated, high dose, intradermal use, unspecified | ||||||
| VAC1116 | Rabies vaccine, whole inactivated, prepared in Vero cell culture, unspecified | ||||||
| VAC0790 | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | Diphtheria-Tetanus-Hepatitis B vaccine, unspecified | |
| VAL218 | PPSV-12F | PPSV-12F | VPP-12F | PPSV-12F | PPSV-12F | PPSV-12F | PPSV-12F |
| VAC0351 | |||||||
| VAC0133 | Smallpox vaccine, unspecified | Smallpox vaccine, unspecified | Smallpox vaccine, unspecified | Smallpox vaccine, unspecified | Smallpox vaccine, unspecified | Smallpox vaccine, unspecified | |
| VAC0266 | |||||||
| VAC0399 | |||||||
| VAC0048 | |||||||
| VAL215 | PPSV-09V | PPSV-09V | VPP-09V | PPSV-09V | PPSV-09V | PPSV-09V | PPSV-09V |
| VAL300 | MenW | MenW | MenW | MenW | MenW | MenW | MenW |
| VAC1113 | COVID-19 protein subunit vaccine, recombinant spike protein, unspecified | ||||||
| VAC1246 | |||||||
| VAC1331 | |||||||
| VAC1379 | |||||||
| VAC1028 | |||||||
| VAC0484 | |||||||
| VAL348 | Lepto-po | Lepto-po | |||||
| VAC0352 | |||||||
| VAC0001 | |||||||
| VAC0134 | BCG vaccine, unspecified | BCG vaccine, unspecified | BCG vaccine, unspecified | BCG vaccine, unspecified | BCG vaccine, unspecified | BCG vaccine, unspecified | |
| VAC0267 | |||||||
| VAC0049 | |||||||
| VAL301 | Rekombinanter trivalenter Impfstoff gegen Influenza | INF-R3 | Inf-R3 | Ανασυνδυασμένο τρισθενές εμβόλιο γρίπης | Rekombinantā trivalentā gripas vakcīna | Rekombinowana trójwartościowa szczepionka przeciw grypie | Vacina trivalente contra a gripe recombinante |
| VAC1114 | Vaccine against typhoid fever and hepatitis A, unspecified | ||||||
| VAC1332 | |||||||
| VAC1029 | |||||||
| VAC0485 | |||||||
| VAC1247 | Hepatitis-A-Impfstoff, nicht näher bezeichnet | Hepatitis A vaccine, unspecified | |||||
| VAC0570 | |||||||
| VAL216 | PPSV-10A | PPSV-10A | VPP-10A | PPSV-10A | PPSV-10A | PPSV-10A | PPSV-10A |
| VAL349 | INF-SUAnd3 | Inf-SUAnd3 | |||||
| VAC0224 | |||||||
| VAC0357 | |||||||
| VAC0139 | |||||||
| VAC0006 | |||||||
| VAC1422 | COVID-19 protein subunit vaccine, recombinant N protein | ||||||
| VAC0575 | |||||||
| VAC1337 | |||||||
| VAC0442 | |||||||
| VAC0660 | |||||||
| VAC0793 | |||||||
| VAC1204 | COVID-19 protein subunit vaccine, recombinant spike protein, with adjuvant, unspecified | ||||||
| VAL306 | Covid-ARNm-S-ORI-3 | COVID-mRNA-S-ORI-3 | Covid-ARNm-S-ORI-3 | COVID-mRNA-S-ORI-3 | COVID-mRNA-S-ORI-3 | COVID-mRNA-S-ORI-3 | COVID-mRNA-S-ORI-3 |
| VAC1119 | COVID-19 inactivated vaccine, whole virus, authorized, unspecified | ||||||
| VAC0310 | |||||||
| VAC0225 | |||||||
| VAC0007 | |||||||
| VAC0358 | Rabies immunoglobulin human origin, unspecified | Rabies immunoglobulin human origin, unspecified | Rabies immunoglobulin human origin, unspecified | Rabies immunoglobulin human origin, unspecified | Rabies immunoglobulin human origin, unspecified | Rabies immunoglobulin human origin, unspecified | |
| VAL080 | Rab-I | Rab-I | Rab-I | Rab-I | Rab-I | Rab-I | Rab-I |
| VAC0576 | |||||||
| VAC0443 | |||||||
| VAC0794 | T-igT, unspecified | T-igT, unspecified | T-igT, unspecified | T-igT, unspecified | T-igT, unspecified | T-igT, unspecified | |
| VAC1205 | Ebola virus vaccine, recombinant live non-replicating viral vector Ad26.ZEBOV, unspecified | ||||||
| VAC1338 | |||||||
| VAC1423 | Live attenuated influenza A(H1N1)pdm09 pandemic vaccine | ||||||
| VAC0661 | |||||||
| VAL307 | Covid-ARNm-S-OMI-BA.4/5-15 | COVID-mRNA-S-OMI-BA.4/5-15 | Covid-ARNm-S-OMI-BA.4/5-15 | COVID-mRNA-S-OMI-BA.4/5-15 | COVID-mRNA-S-OMI-BA.4/5-15 | COVID-mRNA-S-OMI-BA.4/5-15 | COVID-mRNA-S-OMI-BA.4/5-15 |
| VAC0222 | |||||||
| VAC0355 | |||||||
| VAC0137 | DT vaccine, unspecified | DT vaccine, unspecified | DT vaccine, unspecified | DT vaccine, unspecified | DT vaccine, unspecified | DT vaccine, unspecified | |
| VAC0004 | |||||||
| VAC1420 | Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation | ||||||
| VAC1202 | COVID-19 vaccine with live attenuated virus, unspecified | ||||||
| VAC0488 | |||||||
| VAC1117 | COVID-19 bivalent mRNA vaccine against the original virus and the Omicron BA.4/5 variant, 5 micrograms, unspecified | ||||||
| VAC0573 | |||||||
| VAC1335 | |||||||
| VAL219 | PPSV-14 | PPSV-14 | VPP-14 | PPSV-14 | PPSV-14 | PPSV-14 | PPSV-14 |
| VAC0791 | Hexavalenter Diphtherie-Tetanus-Pertussis-Polio-Hib-Hepatitis B-Impfstoff, nicht spezifiziert | Hexavalent vaccine DTPerHibPHepB - Diphtheria-Tetanus-Pertussis-Polio-Hib-Hepatitis B vaccine, unspecified | Εξασθενές εμβόλιο διφθερίτιδας-τετάνου-κοκκύτη-πολιο-χιμπ-ηπατίτιδας Β, ακαθόριστο | Heksavalentā difterijas-Tetanus-Pertuss-Polio-Hib-Hepatīta B vakcīna, neprecizēta | Hexavalent Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B-Hib vaccine, unspecified | Hexavalent Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B-Hib vaccine, unspecified | |
| VAL304 | Covid-ARNm-S-ORI-15 | COVID-mRNA-S-ORI-15 | Covid-ARNm-S-ORI-15 | Covid-ARNm-S-ORI-15 | Covid-ARNm-S-ORI-15 | Covid-ARNm-S-ORI-15 | Covid-ARNm-S-ORI-15 |
| VAC0223 | |||||||
| VAC0356 | |||||||
| VAC0005 | |||||||
| VAC0138 | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio vaccine, unspecified | |
| VAC0489 | |||||||
| VAC1421 | COVID-19 vaccine, mRNA encoding the SARS-CoV-2 spike protein, original virus | ||||||
| VAC0574 | |||||||
| VAC1118 | Enterovirus A71 vaccine, unspecified | ||||||
| VAC0792 | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B pentavalent vaccine, unspecified | |
| VAC0441 | |||||||
| VAC1203 | Brucellosis vaccine, protein (P.I. antigen) | ||||||
| VAC1336 | |||||||
| VAL305 | Covid-ARNm-S-OMI-BA.1-15 | COVID-mRNA-S-OMI-BA.1-15 | Covid-ARNm-S-OMI-BA.1-15 | COVID-mRNA-S-OMI-BA.1-15 | COVID-mRNA-S-OMI-BA.1-15 | Covid-ARNm-S-OMI-BA.1-15 | Covid-ARNm-S-OMI-BA.1-15 |
| VAC0260 | |||||||
| VAC0393 | |||||||
| VAC0175 | |||||||
| VAC0042 | |||||||
| VAL083 | D-d | D-d | D-d | D-d | D-d | D-d | D-d |
| VAC0706 | |||||||
| VAC0839 | Inactivated whole-cell brucella vaccine, unspecified | Inactivated whole-cell brucella vaccine, unspecified | Inactivated whole-cell brucella vaccine, unspecified | Inactivated whole-cell brucella vaccine, unspecified | Inactivated whole-cell brucella vaccine, unspecified | Inactivated whole-cell brucella vaccine, unspecified | |
| VAC1022 | |||||||
| VAC0923 | Monoklonaler Antikörper gegen das Respiratory Syncytial Virus, nicht spezifiziert | Respiratory Syncytial Virus monoclonal antibody, unspecified | Μονόκλωνο αντίσωμα αναπνευστικού συγκυτιακού ιού, απροσδιόριστο | Elpceļu sincitiālā vīrusa monoklonāla antiviela, neprecizēta | Przeciwciało monoklonalne przeciwko wirusowi syncytialnemu układu oddechowego, nieokreślone | Anticorpo monoclonal do vírus sincicial respiratório, não especificado | |
| VAC1240 | 4-component meningococcal B vaccine, unspecified | ||||||
| VAC1373 | |||||||
| VAC1155 | Plasma hepatitis B vaccine, unspecified | ||||||
| VAC1288 | |||||||
| VAC0261 | |||||||
| VAC0394 | |||||||
| VAC0043 | |||||||
| VAC0176 | |||||||
| VAL084 | COVID-VVr-S-VSV | COVID-VVr-S-VSV | Covid-VVr-S-VSV | COVID-VVr-S-VSV | COVID-VVr-S-VSV | COVID-VVr-S-VSV | COVID-VVr-S-VSV |
| VAC0707 | |||||||
| VAC0925 | Trivalenter inaktivierter Grippeimpfstoff, nicht näher bezeichnet | Trivalent inactivated influenza vaccine, unspecified | Τριδύναμο αδρανοποιημένο εμβόλιο γρίπης, απροσδιόριστο | Trīsvērtīgā inaktivēta gripas vakcīna, neprecizēta | Trójwalentna inaktywowana szczepionka przeciw grypie, nieokreślona | Vacina trivalente inativada contra influenza, não especificada | |
| VAC1241 | Shingles vaccine, varicella-zoster virus (VZV) surface glycoprotein E (gE), unspecified | ||||||
| VAC0924 | |||||||
| VAC1374 | |||||||
| VAC1289 | |||||||
| VAC1023 | |||||||
| VAC1156 | Immunoglobulin against botulism, unspecified | ||||||
| VAC0040 | |||||||
| VAC0173 | |||||||
| VAC0088 | DTIPV vaccine, unspecified | DTIPV vaccine, unspecified | DTIPV vaccine, unspecified | DTIPV vaccine, unspecified | DTIPV vaccine, unspecified | DTIPV vaccine, unspecified | |
| VAL081 | Chol | CHOL | Chol | Chol | Chol | Chol | Chol |
| VAC0837 | |||||||
| VAC0703 | |||||||
| VAC1153 | Quadrivalent meningococcal ACWY vaccine, diphtheria toxoid conjugate, unspecified | ||||||
| VAC0921 | Impfstoff gegen Japanische Enzephalitis, nicht näher bezeichnet | Japanese encephalitis vaccine, unspecified | Ιαπωνικό εμβόλιο εγκεφαλίτιδας, απροσδιόριστο | Japānas encefalīta vakcīna, neprecizēta | Szczepionka przeciwko japońskiemu zapaleniu mózgu, nieokreślona | Vacina contra encefalite japonesa, não especificada | |
| VAC1286 | |||||||
| VAC1371 | |||||||
| VAC0836 | |||||||
| VAC1020 | |||||||
| VAC1068 | Impfstoff gegen Rift-Valley-Fieber, nicht näher bezeichnet | Rift Valley fever vaccine, unspecified | Εμβόλιο κατά του πυρετού Rift Valley, απροσδιόριστο | Rifta ielejas drudža vakcīna, neprecizēta | Szczepionka na gorączkę Doliny Rift, nieokreślona | Vacina contra a febre do Vale do Rift, não especificada | |
| VAL308 | Covid-ARNm-S-OMI-BA.4/5-25 | COVID-mRNA-S-OMI-BA.4/5-25 | Covid-ARNm-S-OMI-BA.4/5-25 | COVID-mRNA-S-OMI-BA.4/5-25 | COVID-mRNA-S-OMI-BA.4/5-25 | COVID-mRNA-S-OMI-BA.4/5-25 | COVID-mRNA-S-OMI-BA.4/5-25 |
| VAC0391 | |||||||
| VAC0392 | |||||||
| VAC0041 | |||||||
| VAC0174 | |||||||
| VAL082 | HPV | HPV | VPH | HPV | HPV | HPV | HPV |
| VAC0838 | |||||||
| VAC0705 | |||||||
| VAC0922 | Abgeschwächter Adenovirus-Lebendimpfstoff, Typ 4 und Typ 7, oral | Live attenuated adenovirus vaccine, type 4 and type 7, oral | Εμβόλιο ζωντανού εξασθενημένου αδενοϊού, τύπου 4 και τύπου 7, από του στόματος | Dzīva novājināta adenovīrusa vakcīna, 4. un 7. tipa, perorāla | Żywa, atenuowana szczepionka adenowirusowa typu 4 i typu 7, doustna | Vacina de adenovírus vivo atenuado, tipo 4 e tipo 7, oral | |
| VAC1372 | |||||||
| VAC1021 | |||||||
| VAC1154 | Whole inactivated mumps vaccine, unspecified | ||||||
| VAC1069 | Vaccinia immune globulin | Vaccinia immune globulin | Vaccinia immune globulin | Vaccinia immune globulin | Vaccinia immune globulin | Vaccinia immune globulin | |
| VAC1287 | |||||||
| VAL309 | Covid-ARNm-S-OMI-BA.4/5-5 | COVID-mRNA-S-OMI-BA.4/5-5 | Covid-ARNm-S-OMI-BA.4/5-5 | Covid-ARNm-S-OMI-BA.4/5-5 | Covid-ARNm-S-OMI-BA.4/5-5 | Covid-ARNm-S-OMI-BA.4/5-5 | Covid-ARNm-S-OMI-BA.4/5-5 |
| VAC0131 | Rabies vaccine, unspecified | Rabies vaccine, unspecified | Rabies vaccine, unspecified | Rabies vaccine, unspecified | Rabies vaccine, unspecified | Rabies vaccine, unspecified | |
| VAC0264 | |||||||
| VAC0397 | |||||||
| VAC0046 | |||||||
| VAC0179 | |||||||
| VAL172 | Cbur | Cbur | Cbur | Cbur | Cbur | Cbur | Cbur |
| VAL390 | CHIK | CHIK | CHIK | CHIK | CHIK | CHIK | CHIK |
| VAC0928 | Lebendimpfstoff gegen Hepatitis A, nicht näher bezeichnet | Live attenuated Hepatitis A vaccine, unspecified | Ζωντανό εξασθενημένο εμβόλιο ηπατίτιδας Α, απροσδιόριστο | Dzīva novājināta A hepatīta vakcīna, neprecizēta | Żywa, atenuowana szczepionka przeciwko wirusowemu zapaleniu wątroby typu A, nieokreślona | Vacina viva atenuada contra hepatite A, não especificada | |
| VAC1026 | |||||||
| VAC1111 | Japanese Encephalitis Vaccine, whole inactivated, prepared on Vero cells, unspecified | ||||||
| VAL087 | CYD-TDV | CYD-TDV | CYD-TDV | CYD-TDV | CYD-TDV | CYD-TDV | CYD-TDV |
| VAC1244 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron XBB.1.5 variant, 30 micrograms | ||||||
| VAC1377 | |||||||
| VAC1159 | Recombinant trivalent influenza vaccine, unspecified | ||||||
| VAC0482 | |||||||
| VAC0350 | |||||||
| VAC0265 | |||||||
| VAC0132 | Tetanus vaccine, unspecified | Tetanus vaccine, unspecified | Tetanus vaccine, unspecified | Tetanus vaccine, unspecified | Tetanus vaccine, unspecified | Tetanus vaccine, unspecified | |
| VAC0398 | |||||||
| VAC0047 | |||||||
| VAC0929 | Quadrivalenter inaktivierter Influenza-Impfstoff, pädiatrische Dosis, nicht spezifiziert | Influenza quadrivalent inactivated vaccine, pediatric dose, unspecified | Τετραδύναμο αδρανοποιημένο εμβόλιο κατά της γρίπης, παιδιατρική δόση, απροσδιόριστη | Gripas četrvērtīgā inaktivētā vakcīna, pediatriskā deva, neprecizēta | Czterowalentna inaktywowana szczepionka przeciw grypie, dawka pediatryczna, nieokreślona | Vacina influenza quadrivalente inativada, dose pediátrica, não especificada | |
| VAL173 | Junin-LAV | Junin-LA | Junin-VVA | Junin-LAV | Junin-LAV | Junin-LAV | Junin-LAV |
| VAL040 | INF-SUnd4 | Inf-SUnd4 | |||||
| VAL391 | Chik-VLP | Chik-VLP | Chik-VLP | Chik-VLP | Chik-VLP | Chik-VLP | Chik-VLP |
| VAC1330 | |||||||
| VAC1245 | ABCWY meningococcal vaccine, unspecified | ||||||
| VAL088 | VZV-Ig | VZV-Ig | VZV-Ig | VZV-Ig | VZV-Ig | VZV-Ig | VZV-Ig |
| VAC1378 | |||||||
| VAC1112 | Live attenuated quadrivalent influenza vaccine, unspecified | ||||||
| VAC1027 | |||||||
| VAC0483 | |||||||
| VAC0262 | |||||||
| VAC0395 | |||||||
| VAC0044 | |||||||
| VAC0177 | |||||||
| VAL085 | mOPV3 | mOPV3 | mVPO3 | mOPV3 | mOPV3 | mOPV3 | mOPV3 |
| VAL170 | rHepB-05 | rHepB-05 | rAgHBs-05 | rHepB-05 | rHepB-05 | rHepB-05 | rHepB-05 |
| VAC0926 | |||||||
| VAC0708 | |||||||
| VAC1242 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron XBB.1.5 variant, 25 micrograms | ||||||
| VAC1157 | 3rd generation smallpox vaccine, modified Ankara vaccinia virus, unspecified | ||||||
| VAC1375 | |||||||
| VAC1024 | |||||||
| VAC0480 | |||||||
| VAC0263 | |||||||
| VAC0130 | MMR vaccine, unspecified | MMR vaccine, live attenuated, unspecified | MMR vaccine, unspecified | MMR vaccine, unspecified | MMR vaccine, unspecified | MMR vaccine, unspecified | |
| VAC0045 | |||||||
| VAC0396 | |||||||
| VAC0178 | |||||||
| VAL086 | COVID-LA | COVID-LA | Covid-VA | COVID-LA | COVID-LA | COVID-LA | COVID-LA |
| VAC0709 | |||||||
| VAL171 | VEE | VEE | VEE | VEE | VEE | VEE | VEE |
| VAC0927 | COVID-19-mRNA-Impfstoff, pädiatrische Dosis, nicht spezifiziert | COVID-19 mRNA vaccine, paediatric dose, unspecified | Εμβόλιο mRNA COVID-19, παιδιατρική δόση, απροσδιόριστη | Covid-19 mRNS vakcīna, pediatriskā deva, nav precizēta | Szczepionka mRNA przeciwko COVID-19, dawka pediatryczna, nieokreślona | Vacina de mRNA contra a COVID-19, dose pediátrica, não especificada | |
| VAC1110 | Meningococcal C vaccine unconjugated, unspecified | ||||||
| VAC1376 | |||||||
| VAC1025 | |||||||
| VAC1158 | COVID-19 mRNA vaccine against the Omicron XBB.1.5 variant, 3 micrograms, unspecified | ||||||
| VAC1243 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron XBB.1.5 variant, 50 micrograms | ||||||
| VAC0481 | |||||||
| VAL261 | Rab-I-PHKCV | Rab-I-PHKCV | Rab-I-PHKCV | Rab-I-PHKCV | Rab-I-PHKCV | Rab-I-PHKCV | Rab-I-PHKCV |
| VAL394 | COVID-mRNA-S-OMI-BA.4/5 | Covid-ARNm-S-OMI-BA.4/5 | |||||
| VAC1171 | Inactivated trivalent influenza vaccine, high dose, unspecified | ||||||
| VAC0419 | |||||||
| VAC0769 | |||||||
| VAC0418 | |||||||
| VAC0987 | |||||||
| DIS053 | Lyme-borreliose | Lyme disease | Η νόσος του Lyme | Laima slimība | Borelioza | Doença de lyme | |
| VAC1086 | |||||||
| VAC0503 | Rabies immunoglobulin equine origin, unspecified | Rabies immunoglobulin equine origin, unspecified | Rabies immunoglobulin equine origin, unspecified | Rabies immunoglobulin equine origin, unspecified | Rabies immunoglobulin equine origin, unspecified | Rabies immunoglobulin equine origin, unspecified | |
| VAC0636 | |||||||
| VAC0721 | |||||||
| VAL176 | HPIVs | HPIVs | VPIH | HPIVs | HPIVs | HPIVs | HPIVs |
| VAC0854 | mOPV3 Sabin monovalenter oraler Polioimpfstoff Typ 3, nicht spezifiziert | mOPV3 Sabin monovalent oral polio vaccine type 3, unspecified | mOPV3 Sabin μονοσθενές από του στόματος εμβόλιο πολιομυελίτιδας τύπου 3, απροσδιόριστο | mOPV3 Sabin monovalentā perorālā poliomielīta vakcīna, 3. tips, neprecizēta | mOPV3 Sabin, monowalentna doustna szczepionka przeciw polio typu 3, nieokreślona | Vacina monovalente oral contra poliomielite mOPV3 Sabin tipo 3, não especificada | |
| VAL043 | COVID-mRNA-S | COVID-mRNA-S | Covid-ARNm-S | COVID-mRNA-S | COVID-mRNA-S | COVID-mRNA-S | COVID-mRNA-S |
| VAC0191 | |||||||
| VAL262 | Rab-I-EEV | Rab-I-EEV | Rab-I-VOE | Rab-I-EEV | Rab-I-EEV | Rab-I-EEV | Rab-I-EEV |
| VAC1390 | |||||||
| VAC1172 | Diphtheria toxoid, reduced dose, unspecified | ||||||
| VAC0988 | |||||||
| VAC0637 | |||||||
| VAC0855 | Diphtherie-Tetanus-Polio-Impfstoff, nicht näher bezeichnet | Diphtheria-Tetanus-Polio vaccine, unspecified | Εμβόλιο διφθερίτιδας-τετάνου-πολυομυελίτιδας, απροσδιόριστο | Difterijas-stingumkrampju-poliomielīta vakcīna, neprecizēta | Szczepionka przeciw błonicy, tężcowi i polio, nieokreślona | Vacina contra difteria, tétano e poliomielite, não especificada | |
| DIS052 | Botulismus | Botulism | Δηλητηρίαση από ακάθαρτη τροφή | Botulisms | Zatrucie jadem kiełbasianym | Botulismo | |
| VAC1087 | |||||||
| VAC0504 | |||||||
| VAC0940 | |||||||
| VAC0722 | |||||||
| VAL177 | Hib | Hib | Hib | Hib | Hib | Hib | Hib |
| VAL044 | VZV-LAV | VZV-LA | VZV-VVA | VZV-LAV | VZV-LAV | VZV-LAV | VZV-LAV |
| VAL395 | COVID-mRNA-S-OMI-JN.1 | Covid-ARNm-S-OMI-JN.1 | |||||
| VAC0192 | |||||||
| VAL174 | HAN | HAN | HAN | HAN | HAN | HAN | HAN |
| VAL041 | MCV-A | MCV-A | MCV-A | MCV-A | MCV-A | MCV-A | MCV-A |
| VAL392 | AH5N1-RNA | AH5N1-RNA | AH5N1-ARN | AH5N1-RNA | AH5N1-RNA | AH5N1-RNA | AH5N1-RNA |
| VAC1084 | |||||||
| DIS051 | Milzbrand | Anthrax | Ανθρακας | Sibīrijas mēris | Wąglik | Carbúnculo | |
| VAC0549 | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | dTIPV - Diphtheria-Tetanus-Polio, low dose, unspecified | |
| VAC0416 | |||||||
| VAC0767 | |||||||
| VAC0852 | mOPV2 Sabin monovalenter oraler Polioimpfstoff Typ 2, nicht spezifiziert | mOPV2 Sabin monovalent oral polio vaccine type 2, unspecified | mOPV2 Sabin μονοσθενές από του στόματος εμβόλιο πολιομυελίτιδας τύπου 2, απροσδιόριστο | mOPV2 Sabin monovalentā perorālā poliomielīta vakcīna, 2. tips, neprecizēta | mOPV2 Sabin, monowalentna doustna szczepionka przeciw polio typu 2, nieokreślona | Vacina monovalente oral contra poliomielite mOPV2 Sabin tipo 2, não especificada | |
| VAL089 | JE-I | JE-I | EJ-I | JE-I | JE-I | JE-I | JE-I |
| VAC0634 | |||||||
| VAC0501 | |||||||
| VAC0985 | |||||||
| VAL042 | POLIO | POLIO | POLIO | POLIO | POLIO | POLIO | POLIO |
| VAL393 | COVID-mRNA-S-OMI-BA.1 | Covid-ARNm-S-OMI-BA.1 | |||||
| VAL260 | Rab-I-PVRV | Rab-I-PVRV | Rab-I-PVRV | Rab-I-PVRV | Rab-I-PVRV | Rab-I-PVRV | Rab-I-PVRV |
| VAC1170 | Non-replicating viral vector COVID-19 vaccine, chimpanzee adenovirus ChadOx1 encoding the SARS-CoV-2 spike protein | ||||||
| VAC0417 | |||||||
| VAC0635 | |||||||
| VAC0768 | |||||||
| VAC1085 | |||||||
| VAC0502 | Rabies immunoglobulin, unspecified | Rabies immunoglobulin, unspecified | Rabies immunoglobulin, unspecified | Rabies immunoglobulin, unspecified | Rabies immunoglobulin, unspecified | Rabies immunoglobulin, unspecified | |
| VAC0986 | |||||||
| VAL175 | Leish | Leish | Leish | Leish | Leish | Leish | Leish |
| DIS050 | Geflügelpest | Avian influenza | Γρίπη των πτηνών | Putnu gripa | Ptasia grypa | Gripe aviária | |
| VAC0853 | mOPV1 Sabin monovalenter oraler Polioimpfstoff Typ 1, nicht spezifiziert | mOPV1 Sabin monovalent oral polio vaccine type 1, unspecified | mOPV1 Sabin μονοσθενές από του στόματος εμβόλιο πολιομυελίτιδας τύπου 1, απροσδιόριστο | mOPV1 Sabin monovalentā perorālā poliomielīta vakcīna, 1. tips, neprecizēta | mOPV1 Sabin, monowalentna doustna szczepionka przeciw polio typu 1, nieokreślona | Vacina monovalente oral contra poliomielite mOPV1 Sabin tipo 1, não especificada | |
| VAC0720 | |||||||
| VAC0190 | |||||||
| VAC0195 | |||||||
| VAC0062 | |||||||
| VAL350 | INF-SUAnd4 | Inf-SUAnd4 | |||||
| VAC0859 | Vierwertiger HPV-Impfstoff, nicht näher bezeichnet | HPV vaccine quadrivalent, unspecified | Εμβόλιο HPV τετραδύναμο, απροσδιόριστο | HPV vakcīnas četrvērtīgā, neprecizēta | Szczepionka przeciwko HPV czterowalentna, nieokreślona | Vacina contra HPV quadrivalente, não especificada | |
| VAC1260 | |||||||
| VAC0508 | |||||||
| VAC0725 | |||||||
| VAC1175 | Inactivated trivalent influenza vaccine cell culture, normal dose, unspecified | ||||||
| VAC0943 | Diploide Zellen des Tollwutimpfstoffs, nicht näher bezeichnet | Rabies vaccine diploid cells, unspecified | Διπλοειδή κύτταρα αντιλυσσικού εμβολίου, απροσδιόριστα | Trakumsērgas vakcīnas diploīdās šūnas, neprecizētas | RabKomórki diploidalne szczepionki przeciw wściekliźnie, nieokreślone | Células diplóides da vacina contra a raiva, não especificadas | |
| VAC1393 | |||||||
| VAC0858 | Bivalenter HPV-Impfstoff, nicht spezifiziert | HPV vaccine bivalent, unspecified | Εμβόλιο HPV δισθενές, απροσδιόριστο | HPV vakcīna divvērtīgā, neprecizēta | Szczepionka przeciw HPV dwuwalentna, nieokreślona | Vacina contra HPV bivalente, não especificada | |
| VAC1042 | COVID-19-Impfstoff, nicht replizierender viraler Vektor, nicht spezifiziert | COVID-19 vaccine, non-replicating viral vector, unspecified | Εμβόλιο COVID-19, μη αναπαραγόμενος ιικός φορέας, απροσδιόριστος | Covid-19 vakcīna, nereplicējošs vīrusu vektors, nav precizēts | Szczepionka przeciwko COVID-19, niereplikujący wektor wirusowy, nieokreślony | Vacina contra a COVID-19, vetor viral não replicante, não especificado | |
| VAL047 | IgHepB | IgHepB | IgHepB | IgHepB | IgHepB | IgHepB | IgHepB |
| VAL265 | COVID-IV-CT | COVID-IV-CT | Covid-VI-CT | COVID-IV-CT | COVID-IV-CT | COVID-IV-CT | COVID-IV-CT |
| VAL398 | COVID-VVr-S | Covid-VVr-S | |||||
| VAL132 | mOPV1 | mOPV1 | mVPO1 | mOPV1 | mOPV1 | mOPV1 | mOPV1 |
| VAC0810 | Meningococcal polyvalent polysaccharide vaccine, unspecified | Meningococcal polyvalent polysaccharide vaccine, unspecified | Meningococcal polyvalent polysaccharide vaccine, unspecified | Meningococcal polyvalent polysaccharide vaccine, unspecified | Meningococcal polyvalent polysaccharide vaccine, unspecified | Meningococcal polyvalent polysaccharide vaccine, unspecified | |
| VAC0280 | |||||||
| VAC0063 | |||||||
| VAC0196 | |||||||
| VAC0509 | |||||||
| VAC0727 | |||||||
| VAC0944 | Inaktivierter oraler Cholera-Virionimpfstoff, nicht spezifiziert | Inactivated whole virion oral cholera vaccine, unspecified | Απενεργοποιημένο από του στόματος εμβόλιο χολέρας ολόκληρου ιού, απροσδιόριστο | Inaktivēta visa viriona perorālā holēras vakcīna, neprecizēta | Inaktywowana doustna szczepionka przeciw cholerze z całym wirionem, nieokreślona | Vacina oral contra cólera com virion inteiro inativado, não especificada | |
| VAC1394 | |||||||
| VAC0726 | |||||||
| VAC0811 | Meningococcal B vaccine, unspecified | Meningococcal B vaccine, unspecified | Meningococcal B vaccine, unspecified | Meningococcal B vaccine, unspecified | Meningococcal B vaccine, unspecified | Meningococcal B vaccine, unspecified | |
| VAC1043 | COVID-19-Impfstoff, Proteinuntereinheit, nicht spezifiziert | COVID-19 vaccine, protein subunit, unspecified | Εμβόλιο COVID-19, υπομονάδα πρωτεΐνης, απροσδιόριστο | Covid-19 vakcīna, proteīna apakšvienība, neprecizēta | Szczepionka przeciwko COVID-19, podjednostka białka, nieokreślona | Vacina contra COVID-19, subunidade proteica, não especificada | |
| VAC1176 | COVID-19 vaccine with non-replicating viral vector, adenovirus 5 encoding the S and N proteins of SARS-CoV-2, unspecified | ||||||
| VAL048 | Or-I | MUMPS-I | Or-I | Or-I | Or-I | Or-I | Or-I |
| VAC1261 | |||||||
| VAL399 | Ty-ViC-T | Ty-ViC-T | |||||
| VAL133 | mOPV | mOPV | mVPO | mOPV | mOPV | mOPV | mOPV |
| VAL266 | MCV-C-T | MCV-C-T | MCV-C-T | MCV-C-T | MCV-C-T | MCV-C-T | MCV-C-T |
| VAL351 | INF-V3 | Inf-V3 | |||||
| VAC0281 | |||||||
| VAL130 | HepA-VLP | HepA-VLP | HepA-VLP | HepA-VLP | HepA-VLP | HepA-VLP | HepA-VLP |
| VAC1040 | |||||||
| VAC0639 | |||||||
| VAC1391 | |||||||
| VAC0856 | DTaPHib-Impfstoff, nicht spezifiziert | DTaPHib vaccine, unspecified | Εμβόλιο DTaPHib, απροσδιόριστο | DTaPHib vakcīna, neprecizēta | Szczepionka DTaPHib, nieokreślona | Vacina DTaPHib, não especificada | |
| VAC1088 | |||||||
| VAC0638 | |||||||
| VAC0505 | |||||||
| VAC0723 | |||||||
| VAC1173 | COVID-19 vaccine with replicative viral vector, influenza virus encoding the spike protein of SARS-CoV-2, unspecified | ||||||
| VAC0989 | |||||||
| VAL178 | Covid-mRNA-S-OMI-25 | COVID-mRNA-S-OMI-BA.1-25 | Covid-ARNm-S-OMI-BA.1-25 | COVID-mRNA-S-OMI-BA.1-25 | COVID-mRNA-S-OMI-BA.1-25 | COVID-mRNA-S-OMI-BA.1-25 | COVID-mRNA-S-OMI-BA.1-25 |
| VAL045 | pTy-I | pTy-I | pTy-I | pTy-I | pTy-I | pTy-I | pTy-I |
| VAL263 | Rab-I-PDEV | Rab-I-PDEV | Rab-I-PDEV | Rab-I-PDEV | Rab-I-PDEV | Rab-I-PDEV | Rab-I-PDEV |
| VAC0941 | Immunglobulin gegen Milzbrand, nicht näher bezeichnet | Immunoglobulin against anthrax, unspecified | Ανοσοσφαιρίνη κατά του άνθρακα, απροσδιόριστη | Imūnglobulīns pret Sibīrijas mēri, neprecizēts | Immunoglobulina przeciw wąglikowi, nieokreślona | Imunoglobulina contra antraz, não especificada | |
| VAL396 | COVID-mRNA-S-OMI-XBB.1.5 | Covid-ARNm-S-OMI-XBB.1.5 | |||||
| VAC0193 | |||||||
| VAC0060 | |||||||
| VAC0194 | |||||||
| VAC1392 | |||||||
| VAC0507 | |||||||
| VAC0506 | Pentavalent DTaPHibIPV vaccine, unspecified | Pentavalent DTaPHibIPV vaccine, unspecified | Pentavalent DTaPHibIPV vaccine, unspecified | Pentavalent DTaPHibIPV vaccine, unspecified | Pentavalent DTaPHibIPV vaccine, unspecified | Pentavalent DTaPHibIPV vaccine, unspecified | |
| VAC0857 | Diphtherie-Tetanus-Pertussis-Hepatitis-B-Impfstoff, nicht näher bezeichnet | Diphtheria-Tetanus-Pertussis-Hepatitis B vaccine, unspecified | Εμβόλιο διφθερίτιδας-τετάνου-κοκκύτη-Ηπατίτιδας Β, απροσδιόριστο | Difterijas-stingumkrampju-garā klepus-B hepatīta vakcīna, neprecizēta | Szczepionka przeciw błonicy, tężcowi, krztuścowi i wirusowemu zapaleniu wątroby typu B, nieokreślona | Vacina contra difteria-tétano-coqueluche-hepatite B, não especificada | |
| VAL179 | MCV-mono | MCV-mono | MCV-mono | MCV-mono | MCV-mono | MCV-mono | MCV-mono |
| VAC0724 | |||||||
| VAC1041 | COVID-19-RNA-Impfstoff, nicht spezifiziert | COVID-19 mRNA vaccine, unspecified | Εμβόλιο RNA COVID-19, απροσδιόριστο | Covid-19 RNS vakcīna, neprecizēta | Szczepionka RNA przeciwko Covid-19, nieokreślona | Vacina de RNA COVID-19, não especificada | |
| VAC1174 | Pentavalent DTPaPHepB vaccine - Diphtheria-Tetanus-Pertussis-Polio-Hepatitis B 10µg, unspecified | ||||||
| VAL046 | Typhus | Typhus | Typhus | Typhus | Typhus | Typhus | Typhus |
| VAL397 | COVID-VVnr-S | Covid-VVnr-S | |||||
| VAC0942 | Tollwutimpfstoff gegen Hühnerembryonen, nicht näher bezeichnet | Chicken embryo rabies vaccine, unspecified | Εμβόλιο λύσσας εμβρύου κοτόπουλου, απροσδιόριστο | Vistas embrija trakumsērgas vakcīna, neprecizēta | Szczepionka przeciwko wściekliźnie zarodków kurcząt, nieokreślona | Vacina anti-rábica de embrião de galinha, não especificada | |
| VAL264 | COVID-IV | COVID-IV-Auth | Covid-VI-Aut | COVID-IV-Auth | COVID-IV-Auth | COVID-IV-Auth | COVID-IV-Auth |
| VAL131 | Yp-I | Yp-I | Yp-I | Yp-I | Yp-I | Yp-I | Yp-I |
| VAC1089 | |||||||
| VAC0061 | |||||||
| VAC0325 | |||||||
| VAC0107 | |||||||
| DIS014 | Tuberkulose | Tuberculosis | Φυματίωση | Tuberkuloze | Gruźlica | Tuberculose | |
| VAL269 | MCV-A-CRM | MCV-A-CRM | MCV-A-CRM | MCV-A-CRM | MCV-A-CRM | MCV-A-CRM | MCV-A-CRM |
| VAL136 | MCV-W | MCV-W | MCV-W | MCV-W | MCV-W | MCV-W | MCV-W |
| VAL003 | Per | Per | Coq | Per | Per | Per | Per |
| VAL221 | PPSV-15F | PPSV-15F | VPP-15F | PPSV-15F | PPSV-15F | PPSV-15F | PPSV-15F |
| VAC0458 | |||||||
| VAL354 | PCV-9N | VPC-09N | |||||
| VAC0543 | |||||||
| VAC0676 | |||||||
| VAC0410 | |||||||
| VAC0761 | |||||||
| VAC1305 | |||||||
| VAC0894 | Adenovirus vaccine, unspecified | Adenovirus vaccine, unspecified | Adenovirus vaccine, unspecified | Adenovirus vaccine, unspecified | Adenovirus vaccine, unspecified | Adenovirus vaccine, unspecified | |
| VAC1438 | Influenza vaccine, trivalent, inactivated, fractionated or subunit, adjuvanted | ||||||
| VAC0326 | |||||||
| VAC0108 | |||||||
| VAL137 | MPV-C | MPV-C | MPV-C | MPV-C | MPV-C | MPV-C | MPV-C |
| VAL004 | I-Chol-I | CHOL-I-I | I-Chol-I | I-Chol-I | I-Chol-I | I-Chol-I | I-Chol-I |
| VAL355 | PCV-17F | VPC-17F | |||||
| VAC0459 | |||||||
| VAC0677 | |||||||
| VAL222 | PPSV-17F | PPSV-17F | VPP-17F | PPSV-17F | PPSV-17F | PPSV-17F | PPSV-17F |
| VAC0895 | Impfstoff gegen Venezolanische Pferdeenzephalitis, nicht spezifiziert | Venezuelan Equine Encephalitis Vaccine, Unspecified | Εμβόλιο εγκεφαλίτιδας ιπποειδών της Βενεζουέλας, απροσδιόριστο | Venecuēlas zirgu encefalīta vakcīna, neprecizēta | Wenezuelska szczepionka przeciwko zapaleniu mózgu koni, nieokreślona | Vacina venezuelana contra encefalite equina, não especificada | |
| VAC0544 | |||||||
| VAC0411 | |||||||
| VAC0980 | |||||||
| VAC0762 | |||||||
| VAC1439 | Meningococcal vaccine, polyvalent, conjugate polysaccharide | ||||||
| VAC1306 | |||||||
| VAC0323 | |||||||
| VAC0105 | |||||||
| VAC0238 | |||||||
| VAL049 | Hib-PS | Hib-PS | Hib-PS | Hib-PS | Hib-PS | Hib-PS | Hib-PS |
| VAL267 | MCV-C-D | MCV-C-D | MCV-C-D | MCV-C-D | MCV-C-D | MCV-C-D | MCV-C-D |
| VAL134 | INF-SUid4 | Inf-SUid4 | |||||
| VAL001 | Inf-L3 | INF-L3 | Inf-L3 | Inf-L3 | Inf-L3 | Inf-L3 | Inf-L3 |
| VAC0456 | |||||||
| VAL352 | INF-V4 | Inf-V4 | |||||
| VAC0892 | |||||||
| VAC0541 | |||||||
| VAC0674 | |||||||
| VAC1303 | |||||||
| VAC1436 | |||||||
| VAC1218 | Meningococcal A polysaccharide vaccine conjugated to tetanus toxoid, unspecified | ||||||
| DIS059 | Pest | Plague | Πανούκλα | Mēris | Plaga | Praga | |
| VAC0324 | Pneumococcal conjugate vaccine, 7 valent, unspecified | Pneumococcal conjugate vaccine, 7 valent, unspecified | Pneumococcal conjugate vaccine, 7 valent, unspecified | Pneumococcal conjugate vaccine, 7 valent, unspecified | Pneumococcal conjugate vaccine, 7 valent, unspecified | Pneumococcal conjugate vaccine, 7 valent, unspecified | |
| VAC0106 | |||||||
| DIS011 | Windpocken | Chickenpox | Ανεμοβλογιά | Vējbakas | Ospa wietrzna | Varicela | |
| VAL135 | Covid-ARNm-S-CT | COVID-mRNA-S-CT | Covid-ARNm-S-CT | Covid-ARNm-S-CT | Covid-ARNm-S-CT | Covid-ARNm-S-CT | Covid-ARNm-S-CT |
| DIS010 | Röteln | Rubella | Ερυθρά | Masaliņas | Różyczka | Rubéola | |
| VAL268 | MCV-C-CRM | MCV-C-CRM | MCV-C-CRM | MCV-C-CRM | MCV-C-CRM | MCV-C-CRM | MCV-C-CRM |
| VAL002 | Ty-ViC | Ty-ViC | Ty-ViC | Ty-ViC | Ty-ViC | Ty-ViC | Ty-ViC |
| VAL353 | PCV-02 | VPC-02 | |||||
| VAC0457 | |||||||
| VAC0675 | |||||||
| VAL220 | PPSV-15B | PPSV-15B | VPP-15B | PPSV-15B | PPSV-15B | PPSV-15B | PPSV-15B |
| VAC0542 | |||||||
| VAC1304 | |||||||
| VAC1437 | Meningococcal vaccine, monovalent, conjugate | ||||||
| VAC0893 | |||||||
| VAC0760 | |||||||
| VAC1219 | Hexavalent vaccine DTPeHibMCV-A-C-T - Diphtheria-Tetanus-Pertussis-Hib PRP-Meningococcus A and C, conjugated with tetanus toxoid, unspecified | ||||||
| VAC1082 | |||||||
| DIS058 | Respiratorisches Syncytial-Virus | Human Respiratory Syncytial Virus | Αναπνευστικός συγκυτιακός ιός | Respiratori sinicitāls vīruss | Syncytialny wirus oddechowy | Vírus sincicial respiratório | |
| VAL225 | PPSV-19F | PPSV-19F | VPP-19F | PPSV-19F | PPSV-19F | PPSV-19F | PPSV-19F |
| VAL358 | BIG | BIG | |||||
| VAC0414 | |||||||
| VAC0765 | |||||||
| VAC0983 | |||||||
| VAL310 | Covid-mRNA-S-ORI-5 | COVID-mRNA-S-ORI-5 | Covid-ARNm-S-ORI-5 | Covid-mRNA-S-ORI-5 | Covid-mRNA-S-ORI-5 | Covid-mRNA-S-ORI-5 | Covid-mRNA-S-ORI-5 |
| VAC0898 | Leishmaniose-Impfstoff, nicht näher bezeichnet | Leishmaniasis vaccine, unspecified | Εμβόλιο λεϊσμανίασης, απροσδιόριστο | Leishmaniozes vakcīna, neprecizēta | Szczepionka na leiszmaniozę, nieokreślona | Vacina contra leishmaniose, não especificada | |
| VAC0632 | |||||||
| VAC0850 | |||||||
| VAC1309 | |||||||
| VAL007 | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP | rVSVdG-ZEBOV-GP |
| VAC1083 | |||||||
| DIS057 | COVID-19 | COVID-19 | COVID-19 | COVID-19 | COVID-19 | COVID-19 | |
| VAL226 | PPSV-20 | PPSV-20 | VPP-20 | PPSV-20 | PPSV-20 | PPSV-20 | PPSV-20 |
| VAC0899 | Impfstoff gegen humanes Parainfluenzavirus, nicht spezifiziert | Human Parainfluenza Virus Vaccine, unspecified | Εμβόλιο για τον ιό της ανθρώπινης παραγρίπης, απροσδιόριστο | Cilvēka paragripas vīrusa vakcīna, neprecizēta | Szczepionka przeciwko ludzkiemu wirusowi paragrypy, nieokreślona | Vacina contra o vírus da parainfluenza humana, não especificada | |
| VAL311 | R21/Matrix-M | R21/Matrix-M | R21/Matrix-M | R21/Matrix-M | R21/Matrix-M | R21/Matrix-M | R21/Matrix-M |
| VAC0415 | |||||||
| VAC0633 | |||||||
| VAC0984 | |||||||
| VAC0851 | |||||||
| VAC0766 | |||||||
| VAC0500 | |||||||
| VAL008 | aP | aP | Ca | aP | aP | aP | aP |
| VAL359 | Inaktivierte Ganzzell-Cholera-Valenz, ohne Spezifikation | CHOL-I | Chol-I | Αδρανοποιημένη ολόκληρη χολερική βαλεντία, χωρίς διευκρίνιση | Inaktivēta visa holēras valence, bez precizējuma | Wartość całkowicie inaktywowana przeciwko cholerze, bez określenia | Valência colérica inteira inativada, sem especificação |
| VAC1080 | |||||||
| VAC0327 | |||||||
| DIS056 | Chikungunyafieber | Chikungunya | Τσικουνγκούνια | Čikungunja | Chikungunia | Chicungunha | |
| VAC0109 | |||||||
| VAL138 | MPV-W | MPV-W | MPV-W | MPV-W | MPV-W | MPV-W | MPV-W |
| VAL005 | Meas-LAV | MEAS-LA | Roug-VVA | Meas-LAV | Meas-LAV | Meas-LAV | Meas-LAV |
| VAL223 | PPSV-18C | PPSV-18C | VPP-18C | PPSV-18C | PPSV-18C | PPSV-18C | PPSV-18C |
| VAL356 | PCV-20 | VPC-20 | |||||
| VAC0896 | Q-Fieber-Impfstoff, nicht näher bezeichnet | Q fever vaccine, unspecified | Q-Fieber-Impfstoff, nicht näher bezeichnet | Q drudža vakcīna, neprecizēta | Szczepionka na gorączkę Q, nieokreślona | Vacina contra febre Q, não especificada | |
| VAC0545 | |||||||
| VAC0678 | |||||||
| VAC0412 | |||||||
| VAC0763 | |||||||
| VAC0981 | |||||||
| VAC1307 | |||||||
| DIS055 | Ebolafieber | Ebola | Έμπολα | Ebolas vīrusslimība | Ebola | Ébola | |
| VAC0328 | |||||||
| VAC1081 | |||||||
| VAL006 | Bruc | Bruc | Bruc | Bruc | Bruc | Bruc | Bruc |
| VAL357 | CHOL-LA-O | O-Chol-V | |||||
| VAC0679 | |||||||
| VAL224 | PPSV-19A | PPSV-19A | VPP-19A | PPSV-19A | PPSV-19A | PPSV-19A | PPSV-19A |
| DIS054 | Hepatitis E | Hepatitis E | Ηπατίτιδα Ε | E hepatīts | Wirusowe Zapalenie Wątroby typu E | Hepatite E | |
| VAC0546 | |||||||
| VAC0413 | |||||||
| VAC0631 | |||||||
| VAC0764 | |||||||
| VAC0897 | Hantavirus-Impfstoff, nicht näher bezeichnet | Hantavirus vaccine, unspecified | Εμβόλιο Hantavirus, απροσδιόριστο | Hantavīrusa vakcīna, neprecizēta | Szczepionka hantawirusowa, nieokreślona | Vacina contra hantavírus, não especificada | |
| VAC0982 | |||||||
| VAC1308 | |||||||
| VAL139 | MPV-Y | MPV-Y | MPV-Y | MPV-Y | MPV-Y | MPV-Y | MPV-Y |
| VAC0232 | |||||||
| VAC0014 | |||||||
| VAC0365 | |||||||
| VAC0147 | Influenza A(H1N1)2009 vaccine, unspecified | Influenza A(H1N1)2009 vaccine, unspecified | Influenza A(H1N1)2009 vaccine, unspecified | Influenza A(H1N1)2009 vaccine, unspecified | Influenza A(H1N1)2009 vaccine, unspecified | Influenza A(H1N1)2009 vaccine, unspecified | |
| VAL314 | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU | TBE-Neudorfl-ADU |
| VAC1212 | Trivalent Poliomyelitis vaccine, whole inactivated oral, unspecified | ||||||
| VAC1345 | |||||||
| VAC1430 | COVID-19 bivalent mRNA vaccine against the original virus and the Omicron BA.4/5 variant, 50 micrograms, unspecified | ||||||
| VAC0498 | |||||||
| VAC1127 | Immunoglobulin against hepatitis A, measles, chickenpox and rubella, unspecified | ||||||
| VAL229 | PPSV-33F | PPSV-33F | VPP-33F | PPSV-33F | PPSV-33F | PPSV-33F | PPSV-33F |
| VAC0450 | |||||||
| VAC0233 | |||||||
| VAC0366 | |||||||
| VAC0148 | Leptospirosis vaccine, unspecified | Leptospirosis vaccine, unspecified | Leptospirosis vaccine, unspecified | Leptospirosis vaccine, unspecified | Leptospirosis vaccine, unspecified | Leptospirosis vaccine, unspecified | |
| VAC0015 | |||||||
| VAL400 | Ty-ViC-CRM | Ty-ViC-CRM | |||||
| VAC1431 | RSV vaccine, unspecified | ||||||
| VAC1213 | Cholera vaccine containing recombinant cholera toxin B subunit and inactivated whole V. cholerae O1 bacteria, unspecified | ||||||
| VAC0499 | |||||||
| VAC1128 | COVID-19 plasmid DNA vaccine, unspecified | ||||||
| VAC1346 | |||||||
| VAC0451 | |||||||
| VAL315 | TBE-Neudorfl-PED | TBE-Neudorfl-PED | TBE-Neudorfl-PED | TBE-Neudorfl-PED | TBE-Neudorfl-PED | TBE-Neudorfl-PED | TBE-Neudorfl-PED |
| VAC0230 | |||||||
| VAC0012 | |||||||
| VAC0363 | |||||||
| VAC0145 | Tick-borne encephalitis vaccine, unspecified | Tick-borne encephalitis vaccine, unspecified | Tick-borne encephalitis vaccine, unspecified | Tick-borne encephalitis vaccine, unspecified | Tick-borne encephalitis vaccine, unspecified | Tick-borne encephalitis vaccine, unspecified | |
| VAC0278 | |||||||
| VAC0809 | Meningococcal monovalent polysaccharide vaccine, unspecified | Meningococcal monovalent polysaccharide vaccine, unspecified | Meningococcal monovalent polysaccharide vaccine, unspecified | Meningococcal monovalent polysaccharide vaccine, unspecified | Meningococcal monovalent polysaccharide vaccine, unspecified | Meningococcal monovalent polysaccharide vaccine, unspecified | |
| VAL312 | TBE-K23 | TBE-K23 | TBE-K23 | TBE-K23 | TBE-K23 | TBE-K23 | TBE-K23 |
| VAC1125 | Hepatitis B vaccine, unspecified | ||||||
| VAC1210 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, original virus, 100 micrograms, unspecified | ||||||
| VAC1343 | |||||||
| VAC0496 | |||||||
| VAC1258 | |||||||
| VAL009 | Mala-SPO | Mala-SPO | Palu-SPO | Mala-SPO | Mala-SPO | Mala-SPO | Mala-SPO |
| VAL227 | PPSV-22F | PPSV-22F | VPP-22F | PPSV-22F | PPSV-22F | PPSV-22F | PPSV-22F |
| VAC0231 | |||||||
| VAC0364 | |||||||
| VAC0146 | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | Live attenuated Japanese Encephalitis vaccine 14-14-2 strain, unspecified | |
| VAC0013 | |||||||
| VAL313 | TBE-Neudorfl | TBE-Neudorfl | TBE-Neudorfl | TBE-Neudorfl | TBE-Neudorfl | TBE-Neudorfl | TBE-Neudorfl |
| VAC1344 | |||||||
| VAC1211 | Meningococcal C polysaccharide vaccine conjugated to CRM197 protein, unspecified | ||||||
| VAC0497 | Tetanus immunoglobulin, unspecified | Tetanus immunoglobulin, unspecified | Tetanus immunoglobulin, unspecified | Tetanus immunoglobulin, unspecified | Tetanus immunoglobulin, unspecified | Tetanus immunoglobulin, unspecified | |
| VAC1126 | Pentavalent DTP Hib vaccine - Diphtheria-Tetanus-Pertussis-Hib PRP-Polio, unspecified | ||||||
| VAC1259 | |||||||
| VAC0582 | |||||||
| VAL228 | PPSV-23F | PPSV-23F | VPP-23F | PPSV-23F | PPSV-23F | PPSV-23F | PPSV-23F |
| VAC0321 | |||||||
| VAC0103 | |||||||
| VAC0236 | |||||||
| VAC0018 | |||||||
| VAC0369 | |||||||
| DIS018 | Typhus | Typhoid | Τυφοειδής | Vēdertīfs | Dur brzuszny | Febre tifoide | |
| VAL091 | Ty-LA | Ty-LA-O | Ty-VA | Ty-LA | Ty-LA | Ty-LA | Ty-LA |
| VAC1301 | |||||||
| VAC0454 | |||||||
| VAC1216 | Quadrivalent DTPaHepB vaccine - Diphtheria-Tetanus-Pertussis-Hepatitis B 10µg, unspecified | ||||||
| VAC1349 | |||||||
| VAC1434 | Meningococcal A vaccine, unspecified | ||||||
| VAC0672 | |||||||
| VAL318 | RSV-V | RSV-V | VRS-V | RSV-V | RSV-V | RSV-V | RSV-V |
| VAC0890 | |||||||
| VAL403 | MenX | MenX | |||||
| VAC0322 | |||||||
| VAC0104 | |||||||
| DIS017 | Gelbfieber | Yellow fever | Κίτρινος πυρετός | Dzeltenais drudzis | Żółta gorączka | Febre amarela | |
| VAC0019 | |||||||
| VAL092 | YF | YF | YF | YF | YF | YF | YF |
| VAC0673 | |||||||
| VAC1435 | Rabies vaccine, inactivated, whole virion, cell culture-based, unspecified | ||||||
| VAC0891 | |||||||
| VAC1217 | Vaccine against hepatitis B and Haemophilus influenzae type b, unspecified | ||||||
| VAC0540 | |||||||
| VAL319 | COVID-19-Impfstoff, nicht-replizierender adenoviraler Vektor, der für das SARS-CoV-2-Spike-Protein kodiert, Inhalationsimpfstoff, nicht spezifiziert | COVID-VVnr-S-INH | Covid-VVnr-S-INH | ||||
| VAC1302 | |||||||
| VAL404 | MCV-X | MCV-X | |||||
| VAC0234 | |||||||
| VAC0101 | Hepatitis-B-Impfstoff, rekombinant, ohne nähere Angaben | Hepatitis B vaccine, recombinant, unspecified | Εμβόλιο ανασυνδυασμένης ηπατίτιδας Β, απροσδιόριστο | Rekombinantā B hepatīta vakcīna, neprecizēta | Rekombinowana szczepionka przeciw wirusowemu zapaleniu wątroby typu B, nieokreślona | Vacina recombinante contra a hepatite B, não especificada | |
| VAC0367 | |||||||
| VAC0016 | |||||||
| DIS016 | Hepatitis A | Hepatitis A | Ηπατίτιδα Α | A hepatīts | Wirusowe Zapalenie Wątroby typu A | Hepatite A | |
| VAC0149 | Meningococcal B:14:P1.7,16 vaccine, unspecified | Meningococcal B:14:P1.7,16 vaccine, unspecified | Meningococcal B:14:P1.7,16 vaccine, unspecified | Meningococcal B:14:P1.7,16 vaccine, unspecified | Meningococcal B:14:P1.7,16 vaccine, unspecified | Meningococcal B:14:P1.7,16 vaccine, unspecified | |
| VAL401 | EJ-I-Vero-3 | EJ-I-Vero-3 | |||||
| VAC1432 | Argentine hemorrhagic fever vaccine, Junin virus, unspecified | ||||||
| VAC0585 | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | TdapIPV - Diphtheria-Tetanus-Pertussis-Polio vaccine, low dose, unspecified | |
| VAC1129 | COVID-19 protein subunit vaccine, recombinant spike protein in nanoparticles, unspecified | ||||||
| VAC0452 | |||||||
| VAC1214 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, against the Omicron XBB.1.5 variant, 10µg, unspecified | ||||||
| VAC1347 | |||||||
| VAC0670 | |||||||
| VAL316 | RSV-PreF3 | RSV-PreF3 | VRS-PreF3 | RSV-PreF3 | RSV-PreF3 | RSV-PreF3 | RSV-PreF3 |
| VAC0320 | OPV 1-2-3, unspecified | OPV 1-2-3, unspecified | OPV 1-2-3, unspecified | OPV 1-2-3, unspecified | OPV 1-2-3, unspecified | OPV 1-2-3, unspecified | |
| VAC0102 | Inaktivierter Hepatitis-A-Impfstoff, nicht näher bezeichnet | Inactivated hepatitis A vaccine, unspecified | Αδρανοποιημένο εμβόλιο ηπατίτιδας Α, απροσδιόριστο | Nespecificēta inaktivēta A hepatīta vakcīna | Inaktywowana szczepionka przeciw wirusowemu zapaleniu wątroby typu A, nieokreślona | Vacina inactivada contra a hepatite A, não especificada | |
| VAC0235 | |||||||
| DIS015 | Influenza | Influenza | εποχική γρίπη | Gripa | Grypa sezonowa | Gripe | |
| VAC0368 | |||||||
| VAC0017 | |||||||
| VAL090 | rHBsAg | rHBsAg | rAgHBs | rHBsAg | rHBsAg | rHBsAg | rHBsAg |
| VAL402 | EJ-I-Vero-6 | EJ-I-Vero-6 | |||||
| VAC1300 | |||||||
| VAC1433 | Plague vaccine, unspecified | ||||||
| VAC0586 | |||||||
| VAC1348 | |||||||
| VAC0453 | |||||||
| VAC0671 | |||||||
| VAC1215 | Hexavalent vaccine DTPaHibPHepB - Diphtheria-Tetanus-Pertussis-Hib OMP-Polio-Hepatitis B 10µg, unspecified | ||||||
| VAL317 | RSV-Ab | RSV-Ab | VRS-Ab | RSV-Ab | RSV-Ab | RSV-Ab | RSV-Ab |
| VAC0490 | |||||||
| VAC0272 | |||||||
| VAC0054 | |||||||
| VAC0187 | |||||||
| VAL095 | COVID-VVr-S-Nv | COVID-VVr-S-Nv | Covid-VVr-S-Nv | COVID-VVr-S-Nv | COVID-VVr-S-Nv | COVID-VVr-S-Nv | COVID-VVr-S-Nv |
| VAC0718 | |||||||
| VAC0936 | |||||||
| VAL180 | Covid-mRNA-S-100 | COVID-mRNA-S-ORI-100 | Covid-ARNm-S-ORI-100 | COVID-mRNA-S-ORI-100 | COVID-mRNA-S-ORI-100 | COVID-mRNA-S-ORI-100 | COVID-mRNA-S-ORI-100 |
| VAC1252 | |||||||
| VAC0935 | |||||||
| VAC1385 | |||||||
| VAC0802 | Monovalent oral polio vaccine - type unknown, unspecified | Monovalent oral polio vaccine - type unknown, unspecified | Monovalent oral polio vaccine - type unknown, unspecified | Monovalent oral polio vaccine - type unknown, unspecified | Monovalent oral polio vaccine - type unknown, unspecified | Monovalent oral polio vaccine - type unknown, unspecified | |
| VAC1034 | |||||||
| VAC1167 | Acellular Pertussis Vaccine, unspecified | ||||||
| VAL407 | COVID-mRNA-S-OMI-KP.2-3 | Covid-ARNm-S-OMI-KP.2-3 | |||||
| VAC0140 | |||||||
| VAC0273 | |||||||
| VAC0188 | |||||||
| VAL096 | BCG | BCG | BCG | BCG | BCG | BCG | BCG |
| VAL181 | Covid-mRNA-S-ORI-25 | COVID-mRNA-S-ORI-25 | Covid-ARNm-S-ORI-25 | Covid-mRNA-S-ORI-25 | Covid-mRNA-S-ORI-25 | Covid-mRNA-S-ORI-25 | Covid-mRNA-S-ORI-25 |
| VAC0937 | Botulismus-Impfstoff, nicht näher bezeichnet | Botulism vaccine, unspecified | Εμβόλιο αλλαντίασης, απροσδιόριστο | Botulisma vakcīna, neprecizēta | Szczepionka na botulizm, nieokreślona | Vacina contra botulismo, não especificada | |
| VAC0804 | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified | Anthrax vaccine, unspecified | |
| VAC0719 | |||||||
| VAC1120 | Trivalent leptospirosis vaccine, unspecified | ||||||
| VAC1253 | |||||||
| VAC0803 | |||||||
| VAC1168 | Quadrivalent DTPeHib- Diphtheria-Tetanus-Pertussis-Hib OC vaccine, unspecified | ||||||
| VAC1386 | |||||||
| VAC1035 | |||||||
| VAL408 | COVID-mRNA-S-OMI-KP.2-10 | Covid-ARNm-S-OMI-KP.2-10 | |||||
| VAC0491 | |||||||
| VAC0052 | |||||||
| VAC0185 | |||||||
| VAL093 | Meas-I | MEAS-I | Roug-I | Meas-I | Meas-I | Meas-I | Meas-I |
| VAC0849 | Tularämie-Impfstoff, nicht näher bezeichnet | Tularemia vaccine, unspecified | Εμβόλιο για την τουλαραιμία, απροσδιόριστο | Vakcīna pret tularēmiju, neprecizēta | Szczepionka na tularemię, nieokreślona | Vacina contra tularemia, não especificada | |
| VAC0716 | |||||||
| VAC0933 | |||||||
| VAC1383 | |||||||
| VAC0800 | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | Diphtheria-tetanus-pertussis-Hib vaccine, unspecified | |
| VAC0715 | |||||||
| VAC1032 | |||||||
| VAC1165 | Diphtheria toxoid, standard dose, unspecified | ||||||
| VAC1250 | |||||||
| VAC1298 | |||||||
| VAL405 | INF-pdm09-V | Inf-pdm09-V | |||||
| VAC0270 | Inactivated Polio vaccine, unspecified | Inactivated Polio vaccine, unspecified | Inactivated Polio vaccine, unspecified | Inactivated Polio vaccine, unspecified | Inactivated Polio vaccine, unspecified | Inactivated Polio vaccine, unspecified | |
| VAC0271 | |||||||
| VAC0186 | |||||||
| VAC0053 | |||||||
| VAL094 | INF-SUhd3 | Inf-SUhd3 | |||||
| VAC0717 | |||||||
| VAC0801 | HepB-Hib, unspecified | HepB-Hib, unspecified | HepB-Hib, unspecified | HepB-Hib, unspecified | HepB-Hib, unspecified | HepB-Hib, unspecified | |
| VAC1033 | |||||||
| VAC0934 | |||||||
| VAC1251 | |||||||
| VAC1384 | |||||||
| VAC1166 | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, currently in clinical trial, unspecified | ||||||
| VAC1299 | |||||||
| VAL406 | COVID-mRNA-S-OMI-KP.2 | Covid-ARNm-S-OMI-KP.2 | |||||
| VAC0361 | |||||||
| VAC0010 | |||||||
| VAC0276 | |||||||
| VAC0143 | Haemophilus influenzae B (or Hib) vaccine, unspecified | Haemophilus influenzae B (or Hib) vaccine, unspecified | Haemophilus influenzae B (or Hib) vaccine, unspecified | Haemophilus influenzae B (or Hib) vaccine, unspecified | Haemophilus influenzae B (or Hib) vaccine, unspecified | Haemophilus influenzae B (or Hib) vaccine, unspecified | |
| VAC0058 | |||||||
| VAL184 | PCV | PCV | VPC | PCV | PCV | PCV | PCV |
| VAL051 | AH5N1 | AH5N1 | AH5N1 | AH5N1 | AH5N1 | AH5N1 | AH5N1 |
| VAC0807 | Cholera-Typhoid inactivated vaccine, unspecified | Cholera-Typhoid inactivated vaccine, unspecified | Cholera-Typhoid inactivated vaccine, unspecified | Cholera-Typhoid inactivated vaccine, unspecified | Cholera-Typhoid inactivated vaccine, unspecified | Cholera-Typhoid inactivated vaccine, unspecified | |
| VAC1341 | SPIKEVAX BA.4-5 0,1 mg/mL dose 50 µg | COVID-19 mRNA vaccine encoding the SARS-CoV-2 spike protein, Omicron XBB.1.5 variant, unspecified dose | SPIKEVAX BA.4-5 0,1 mg/mL dose 50 µg | SPIKEVAX BA.4-5 0,1 mg/mL dose 50 µg | SPIKEVAX BA.4-5 0,1 mg/mL dose 50 µg | SPIKEVAX BA.4-5 0,1 mg/mL dose 50 µg | |
| VAC1256 | Hexavalent vaccine DTwPHibPHepB - Diphtheria-Tetanus-Pertussis-Hib-Polio-Hepatitis B 15µg, unspecified | ||||||
| VAL099 | Inf-pdm09 | INF-pdm09 | Inf-pdm09 | Inf-pdm09 | Inf-pdm09 | Inf-pdm09 | Inf-pdm09 |
| VAC1389 | |||||||
| VAC1123 | Live attenuated trivalent influenza vaccine, unspecified | ||||||
| VAC1038 | Impfstoff gegen Zeckenenzephalitis, Stamm Neudörfl, Erwachsenendosis, nicht spezifiziert | Tick-borne encephalitis vaccine, Neudörfl strain, adult dose, unspecified | Εμβόλιο εγκεφαλίτιδας που μεταδίδεται από κρότωνες, στέλεχος Neudörfl, δόση ενηλίκων, μη καθορισμένη | Vakcīna pret ērču encefalītu, Neudörfl celms, pieaugušo deva, neprecizēta | Szczepionka na kleszczowe zapalenie mózgu, szczep Neudörfl, dawka dla dorosłych, nieokreślona | Vacina contra encefalite transmitida por carrapatos, cepa Neudörfl, dose para adultos, não especificada | |
| VAC0494 | |||||||
| VAC0362 | |||||||
| VAC0144 | Cholera vaccine, unspecified | Cholera vaccine, unspecified | Cholera vaccine, unspecified | Cholera vaccine, unspecified | Cholera vaccine, unspecified | Cholera vaccine, unspecified | |
| VAC0011 | |||||||
| VAC0277 | |||||||
| VAL185 | PPSV | PPSV | VPP | PPSV | PPSV | PPSV | PPSV |
| VAC0808 | Hib-MenCY, unspecified | Hib-MenCY, unspecified | Hib-MenCY, unspecified | Hib-MenCY, unspecified | Hib-MenCY, unspecified | Hib-MenCY, unspecified | |
| VAC0059 | |||||||
| VAL052 | HPV-04-valent | HPV-04-valent | VPH-04-valent | HPV-04-valent | HPV-04-valent | HPV-04-valent | HPV-04-valent |
| VAL270 | MCV-A-D | MCV-A-D | MCV-A-D | MCV-A-D | MCV-A-D | MCV-A-D | MCV-A-D |
| VAC1124 | Inactivated whole virus COVID-19 vaccine, in clinical trial, unspecified | ||||||
| VAC1257 | Cholera vaccine, whole inactivated oral, bivalent containing the whole inactivated V. cholerae O1 and O139 bacteria, unspecified | ||||||
| VAC1342 | |||||||
| VAC1039 | COVID-19-mRNA-Impfstoff, Originalvirus, 50 µg, nicht spezifiziert | COVID-19 mRNA vaccine, original virus, 50 µg, unspecified | Εμβόλιο mRNA COVID-19, αρχικός ιός, 50 μg, απροσδιόριστο | Covid-19 mRNS vakcīna, oriģināls vīruss, 50 µg, neprecizēts | Szczepionka mRNA przeciwko COVID-19, wirus oryginalny, 50 µg, nieokreślony | Vacina de mRNA contra COVID-19, vírus original, 50 µg, não especificado | |
| VAC0495 | |||||||
| VAC0580 | |||||||
| VAC0141 | |||||||
| VAC0274 | |||||||
| VAC0056 | |||||||
| VAC0189 | |||||||
| VAL097 | D | D | D | D | D | D | D |
| VAL182 | Meas | MEAS | Roug | Meas | Meas | Meas | Meas |
| VAC0805 | Whole-cell inactivated cholera vaccine, unspecified | Whole-cell inactivated cholera vaccine, unspecified | Whole-cell inactivated cholera vaccine, unspecified | Whole-cell inactivated cholera vaccine, unspecified | Whole-cell inactivated cholera vaccine, unspecified | Whole-cell inactivated cholera vaccine, unspecified | |
| VAC0938 | Quadrivalenter Grippeimpfstoff, nicht näher bezeichnet | Quadrivalent influenza vaccine, unspecified | Τετραδύναμο εμβόλιο γρίπης, απροσδιόριστο | Neprecizēta četrvērtīgā gripas vakcīna | Czterowalentna szczepionka przeciw grypie, nieokreślona | Vacina quadrivalente contra influenza, não especificada | |
| VAC1121 | Hexavalent vaccine DTPaHibPHepB - Diphtheria-Tetanus-Pertussis-Hib-Polio-Hepatitis B 10µg, unspecified | ||||||
| VAC1387 | |||||||
| VAC1036 | |||||||
| VAC1169 | COVID-19 Bivalent mRNA vaccine, original virus + Omicron BA.4/5 variant, 15 micrograms, unspecified | ||||||
| VAC1254 | |||||||
| VAL409 | COVID-mRNA-S-OMI-KP.2-30 | Covid-ARNm-S-OMI-KP.2-30 | |||||
| VAC0492 | |||||||
| VAC0360 | |||||||
| VAC0275 | |||||||
| VAC0057 | |||||||
| VAL183 | Mumps | MUMPS | Oreillons | Mumps | Mumps | Mumps | Mumps |
| VAL050 | COVID-VVnr-S-Ad5 | COVID-VVnr-S-Ad5 | Covid-VVnr-S-Ad5 | COVID-VVnr-S-Ad5 | COVID-VVnr-S-Ad5 | COVID-VVnr-S-Ad5 | COVID-VVnr-S-Ad5 |
| VAC0939 | |||||||
| VAC0806 | Live attenuated cholera vaccine, unspecified | Live attenuated cholera vaccine, unspecified | Live attenuated cholera vaccine, unspecified | Live attenuated cholera vaccine, unspecified | Live attenuated cholera vaccine, unspecified | Live attenuated cholera vaccine, unspecified | |
| VAC1340 | |||||||
| VAC1037 | Impfstoff gegen Zeckenenzephalitis, Stamm Neudörfl, pädiatrische Dosis, nicht spezifiziert | Tick-borne encephalitis vaccine, Neudörfl strain, paediatric dose, unspecified | Εμβόλιο εγκεφαλίτιδας από κρότωνες, στέλεχος Neudörfl, παιδιατρική δόση, μη καθορισμένη | Vakcīna pret ērču encefalītu, Neudörfl celms, pediatriskā deva, neprecizēta | Szczepionka na kleszczowe zapalenie mózgu, szczep Neudörfl, dawka pediatryczna, nieokreślona | Vacina contra encefalite transmitida por carrapatos, cepa Neudörfl, dose pediátrica, não especificada | |
| VAC1122 | 1st generation live smallpox vaccine, unspecified | ||||||
| VAL098 | 4CMenB | 4CMenB | 4CMenB | 4CMenB | 4CMenB | 4CMenB | 4CMenB |
| VAC1255 | |||||||
| VAC1388 | |||||||
| VAL273 | MCV-W-D | MCV-W-D | MCV-W-D | MCV-W-D | MCV-W-D | MCV-W-D | MCV-W-D |
| VAL140 | Inf-L | INF-L | Inf-L | Inf-L | Inf-L | Inf-L | Inf-L |
| DIS066 | Hantavirus | Hantavirus | Χανταϊός | Hantavīruss | Hantawirus | Hantavírus | |
| VAC1050 | |||||||
| VAC1183 | Non-replicating viral vector Ebola vaccine, unspecified | ||||||
| VAC0648 | COVID-19 vaccine, unspecified | COVID-19 vaccine, unspecified | COVID-19 vaccine, unspecified | COVID-19 vaccine, unspecified | COVID-19 vaccine, unspecified | COVID-19 vaccine, unspecified | |
| VAC0999 | |||||||
| VAC0866 | Meningokokken-Konjugatimpfstoff A, nicht näher bezeichnet | Meningococcal conjugate vaccine A, unspecified | Μηνιγγιτιδοκοκκικό συζευγμένο εμβόλιο Α, απροσδιόριστο | Meningokoku konjugētā vakcīna A, neprecizēta | Szczepionka skoniugowana przeciwko meningokokom A, nieokreślona | Vacina meningocócica conjugada A, não especificada | |
| VAC1098 | |||||||
| VAC0515 | |||||||
| DIS065 | Q-Fieber | Q fever | Q πυρετός | Q drudzis | Gorączka Q | febre Q | |
| VAC0951 | |||||||
| VAC0600 | OPV bivalent 1-3, unspecified | OPV bivalent 1-3, unspecified | OPV bivalent 1-3, unspecified | OPV bivalent 1-3, unspecified | OPV bivalent 1-3, unspecified | OPV bivalent 1-3, unspecified | |
| VAL188 | PCV-04 | PCV-04 | VPC-04 | PCV-04 | PCV-04 | PCV-04 | PCV-04 |
| VAC0733 | |||||||
| VAL055 | Ig-Measles | MEAS-Ig | Ig-Rougeole | Ig-Measles | Ig-Measles | Ig-Measles | Ig-Measles |
| VAC0070 | |||||||
| VAL141 | Rota-mv-RIX4414 | ROTA-LA-mv-RIX4414 | Rota-mv-RIX4414 | Rota-mv-RIX4414 | Rota-mv-RIX4414 | Rota-mv-RIX4414 | Rota-mv-RIX4414 |
| VAC1051 | |||||||
| VAC0867 | Diphtherie-Antitoxin, nicht näher bezeichnet | Diphtheria antitoxin, unspecified | Αντιτοξίνη διφθερίτιδας, μη καθορισμένη | Difterijas antitoksīns, neprecizēts | Antytoksyna błonicza, nieokreślona | Antitoxina diftérica, não especificada | |
| VAC1099 | |||||||
| VAC0649 | |||||||
| VAC0516 | |||||||
| VAC0734 | |||||||
| DIS064 | Venezolanische Pferdeenzephalitis | Venezuelan equine encephalitis | Βενεζουελανική εγκεφαλίτιδα ιπποειδών | Venecuēlas zirgu encefalīts | Wenezuelskie zapalenie mózgu koni | Encefalite equina venezuelana | |
| VAC1184 | Meningococcal C polysaccharide vaccine conjugated to tetanus toxoid, unspecified | ||||||
| VAL189 | PCV-05 | PCV-05 | VPC-05 | PCV-05 | PCV-05 | PCV-05 | PCV-05 |
| VAL056 | POLIO-I | IPV | VPI | POLIO-I | POLIO-I | POLIO-I | POLIO-I |
| VAC0601 | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | DPT Diphtheria-Pertussis-Tetanus vaccine, unspecified | |
| VAL274 | MCV-W-CRM | MCV-W-CRM | MCV-W-CRM | MCV-W-CRM | MCV-W-CRM | MCV-W-CRM | MCV-W-CRM |
| VAC0952 | |||||||
| VAC0071 | |||||||
| VAC1409 | COVID-19 mRNA vaccine, Omicron JN.1 subvariant, 50 micrograms per dose, multidose vial | ||||||
| VAL053 | COVID-PS | COVID-PS | Covid-SP | COVID-PS | COVID-PS | COVID-PS | COVID-PS |
| VAL271 | MCV-A-T | MCV-A-T | MCV-A-T | MCV-A-T | MCV-A-T | MCV-A-T | MCV-A-T |
| VAC1181 | Pentavalent vaccine DTPeHibHepB - Diphtheria-Tetanus-Pertussis-Hib PRP-HepatitisB 10µg, unspecified | ||||||
| VAC0428 | |||||||
| DIS063 | Adenovirus | Adenovirus | Αδενοϊός | Adenovīruss | Adenowirus | Adenovírus | |
| VAC0646 | |||||||
| VAC0779 | |||||||
| VAC1096 | |||||||
| VAC0513 | |||||||
| VAC0997 | 13-valenter Konjugatimpfstoff gegen Pneumokokken, nicht näher bezeichnet | Pneumococcal 13-valent conjugate vaccine, unspecified | Πνευμονιόκοκκο 13-δύναμο συζευγμένο εμβόλιο, απροσδιόριστο | 13-valentā konjugāta pneimokoku vakcīna, neprecizēta | 13-walentna szczepionka skoniugowana przeciwko pneumokokom, nieokreślona | Vacina pneumocócica conjugada 13-valente, não especificada | |
| VAL186 | PCV-01 | PCV-01 | VPC-01 | PCV-01 | PCV-01 | PCV-01 | PCV-01 |
| VAC0864 | Varizella-Zoster-Immunglobulin, nicht näher bezeichnet | Varicella-Zoster immunoglobulin, unspecified | Ανοσοσφαιρίνη ανεμευλογιάς-ζωστήρα, μη καθορισμένη | Varicella-Zoster imūnglobulīns, neprecizēts | Immunoglobulina przeciwko ospie wietrznej i półpaścu, nieokreślona | Imunoglobulina varicela-zoster, não especificada | |
| VAC0731 | |||||||
| VAC1408 | |||||||
| VAL272 | MCV-W-T | MCV-W-T | MCV-W-T | MCV-W-T | MCV-W-T | MCV-W-T | MCV-W-T |
| VAC1182 | Meningococcal ACWY polysaccharide vaccine conjugated to tetanus toxoid, unspecified | ||||||
| VAC0429 | |||||||
| DIS062 | Argentinisches hämorrhagisches Fieber | Argentine hemorrhagic fever | Αργεντινός αιμορραγικός πυρετός | Argentīnas hemorāģiskais drudzis | Argentyńska gorączka krwotoczna | febre hemorrágica argentina | |
| VAC0998 | |||||||
| VAC1097 | |||||||
| VAC0647 | |||||||
| VAC0514 | |||||||
| VAC0732 | |||||||
| VAC0950 | |||||||
| VAL187 | PCV-03 | PCV-03 | VPC-03 | PCV-03 | PCV-03 | PCV-03 | PCV-03 |
| VAC0865 | Polysaccharid-Meningokokken-A-Impfstoff, nicht spezifiziert | Polysaccharide meningococcal A vaccine, unspecified | Εμβόλιο πολυσακχαρίτη μηνιγγιτιδοκοκκικού Α, απροσδιόριστο | Polisaharīdu meningokoku A vakcīna, neprecizēta | Szczepionka polisacharydowa przeciwko meningokokom typu A, nieokreślona | Vacina polissacarídica meningocócica A, não especificada | |
| VAL054 | COVID-VVnr-S-MVA | COVID-VVnr-S-MVA | Covid-VVnr-S-MVA | COVID-VVnr-S-MVA | COVID-VVnr-S-MVA | COVID-VVnr-S-MVA | COVID-VVnr-S-MVA |
| VAC0074 | |||||||
| VAC0955 | |||||||
| VAC0737 | |||||||
| VAC0822 | Influenza vaccine, live attenuated, unspecified | Influenza vaccine, live attenuated, unspecified | Influenza vaccine, live attenuated, unspecified | Influenza vaccine, live attenuated, unspecified | Influenza vaccine, live attenuated, unspecified | Influenza vaccine, live attenuated, unspecified | |
| VAC1054 | |||||||
| VAC1187 | COVID-19 vaccine with replicative viral vector, measles virus encoding the SARS-CoV-2 spike protein, unspecified | ||||||
| VAL059 | Quadrivalente lebend-attenuierte Influenza-Valenz, normale Dosis | INF-L4 | Inf-L4 | Τετρασθενής ζωντανή εξασθενημένη βαλεντία της γρίπης, κανονική δόση | Četrvalenta dzīva novājināta gripas valence, normāla deva | Czterowalentna żywa atenuowana wartość przeciwko grypie, normalna dawka | Valência vacinal tetravalente viva atenuada contra a gripe, dose normal |
| VAC1272 | |||||||
| VAL277 | MCV-Y-D | MCV-Y-D | MCV-Y-D | MCV-Y-D | MCV-Y-D | MCV-Y-D | MCV-Y-D |
| VAL144 | HepA-mv-ADU | HepA-mv-ADU | HepA-mv-ADU | HepA-mv-ADU | HepA-mv-ADU | HepA-mv-ADU | HepA-mv-ADU |
| VAL011 | COVID-PS-rRBD | COVID-PS-rRBD | Covid-SP-rRBD | COVID-PS-rRBD | COVID-PS-rRBD | COVID-PS-rRBD | COVID-PS-rRBD |
| VAL362 | INF-V | Inf-V | |||||
| DIS061 | Tularämie | Tularemia | Τουλαραιμία | Tularēmija | Tularemia | Tularemia | |
| VAC0292 | |||||||
| VAC0293 | |||||||
| VAC0739 | |||||||
| VAC0823 | VLP influenza vaccine, unspecified | VLP influenza vaccine, unspecified | VLP influenza vaccine, unspecified | VLP influenza vaccine, unspecified | VLP influenza vaccine, unspecified | VLP influenza vaccine, unspecified | |
| VAC1055 | |||||||
| VAL278 | Adeno-LAV | AD-LA | Adeno-VVA | Adeno-LAV | Adeno-LAV | Adeno-LAV | Adeno-LAV |
| VAC1140 | COVID-19 bivalent mRNA vaccine against the original virus and the Omicron BA.4/5 variant, 25 micrograms, unspecified | ||||||
| VAC0956 | |||||||
| VAC1273 | |||||||
| VAL145 | HepA-bv-ADU | HepA-bv-ADU | HepA-bv-ADU | HepA-bv-ADU | HepA-bv-ADU | HepA-bv-ADU | HepA-bv-ADU |
| VAL012 | rHBsAg-40 | rHBsAg-40 | rAgHBs-40 | rHBsAg-40 | rHBsAg-40 | rHBsAg-40 | rHBsAg-40 |
| VAL230 | Quadrivalente inaktivierte Influenza-Valenz, Spalt- oder Untereinheit, ohne Spezifikation | INF-SU4 | Inf-SU4 | Τετρασθενής αδρανοποιημένη βαλεντία της γρίπης, κλασματοποιημένη ή υπομονάδα, χωρίς διευκρίνιση | Četrvalenta inaktivēta gripas valence, frakcionēta vai apakšvienība, bez precizējuma | Czterowalentna inaktywowana wartość przeciwko grypie, dzielona lub podjednostkowa, bez określenia | Valência vacinal tetravalente inativada da gripe, fracionada ou de subunidade, sem especificação |
| DIS060 | Herpes | Herpes | Ερπης | Herpes | Opryszczka | Herpes | |
| VAC1188 | COVID-19 mRNA vaccine encoding the spike protein of SARS-CoV-2, original virus, 3 micrograms, unspecified | ||||||
| VAL363 | INF-VLP3 | Inf-VLP3 | |||||
| VAC0160 | Live attenuated shingles vaccine, unspecified | Live attenuated shingles vaccine, unspecified | Live attenuated shingles vaccine, unspecified | Live attenuated shingles vaccine, unspecified | Live attenuated shingles vaccine, unspecified | Live attenuated shingles vaccine, unspecified | |
| VAL360 | Inaktivierte Influenza-Valenz aus Zellkultur, spalt- oder untereinheitlich, normale Dosis, ohne Spezifikation | INF-CC | Inf-CC | Αδρανοποιημένη βαλεντία της γρίπης που προέρχεται από κυτταροκαλλιέργεια, κλασματοποιημένη ή υπομονάδα, κανονική δόση, χωρίς διευκρίνιση | Inaktivēta gripas valence, iegūta no šūnu kultūras, frakcionēta vai apakšvienība, normāla deva, bez precizējuma | Wartość inaktywowana przeciwko grypie uzyskana z hodowli komórkowej, dzielona lub podjednostkowa, normalna dawka, bez określenia | Valência vacinal inativada da gripe obtida por cultura celular, fracionada ou de subunidade, dose normal, sem especificação |
| VAC1270 | |||||||
| VAC0518 | |||||||
| VAC0517 | |||||||
| VAC0602 | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | DTaP - Diphtheria-Tetanus-Pertussis vaccine, standard dose, unspecified | |
| VAC0735 | |||||||
| VAC0868 | |||||||
| VAC1052 | |||||||
| VAC1185 | COVID-19 vaccine with non-replicating viral vector, adenovirus 26 encoding the spike protein of SARS-CoV-2, unspecified | ||||||
| VAL057 | MCV-C | MCV-C | MCV-C | MCV-C | MCV-C | MCV-C | MCV-C |
| VAC0953 | |||||||
| VAL142 | HepA-mv-PED | HepA-mv-PED | HepA-mv-PED | HepA-mv-PED | HepA-mv-PED | HepA-mv-PED | HepA-mv-PED |
| VAC0820 | Inactivated whole influenza vaccine, unspecified | Inactivated whole influenza vaccine, unspecified | Inactivated whole influenza vaccine, unspecified | Inactivated whole influenza vaccine, unspecified | Inactivated whole influenza vaccine, unspecified | Inactivated whole influenza vaccine, unspecified | |
| VAL275 | MCV-Y-CRM | MCV-Y-CRM | MCV-Y-CRM | MCV-Y-CRM | MCV-Y-CRM | MCV-Y-CRM | MCV-Y-CRM |
| VAC0290 | |||||||
| VAC0072 | |||||||
| VAC0073 | |||||||
| VAL361 | Rekombinante Influenza-Valenz, ohne Spezifikation | INF-R | Inf-R | Aνασυνδυασμένη βαλεντία της γρίπης, χωρίς διευκρίνιση | Rekombinanta gripas valence, bez precizējuma | Rekombinowana wartość przeciwko grypie, bez określenia | Valência vacinal recombinante da gripe, sem especificação |
| VAC1271 | |||||||
| VAC0736 | |||||||
| VAC1186 | COVID-19 vaccine with replicative viral vector with antigen-presenting cells, unspecified | ||||||
| VAC0954 | |||||||
| VAC0869 | |||||||
| VAC1053 | |||||||
| VAL058 | Inaktivierte Influenza-Valenz, Spalt- oder Untereinheit, ohne Spezifikation | INF-SU | Inf-SU | Αδρανοποιημένη βαλεντία της γρίπης, κλασματοποιημένη ή υπομονάδα, χωρίς διευκρίνιση | Inaktivēta gripas valence, frakcionēta vai apakšvienība, bez precizējuma | Inaktywowana wartość przeciwko grypie, dzielona lub podjednostkowa, bez określenia | Valência vacinal inativada da gripe, fracionada ou de subunidade, sem especificação |
| VAC0603 | |||||||
| VAL276 | MCV-Y-T | MCV-Y-T | MCV-Y-T | MCV-Y-T | MCV-Y-T | MCV-Y-T | MCV-Y-T |
| VAL143 | HepA-bv-PED | HepA-bv-PED | HepA-bv-PED | HepA-bv-PED | HepA-bv-PED | HepA-bv-PED | HepA-bv-PED |
| VAC0821 | Inactivated influenza vaccine, split or subunit, unspecified | Inactivated influenza vaccine, split or subunit, unspecified | Inactivated influenza vaccine, split or subunit, unspecified | Inactivated influenza vaccine, split or subunit, unspecified | Inactivated influenza vaccine, split or subunit, unspecified | Inactivated influenza vaccine, split or subunit, unspecified | |
| VAL010 | wP | wP | Ce | wP | wP | wP | wP |
| VAC0291 | |||||||
| VAC1090 | |||||||
| VAC0204 | |||||||
| VAC0337 | |||||||
| VAL148 | RSV-IG | RSV-IG | VRS-Ig | RSV-IG | RSV-IG | RSV-IG | RSV-IG |
| VAL015 | INF-SUnd3 | Inf-SUnd3 | |||||
| VAL366 | RNA-basierte Influenza-Valenz, ohne Spezifikation | INF-RNA | INF-ARN | Βαλεντία της γρίπης με βάση το RNA, χωρίς διευκρίνιση | RNS bāzes gripas valence, bez precizējuma | Wartość przeciwko grypie oparta na RNA, bez określenia | Valência vacinal de RNA contra a gripe, sem especificação |
| VAC0688 | |||||||
| VAL100 | JE-LAV-14-14-2 | JE-LA-14-14-2 | EJ-VVA-14-14-2 | JE-LAV-14-14-2 | JE-LAV-14-14-2 | JE-LAV-14-14-2 | JE-LAV-14-14-2 |
| VAL233 | PPSV-25 | PPSV-25 | VPP-25 | PPSV-25 | PPSV-25 | PPSV-25 | PPSV-25 |
| VAC0555 | |||||||
| VAC0991 | |||||||
| VAC0640 | |||||||
| VAC1402 | |||||||
| VAC0773 | |||||||
| VAC1317 | |||||||
| VAC1091 | |||||||
| VAC0205 | |||||||
| VAC0338 | |||||||
| DIS025 | Pneumokokken | Pneumococcus | Πνευμονιόκοκκος | Pneimokoku | Pneumokoki | Pneumococo | |
| VAL149 | Covid-mRNA-S-25 | COVID-mRNA-S-OMI | Covid-ARNm-S-OMI | Covid-mRNA-S-25 | Covid-mRNA-S-25 | Covid-mRNA-S-25 | Covid-mRNA-S-25 |
| VAL016 | RIG | RIG | RIG | RIG | RIG | RIG | RIG |
| VAL234 | Men | Men | Men | Men | Men | Men | Men |
| VAL367 | CHOL-I-O1-O | O-Chol-O1-I | |||||
| VAL101 | COVID-VVnr-S-Nv | COVID-VVnr-S-Nv | Covid-VVnr-S-Nv | COVID-VVnr-S-Nv | COVID-VVnr-S-Nv | COVID-VVnr-S-Nv | COVID-VVnr-S-Nv |
| VAC0556 | |||||||
| VAC0689 | |||||||
| VAC0774 | |||||||
| VAC0423 | |||||||
| VAC0641 | |||||||
| VAC0992 | |||||||
| VAC1403 | |||||||
| VAC1318 | |||||||
| VAC0202 | |||||||
| VAC0335 | |||||||
| VAL146 | Bruc-I | Bruc-I | Bruc-I | Bruc-I | Bruc-I | Bruc-I | Bruc-I |
| VAL279 | INF-SUped4 | Inf-SUped4 | |||||
| VAL013 | Shingles-gE | Shingles-gE | Zona-gE | Shingles-gE | Shingles-gE | Shingles-gE | Shingles-gE |
| VAL364 | Nicht-lebende Influenza-Valenz, ohne Spezifikation | INF-NL | Inf-NL | Μη ζωντανή βαλεντία της γρίπης, χωρίς διευκρίνιση | Nedzīva gripas valence, bez precizējuma | Nieżywa wartość przeciwko grypie, bez określenia | Valência vacinal não viva da gripe, sem especificação |
| VAC0468 | |||||||
| VAC0686 | |||||||
| VAC1400 | |||||||
| VAL231 | INF-SUimsc3 | Inf-SUimsc3 | |||||
| VAC0553 | Pentavalent DTwPHibIPV vaccine, unspecified | Pentavalent DTwPHibIPV vaccine, unspecified | Pentavalent DTwPHibIPV vaccine, unspecified | Pentavalent DTwPHibIPV vaccine, unspecified | Pentavalent DTwPHibIPV vaccine, unspecified | Pentavalent DTwPHibIPV vaccine, unspecified | |
| VAC1315 | |||||||
| VAC0420 | |||||||
| VAC0771 | |||||||
| VAC0203 | |||||||
| VAC0336 | |||||||
| VAL147 | Bruc-IP | Bruc-IP | Bruc-PI | Bruc-IP | Bruc-IP | Bruc-IP | Bruc-IP |
| VAL014 | Ty | Ty | Ty | Ty | Ty | Ty | Ty |
| VAC0469 | |||||||
| VAL232 | PPSV-06A | PPSV-06A | VPP-06A | PPSV-06A | PPSV-06A | PPSV-06A | PPSV-06A |
| VAL365 | Nicht-lebende Influenza-Valenz aus Eikultur, ohne Spezifikation | INF-E | Inf-E | Μη ζωντανή βαλεντία της γρίπης που προέρχεται από καλλιέργεια σε αυγά, χωρίς διευκρίνιση | Nedzīva gripas valence, iegūta no olu kultūras, bez precizējuma | Nieżywa wartość przeciwko grypie uzyskana z hodowli na jajach, bez określenia | Valência vacinal não viva da gripe obtida por cultura em ovos, sem especificação |
| VAC0554 | |||||||
| VAC0687 | |||||||
| VAC0421 | |||||||
| VAC0772 | |||||||
| VAC0990 | |||||||
| VAC1316 | |||||||
| VAC1401 | |||||||
| VAC1094 | |||||||
| VAC0208 | |||||||
| VAL237 | HPV-poly | HPV-poly | VPH-poly | HPV-poly | HPV-poly | HPV-poly | HPV-poly |
| VAL104 | COVID-PS-rS | COVID-PS-rS | Covid-SP-rS | COVID-PS-rS | COVID-PS-rS | COVID-PS-rS | COVID-PS-rS |
| VAL322 | RSV-PreFAB | RSV-PreFAB | VRS-PreFAB | RSV-PreFAB | RSV-PreFAB | RSV-PreFAB | RSV-PreFAB |
| VAC0426 | |||||||
| VAC0644 | |||||||
| VAC0995 | |||||||
| VAC0862 | Masern-Immunglobulin, nicht näher bezeichnet | Measles immunoglobulin, unspecified | Ανοσοσφαιρίνη ιλαράς, απροσδιόριστη | Masalu imūnglobulīns, neprecizēts | Immunoglobulina odry, nieokreślona | Imunoglobulina contra o sarampo, não especificada | |
| VAC0777 | |||||||
| VAC0511 | |||||||
| VAC1406 | |||||||
| VAL019 | DATx | DATx | DATx | DATx | DATx | DATx | DATx |
| VAC1095 | |||||||
| VAC1180 | Recombinant Lyme disease vaccine, unspecified | ||||||
| VAC0209 | |||||||
| VAL105 | Pneumo | Pneumo | Pneumo | Pneumo | Pneumo | Pneumo | Pneumo |
| VAC0778 | |||||||
| VAC0427 | |||||||
| VAL323 | COVID-mRNA-S-OMI-XBB.1.5-30 | Covid-ARNm-S-OMI-XBB.1.5-30 | |||||
| VAC0863 | Hepatitis-B-Immunglobulin, nicht näher bezeichnet | Hepatitis B immunoglobulin, unspecified | Ανοσοσφαιρίνη ηπατίτιδας Β, μη καθορισμένη | B hepatīta imūnglobulīns, neprecizēts | Immunoglobulina przeciw wirusowi zapalenia wątroby typu B, nieokreślona | Imunoglobulina contra hepatite B, não especificada | |
| VAC0512 | Typhus vaccine, unspecified | Typhus vaccine, unspecified | Typhus vaccine, unspecified | Typhus vaccine, unspecified | Typhus vaccine, unspecified | Typhus vaccine, unspecified | |
| VAC0645 | |||||||
| VAC0730 | |||||||
| VAC0996 | |||||||
| VAL238 | HPV-06 | HPV-06 | VPH-06 | HPV-06 | HPV-06 | HPV-06 | HPV-06 |
| VAC1407 | |||||||
| VAC0206 | |||||||
| VAC0339 | Pneumococcal polysaccharide vaccine 23-valent, unspecified | Pneumococcal polysaccharide vaccine 23-valent, unspecified | Pneumococcal polysaccharide vaccine 23-valent, unspecified | Pneumococcal polysaccharide vaccine 23-valent, unspecified | Pneumococcal polysaccharide vaccine 23-valent, unspecified | Pneumococcal polysaccharide vaccine 23-valent, unspecified | |
| DIS068 | Menschliche Parainfluenza-Viren | Human parainfluenza viruses | Ανθρώπινοι ιοί παραγρίπης | Cilvēka paragripas vīrusi | Wirusy paragrypy ludzkiej | Vírus da parainfluenza humana | |
| VAC1092 | |||||||
| VAL017 | ap | ap | ca | ap | ap | ap | ap |
| VAL368 | CHOL-I-O139-O | O-Chol-O139-I | |||||
| VAL235 | MCV-poly | MCV-poly | MCV-poly | MCV-poly | MCV-poly | MCV-poly | MCV-poly |
| VAL102 | HepE | HepE | HepE | HepE | HepE | HepE | HepE |
| VAL320 | RSV-mAb | VRS-mAb | |||||
| VAC0424 | Live attenuated oral typhoid vaccine, unspecified | Live attenuated oral typhoid vaccine, unspecified | Live attenuated oral typhoid vaccine, unspecified | Live attenuated oral typhoid vaccine, unspecified | Live attenuated oral typhoid vaccine, unspecified | Live attenuated oral typhoid vaccine, unspecified | |
| VAC0642 | |||||||
| VAC0775 | DTwPHib, unspecified | DTwPHib, unspecified | DTwPHib, unspecified | DTwPHib, unspecified | DTwPHib, unspecified | DTwPHib, unspecified | |
| VAC0993 | |||||||
| VAC1404 | |||||||
| VAC0860 | Nonavalenter HPV-Impfstoff, nicht spezifiziert | HPV vaccine nonavalent, unspecified | Εμβόλιο HPV μη δυναμικό, απροσδιόριστο | HPV vakcīna nevalenta, neprecizēta | Szczepionka przeciwko HPV nieważna, nieokreślona | Vacina contra HPV nonavalente, não especificada | |
| VAC1319 | |||||||
| VAC0207 | |||||||
| DIS067 | Leishmaniose | Leishmaniasis | Λεϊσμανίαση | Leišmanioze | Leiszmanioza | Leishmaniose | |
| VAC1093 | |||||||
| VAL236 | HPV-mono | HPV-mono | VPH-mono | HPV-mono | HPV-mono | HPV-mono | HPV-mono |
| VAL369 | PCV-15A | VPC-15A | |||||
| VAL103 | Hib-C | Hib-C | Hib-C | Hib-C | Hib-C | Hib-C | Hib-C |
| VAC0776 | |||||||
| VAC0425 | |||||||
| VAC0994 | |||||||
| VAL321 | VRS-mAb-nir | VRS-mAb-nir | VRS-mAb-nir | VRS-mAb-nir | VRS-mAb-nir | VRS-mAb-nir | VRS-mAb-nir |
| VAC0510 | |||||||
| VAC0643 | Meningococcal ACWY conjugate vaccine, unspecified | Meningococcal ACWY conjugate vaccine, unspecified | Meningococcal ACWY conjugate vaccine, unspecified | Meningococcal ACWY conjugate vaccine, unspecified | Meningococcal ACWY conjugate vaccine, unspecified | Meningococcal ACWY conjugate vaccine, unspecified | |
| VAC0861 | Mehrkomponenten-Meningokokken-B-Impfstoff, nicht näher bezeichnet | Multicomponent meningococcal B vaccine, unspecified | Πολυσυστατικό εμβόλιο μηνιγγιτιδοκοκκικού Β, απροσδιόριστο | Daudzkomponentu meningokoku B vakcīna, neprecizēta | Wieloskładnikowa szczepionka przeciw meningokokom typu B, nieokreślona | Vacina meningocócica B multicomponente, não especificada | |
| VAC1405 | |||||||
| VAL018 | Pox-3G-LC16 | POX-3G-LC16 | POX-3G-LC16 | Pox-3G-LC16 | Pox-3G-LC16 | Pox-3G-LC16 | Pox-3G-LC16 |
| VAC0111 | Yellow fever vaccine, unspecified | Yellow fever vaccine, unspecified | Yellow fever vaccine, unspecified | Yellow fever vaccine, unspecified | Yellow fever vaccine, unspecified | Yellow fever vaccine, unspecified | |
| VAC0244 | |||||||
| VAC0377 | |||||||
| VAC0908 | Impfstoff gegen Adenovirus Typ 7, nicht spezifiziert | Vaccine against adenovirus type 7, unspecified | Εμβόλιο κατά του αδενοϊού τύπου 7, απροσδιόριστο | Vakcīna pret 7. tipa adenovīrusu, neprecizēts | Szczepionka przeciwko adenowirusowi typu 7, nieokreślona | Vacina contra adenovírus tipo 7, não especificada | |
| VAC0159 | Chickenpox vaccine, unspecified | Chickenpox vaccine, unspecified | Chickenpox vaccine, unspecified | Chickenpox vaccine, unspecified | Chickenpox vaccine, unspecified | Chickenpox vaccine, unspecified | |
| VAC0026 | |||||||
| VAL411 | COVID-mRNA-S-OMI-BA.4/5-50 | COVID-mRNA-S-OMI-BA.4/5-50 | Covid-ARNm-S-OMI-BA.4/5-50 | COVID-mRNA-S-OMI-BA.4/5-50 | COVID-mRNA-S-OMI-BA.4/5-50 | COVID-mRNA-S-OMI-BA.4/5-50 | COVID-mRNA-S-OMI-BA.4/5-50 |
| VAC1442 | Influenza vaccine, quadrivalent, virosomal, unspecified | ||||||
| VAC1224 | Respiratory syncytial virus (RSV) vaccine, recombinant, F-glycoprotein (prefusion) RSV subtypes A and B, unspecified | ||||||
| VAC1139 | COVID-19 vaccine, non-replicating vector, Newcastle disease virus encoding the SARS-CoV-2 spike protein, unspecified | ||||||
| VAC0595 | |||||||
| VAC1006 | |||||||
| VAC1357 | |||||||
| VAC0462 | |||||||
| VAC0680 | |||||||
| VAL108 | ZebovVRnrAd26 | ZebovVRnrAd26 | ZebovVRnrAd26 | ZebovVRnrAd26 | ZebovVRnrAd26 | ZebovVRnrAd26 | ZebovVRnrAd26 |
| VAL326 | COVID-mRNA-S-OMI-BA.4/5-1.5 | COVID-mRNA-S-OMI-BA.4/5-1.5 | Covid-ARNm-S-OMI-BA.4/5-1,5 | COVID-mRNA-S-OMI-BA.4/5-1.5 | COVID-mRNA-S-OMI-BA.4/5-1.5 | COVID-mRNA-S-OMI-BA.4/5-1.5 | COVID-mRNA-S-OMI-BA.4/5-1.5 |
| VAC0330 | |||||||
| VAC0245 | |||||||
| VAC0112 | Typhoid vaccine, unspecified | Typhoid vaccine, unspecified | Typhoid vaccine, unspecified | Typhoid vaccine, unspecified | Typhoid vaccine, unspecified | Typhoid vaccine, unspecified | |
| VAC0027 | |||||||
| VAC0378 | |||||||
| VAC0909 | Botulinum-Antitoxin | Botulinum antitoxin | Αντιτοξίνη αλλαντίασης | Botulīna antitoksīns | Antytoksyna botulinowa | Antitoxina botulínica | |
| VAL412 | Covid-ARNm-S-OMI-BA.1-50 | COVID-mRNA-S-OMI-BA.1-50 | Covid-ARNm-S-OMI-BA.1-50 | Covid-ARNm-S-OMI-BA.1-50 | Covid-ARNm-S-OMI-BA.1-50 | Covid-ARNm-S-OMI-BA.1-50 | Covid-ARNm-S-OMI-BA.1-50 |
| VAC1310 | |||||||
| VAC1443 | Influenza vaccine, trivalent, virosomal, unspecified | ||||||
| VAC0596 | DTaPHibHepB pentavalent vaccine, unspecified | DTaPHibHepB pentavalent vaccine, unspecified | DTaPHibHepB pentavalent vaccine, unspecified | DTaPHibHepB pentavalent vaccine, unspecified | DTaPHibHepB pentavalent vaccine, unspecified | DTaPHibHepB pentavalent vaccine, unspecified | |
| VAC1007 | |||||||
| VAC0463 | |||||||
| VAC1225 | Diphtheria, tetanus, typhoid and paratypoid A and B vaccines, unspecified | ||||||
| VAC1358 | |||||||
| VAL109 | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo | Ebola-MVA-BN-Filo |
| VAC0681 | |||||||
| VAL327 | COVID-mRNA-S-ORI-1.5 | COVID-mRNA-S-ORI-1.5 | Covid-ARNm-S-ORI-1,5 | COVID-mRNA-S-ORI-1.5 | COVID-mRNA-S-ORI-1.5 | COVID-mRNA-S-ORI-1.5 | COVID-mRNA-S-ORI-1.5 |
| VAC0242 | |||||||
| VAC0375 | |||||||
| VAC0157 | Pneumococcal vaccine, unspecified | Pneumococcal vaccine, unspecified | Pneumococcal vaccine, unspecified | Pneumococcal vaccine, unspecified | Pneumococcal vaccine, unspecified | Pneumococcal vaccine, unspecified | |
| VAC0024 | |||||||
| VAC0906 | Gürtelrose-Impfstoff, nicht näher bezeichnet | Shingles vaccine, unspecified | Εμβόλιο κατά του έρπητα ζωστήρα, απροσδιόριστο | Vakcīna pret jostas rozi, neprecizēta | Szczepionka na półpasiec, nieokreślona | Vacina contra herpes zoster, não especificada | |
| VAL324 | COVID-mRNA-S-OMI-XBB.1.5-10 | Covid-ARNm-S-OMI-XBB.1.5-10 | |||||
| VAC1440 | Influenza vaccine, quadrivalent, inactivated, fractionated or subunit, adjuvanted, normal dose | ||||||
| VAC1004 | |||||||
| VAC1355 | |||||||
| VAC1222 | Human monoclonal antibody against respiratory syncytial virus (RSV), palivizumab, unspecified | ||||||
| VAC1137 | Whole inactivated tick-borne encephalitis vaccine, strain K23, unspecified | ||||||
| VAC0593 | |||||||
| VAC0460 | |||||||
| VAL239 | HVP-11 | HPV-11 | VPH-11 | HVP-11 | HVP-11 | HVP-11 | HVP-11 |
| VAL106 | Rota | ROTA-LA | Rota | Rota | Rota | Rota | Rota |
| VAC0110 | Influenza vaccine, unspecified | Influenza vaccine, unspecified | Influenza vaccine, unspecified | Influenza vaccine, unspecified | Influenza vaccine, unspecified | Influenza vaccine, unspecified | |
| VAC0243 | |||||||
| VAC0025 | |||||||
| VAC0376 | |||||||
| VAC0907 | Impfstoff gegen Adenovirus Typ 4, nicht spezifiziert | Vaccine against adenovirus type 4, unspecified | Εμβόλιο κατά του αδενοϊού τύπου 4, απροσδιόριστο | Vakcīna pret 4. tipa adenovīrusu, neprecizēts | Szczepionka przeciwko adenowirusowi typu 4, nieokreślona | Vacina contra adenovírus tipo 4, não especificada | |
| VAC0158 | Rotavirus vaccine, unspecified | Rotavirus vaccine, unspecified | Rotavirus vaccine, unspecified | Rotavirus vaccine, unspecified | Rotavirus vaccine, unspecified | Rotavirus vaccine, unspecified | |
| VAL325 | COVID-mRNA-S-OMI-XBB.1.5-3 | Covid-ARNm-S-OMI-XBB.1.5-3 | |||||
| VAL410 | COVID-PS-rN | Covid-SP-rN | |||||
| VAC1223 | Immunoglobulin against respiratory syncytial virus (RSV), unspecified | ||||||
| VAC1356 | |||||||
| VAC1441 | Influenza vaccine, quadrivalent, inactivated, split or subunit, intradermal route, unspecified | ||||||
| VAC0594 | |||||||
| VAC1005 | |||||||
| VAC1138 | COVID-19 recombinant protein subunit vaccine | ||||||
| VAC0461 | |||||||
| VAL107 | COVID-19-Impfstoff, Protein-Untereinheit, rekombinante Spike-Protein-Nanopartikel | COVID-PS-rSnp | Covid-SP-rSnp | Εμβόλιο COVID-19, πρωτεϊνική υπομονάδα, ανασυνδυασμένα νανοσωματίδια πρωτεΐνης αιχμής | COVID-19 vakcīna, proteīna apakšvienība, rekombinantās smaiļveida proteīna nanodaļiņas | Szczepionka COVID-19, podjednostka białkowa, rekombinowane nanocząstki białka kolczastego | Vacina COVID-19, subunidade de proteína, nanopartículas de proteína recombinante de espigão |
| VAC0200 | |||||||
| VAC0333 | |||||||
| VAC0115 | |||||||
| VAC0248 | |||||||
| VAC0599 | DTPerHibHepB pentavalent vaccine, unspecified | DTPerHibHepB pentavalent vaccine, unspecified | DTPerHibHepB pentavalent vaccine, unspecified | DTPerHibHepB pentavalent vaccine, unspecified | DTPerHibHepB pentavalent vaccine, unspecified | DTPerHibHepB pentavalent vaccine, unspecified | |
| VAC0466 | |||||||
| VAC0684 | |||||||
| VAC1446 | Japanese encephalitis vaccine, inactivated, whole-virus, derived from Vero cells, 3 micrograms | ||||||
| VAC1228 | Respiratory syncytial virus (RSV) vaccine, recombinant, F protein-derived RSVPreF3 antigen, unspecified | ||||||
| VAC0551 | DTaPIPV vaccine, standard dose, unspecified | DTaPIPV vaccine, standard dose, unspecified | DTaPIPV vaccine, standard dose, unspecified | DTaPIPV vaccine, standard dose, unspecified | DTaPIPV vaccine, standard dose, unspecified | DTaPIPV vaccine, standard dose, unspecified | |
| VAC1313 | |||||||
| VAL415 | BantAdj | BantAdj | BantAdj | BantAdj | BantAdj | BantAdj | BantAdj |
| VAC0201 | |||||||
| VAC0334 | |||||||
| VAC0249 | |||||||
| DIS029 | Pocken-Monkeypox | Smallpox-Monkeypox | Ευλογιά-Μαϊμουδοπανώλη | Bakas-Monkeypox | Ospa-Monkeypox | Varíola-Monkeypox | |
| VAC0116 | |||||||
| VAC0467 | |||||||
| VAC0552 | DTPCaHibHepB hexavalenter Impfstoff - Diphtherie-Tetanus-Polio-zelluläre Keuchhusten-Hib-HepB, nicht spezifiziert | Hexavalent vaccine DTPCaHibHepB - Diphtheria-Tetanus-Polio-Acellular Pertussis-Hib-HepB, unspecified | DTaPHibHepBIPV hexavalent vaccine, unspecified | DTaPHibHepBIPV hexavalent vaccine, unspecified | DTaPHibHepBIPV hexavalent vaccine, unspecified | DTaPHibHepBIPV hexavalent vaccine, unspecified | |
| VAC0685 | |||||||
| VAC0770 | |||||||
| VAC1314 | |||||||
| VAL416 | COVID-PS-rS-A | Covid-SP-rS-A | |||||
| VAC1229 | Vaccine against meningococcal serogroups B (outer membrane vesicle proteins) and C | ||||||
| VAC0113 | Rubella vaccine, unspecified | Rubella vaccine, live attenuated, unspecified | Rubella vaccine, unspecified | Rubella vaccine, unspecified | Rubella vaccine, unspecified | Rubella vaccine, unspecified | |
| VAC0246 | |||||||
| VAC0379 | |||||||
| DIS028 | Japanische enzephalitis | Japanese encephalitis | Ιαπωνική εγκεφαλίτιδα | Japāņu encefalīts | Japońskie zapalenie mózgu | Encefalite japonesa | |
| VAC0028 | |||||||
| VAL413 | Covid-SP-rRBD-XBB.1.16 | COVID-PS-rRBD-XBB.1.16 | Covid-SP-rRBD-XBB.1.16 | Covid-SP-rRBD-XBB.1.16 | Covid-SP-rRBD-XBB.1.16 | Covid-SP-rRBD-XBB.1.16 | Covid-SP-rRBD-XBB.1.16 |
| VAC1311 | Meningococcal ACWXY conjugate vaccine, unspecified | Meningococcal ACWXY conjugate vaccine, unspecified | Meningococcal ACWXY conjugate vaccine, unspecified | ||||
| VAC1444 | Influenza vaccine, trivalent, VLP, unspecified | ||||||
| VAC1008 | |||||||
| VAC1359 | |||||||
| VAC0464 | |||||||
| VAC0682 | |||||||
| VAC1226 | Combined hepatitis A and B vaccine, pediatric dose, unspecified | ||||||
| VAL328 | COVID-SP-rSnp-XBB | COVID-PS-rSnp-XBB | Covid-SP-rSnp-XBB | ||||
| VAC0332 | |||||||
| VAC0114 | Live attenuated measles vaccine, unspecified | Live attenuated measles vaccine, unspecified | Live attenuated measles vaccine, unspecified | Live attenuated measles vaccine, unspecified | Live attenuated measles vaccine, unspecified | ||
| DIS027 | Frühsommer-Meningoenzephalitis | Tick-borne encephalitis | Εγκεφαλίτιδα από τσιμπούρια | Ērču encefalīts | Kleszczowe zapalenie mózgu | Encefalite transmitida por carrapatos | |
| VAC0247 | |||||||
| VAC0029 | |||||||
| VAC1312 | |||||||
| VAC0598 | DTwPHibHepB pentavalent vaccine, unspecified | DTwPHibHepB pentavalent vaccine, unspecified | DTwPHibHepB pentavalent vaccine, unspecified | DTwPHibHepB pentavalent vaccine, unspecified | DTwPHibHepB pentavalent vaccine, unspecified | DTwPHibHepB pentavalent vaccine, unspecified | |
| VAC0465 | |||||||
| VAC1227 | Recombinant hepatitis B vaccine, pediatric dose, unspecified | ||||||
| VAC1445 | Avian influenza vaccine, mRNA | ||||||
| VAC0550 | Measles-Rubella vaccine, unspecified | Measles-Rubella vaccine, unspecified | Measles-Rubella vaccine, unspecified | Measles-Rubella vaccine, unspecified | Measles-Rubella vaccine, unspecified | Measles-Rubella vaccine, unspecified | |
| VAC0683 | |||||||
| VAL329 | Covid-ARNm-S-OMI-XBB.1.5-50 | COVID-mRNA-S-OMI-XBB.1.5-50 | Covid-ARNm-S-OMI-XBB.1.5-50 | Covid-ARNm-S-OMI-XBB.1.5-50 | Covid-ARNm-S-OMI-XBB.1.5-50 | Covid-ARNm-S-OMI-XBB.1.5-50 | Covid-ARNm-S-OMI-XBB.1.5-50 |
| VAL414 | DIPH | DIPH | DIPH | DIPH | DIPH | DIPH | DIPH |
| VAC1009 | |||||||
| VAC0151 | Meningococcal A + C vaccine, unspecified | Meningococcal A + C vaccine, unspecified | Meningococcal A + C vaccine, unspecified | Meningococcal A + C vaccine, unspecified | Meningococcal A + C vaccine, unspecified | Meningococcal A + C vaccine, unspecified | |
| VAC0284 | |||||||
| VAC0066 | |||||||
| VAC0199 | |||||||
| VAL192 | PCV-07F | PCV-07F | VPC-07F | PCV-07F | PCV-07F | PCV-07F | PCV-07F |
| VAC0948 | |||||||
| VAC0815 | Pneumo-Hib, unspecified | Pneumo-Hib, unspecified | Pneumo-Hib, unspecified | Pneumo-Hib, unspecified | Pneumo-Hib, unspecified | Pneumo-Hib, unspecified | |
| VAC1131 | 17-valent unconjugated pneumococcal vaccine, unspecified | ||||||
| VAC1264 | A(H5) avian influenza vaccine, unspecified | A(H5) avian influenza vaccine, unspecified | A(H5) avian influenza vaccine, unspecified | A(H5) avian influenza vaccine, unspecified | A(H5) avian influenza vaccine, unspecified | A(H5) avian influenza vaccine, unspecified | |
| VAC0814 | Pneumococcal conjugate vaccine, serotypes unspecified | Pneumococcal conjugate vaccine, serotypes unspecified | Pneumococcal conjugate vaccine, serotypes unspecified | Pneumococcal conjugate vaccine, serotypes unspecified | Pneumococcal conjugate vaccine, serotypes unspecified | Pneumococcal conjugate vaccine, serotypes unspecified | |
| VAC1179 | Cholera and typhoid vaccine, injectable, unspecified | ||||||
| VAC1397 | |||||||
| VAC1046 | |||||||
| VAL419 | BOT | BOT | |||||
| VAC0370 | |||||||
| VAC0152 | Unconjugated meningococcal vaccine ACWY, unspecified | Unconjugated meningococcal vaccine ACWY, unspecified | Unconjugated meningococcal vaccine ACWY, unspecified | Unconjugated meningococcal vaccine ACWY, unspecified | Unconjugated meningococcal vaccine ACWY, unspecified | Unconjugated meningococcal vaccine ACWY, unspecified | |
| VAC0285 | |||||||
| VAC0067 | |||||||
| VAL193 | PCV-08 | PCV-08 | VPC-08 | PCV-08 | PCV-08 | PCV-08 | PCV-08 |
| VAL060 | CHIK-LA | CHIK-LA | CHIK-LA | CHIK-LA | CHIK-LA | CHIK-LA | CHIK-LA |
| VAC0816 | |||||||
| VAC0949 | |||||||
| VAC0900 | |||||||
| VAC1132 | COVID-19 bivalent mRNA vaccine, original virus + Omicron BA.4/5 variant, 1.5 micrograms, unspecified | ||||||
| VAC1350 | |||||||
| VAC1398 | |||||||
| VAC1047 | |||||||
| VAC1265 | |||||||
| VAC0282 | |||||||
| VAC0064 | |||||||
| VAC0197 | |||||||
| VAL190 | PCV-06A | PCV-06A | VPC-06A | PCV-06A | PCV-06A | PCV-06A | PCV-06A |
| VAC0728 | |||||||
| VAC0812 | Inactivated whole plague vaccine, unspecified | Inactivated whole plague vaccine, unspecified | Inactivated whole plague vaccine, unspecified | Inactivated whole plague vaccine, unspecified | Inactivated whole plague vaccine, unspecified | Inactivated whole plague vaccine, unspecified | |
| VAC1044 | COVID-19-Impfstoff, ganzes Virion inaktiviert, nicht spezifiziert | COVID-19 vaccine, whole virion inactivated, unspecified | Εμβόλιο COVID-19, αδρανοποιημένο ολόκληρο ιοσωμάτιο, απροσδιόριστο | Covid-19 vakcīna, viss virions inaktivēts, neprecizēts | Szczepionka przeciwko COVID-19, inaktywowany cały wirion, nieokreślony | Vacina contra a COVID-19, virião inteiro inativado, não especificado | |
| VAC0945 | Serogruppe des Meningokokken-Impfstoffs unbekannt, nicht spezifiziert | Meningococcal vaccine serogroup unknown, unspecified | Άγνωστη οροομάδα εμβολίου μηνιγγιτιδοκοκκικού, απροσδιόριστη | Meningokoku vakcīnas serogrupa nav zināma, nav precizēta | Grupa serologiczna szczepionki przeciw meningokokom nieznana, nieokreślona | Sorogrupo da vacina meningocócica desconhecido, não especificado | |
| VAC1262 | |||||||
| VAC1395 | |||||||
| VAC1177 | 3rd generation smallpox vaccine, live vaccinia virus with minimal replication, unspecified | ||||||
| VAL417 | COVID-mRNA-S-OMI-BA.2 | Covid-ARNm-S-OMI-BA.2 | |||||
| VAC0283 | |||||||
| VAC0150 | Meningococcal conjugate vaccine C, unspecified | Meningococcal conjugate vaccine C, unspecified | Meningococcal conjugate vaccine C, unspecified | Meningococcal conjugate vaccine C, unspecified | Meningococcal conjugate vaccine C, unspecified | Meningococcal conjugate vaccine C, unspecified | |
| VAC0198 | |||||||
| VAC0729 | |||||||
| VAL191 | PCV-06B | PCV-06B | VPC-06B | PCV-06B | PCV-06B | PCV-06B | PCV-06B |
| VAC0947 | |||||||
| VAC1263 | mRNA-Covid-Impfstoff, der das SARS-COV-2-Spike-Protein kodiert, zugelassen | COVID-19 mRNA vaccine encoding the SARS-COV-2 spike protein, authorized | Εμβόλιο mRNA για τον covid που κωδικοποιεί την πρωτεΐνη ακίδας SARS-COV-2, εγκεκριμένο | Autorizēta mRNS Covid vakcīna, kas kodē SARS-COV-2 smaile proteīnu | Zatwierdzona szczepionka mRNA covid, kodująca białko kolczaste SARS-COV-2 | Vacina mRNA covid que codifica a proteína spike SARS-COV-2, autorizada | |
| VAC0946 | |||||||
| VAC1396 | |||||||
| VAC0813 | Pneumococcal unconjugated polysaccharide vaccine, unspecified | Pneumococcal unconjugated polysaccharide vaccine, unspecified | Pneumococcal unconjugated polysaccharide vaccine, unspecified | Pneumococcal unconjugated polysaccharide vaccine, unspecified | Pneumococcal unconjugated polysaccharide vaccine, unspecified | Pneumococcal unconjugated polysaccharide vaccine, unspecified | |
| VAC1130 | Trivalent inactivated seasonal influenza vaccine and tetanus toxoid, unspecified | ||||||
| VAC1045 | |||||||
| VAC1178 | Tetravalent Dengue vaccine, live attenuated chimeric recombinant, unspecified | ||||||
| VAL418 | POX | POX | |||||
| VAC0240 | |||||||
| VAC0373 | |||||||
| VAC0155 | Dengue vaccine, unspecified | Dengue vaccine, unspecified | Dengue vaccine, unspecified | Dengue vaccine, unspecified | Dengue vaccine, unspecified | Dengue vaccine, unspecified | |
| VAC0022 | |||||||
| VAC0288 | |||||||
| VAL196 | PCV-11A | PCV-11A | VPC-11A | PCV-11A | PCV-11A | PCV-11A | PCV-11A |
| VAC0819 | Inactivated Japanese Encephalitis vaccine, unspecified | Inactivated Japanese Encephalitis vaccine, unspecified | Inactivated Japanese Encephalitis vaccine, unspecified | Inactivated Japanese Encephalitis vaccine, unspecified | Inactivated Japanese Encephalitis vaccine, unspecified | Inactivated Japanese Encephalitis vaccine, unspecified | |
| VAL063 | BAT | BAT | BAT | BAT | BAT | BAT | BAT |
| VAL281 | Adeno-7 | AD7-LA | Adeno-7 | Adeno-7 | Adeno-7 | Adeno-7 | Adeno-7 |
| VAC0904 | Impfstoff gegen Tollwut-Entenembryonen, nicht näher bezeichnet | Rabies duck embryo vaccine, unspecified | Εμβόλιο εμβρύου πάπιας λύσσας, απροσδιόριστο | Trakumsērgas pīļu embrija vakcīna, neprecizēta | Szczepionka przeciwko wściekliźnie zarodków kaczych, nieokreślona | Vacina contra raiva em embrião de pato, não especificada | |
| VAC1220 | Meningococcal CY and anti-Haemophilus influenzae type b vaccine, conjugated with tetanus toxoid, unspecified | ||||||
| VAC1135 | COVID-19 Plasmid DNA vaccine with non-replicating viral vector, adenovirus encoding the spike protein of SARS-CoV-2, by inhalation, unspecified | ||||||
| VAC1268 | |||||||
| VAC1002 | |||||||
| VAC1353 | |||||||
| VAC0591 | |||||||
| VAC0241 | |||||||
| VAC0023 | |||||||
| VAC0374 | |||||||
| VAC0156 | HPV Vaccine | HPV Vaccine | HPV Vaccine | HPV Vaccine | HPV Vaccine | HPV Vaccine | |
| VAC0289 | |||||||
| VAL064 | INF-SUNA4 | Inf-SUNA4 | |||||
| VAL282 | Adeno-4 | AD4-LA | Adeno-4 | Adeno-4 | Adeno-4 | Adeno-4 | Adeno-4 |
| VAC0905 | Tollwutimpfstoff PHKCV, nicht spezifiziert | Rabies vaccine PHKCV, unspecified | Αντιλυσσικό εμβόλιο PHKCV, απροσδιόριστο | Vakcīna pret trakumsērgu PHKCV, neprecizēta | Szczepionka przeciwko wściekliźnie PHKCV, nieokreślona | Vacina anti-rábica PHKCV, não especificada | |
| VAC1003 | |||||||
| VAC1136 | 23-valenter konjugierter Pneumokokken-Impfstoff, nicht näher bezeichnet | 23-valent Pneumococcus conjugate vaccine, unspecified | Πνευμονιοκοκκικό 23-δύναμο συζευγμένο εμβόλιο, απροσδιόριστο | Pneimokoku 23-valenta konjugētā vakcīna, neprecizēta | 23-walentna skoniugowana szczepionka przeciw pneumokokom, nieokreślona | Vacina pneumocócica conjugada 23-valente, não especificada | |
| VAC1221 | Trivalent vaccine against diphtheria, tetanus and rubella, unspecified | ||||||
| VAL197 | PCV-12F | PCV-12F | VPC-12F | PCV-12F | PCV-12F | PCV-12F | PCV-12F |
| VAC1354 | |||||||
| VAC1269 | |||||||
| VAC0592 | |||||||
| VAC0371 | |||||||
| VAC0153 | Mumps vaccine, unspecified | Mumps vaccine, unspecified | Mumps vaccine, unspecified | Mumps vaccine, unspecified | Mumps vaccine, unspecified | Mumps vaccine, unspecified | |
| VAC0020 | |||||||
| VAC0286 | |||||||
| VAC0068 | |||||||
| VAL194 | PCV-09V | PCV-09V | VPC-09V | PCV-09V | PCV-09V | PCV-09V | PCV-09V |
| VAL061 | COVID-PS-CpG1018 | COVID-PS-CpG1018 | Covid-SP-CpG1018 | COVID-PS-CpG1018 | COVID-PS-CpG1018 | COVID-PS-CpG1018 | COVID-PS-CpG1018 |
| VAC0817 | Inactivated Typhoid vaccine, unspecified | Inactivated Typhoid vaccine, unspecified | Inactivated Typhoid vaccine, unspecified | Inactivated Typhoid vaccine, unspecified | Inactivated Typhoid vaccine, unspecified | Inactivated Typhoid vaccine, unspecified | |
| VAC1000 | |||||||
| VAC1351 | |||||||
| VAC0901 | |||||||
| VAC1048 | |||||||
| VAC1133 | Meningococcal ACWY polysaccharide conjugate vaccine, unspecified | ||||||
| VAC1266 | |||||||
| VAC1399 | |||||||
| VAC0021 | |||||||
| VAC0372 | |||||||
| VAC0287 | |||||||
| VAC0154 | Malaria vaccine, unspecified | Malaria vaccine, unspecified | Malaria vaccine, unspecified | Malaria vaccine, unspecified | Malaria vaccine, unspecified | Malaria vaccine, unspecified | |
| VAC0069 | |||||||
| VAL195 | PCV-10A | PCV-10A | VPC-10A | PCV-10A | PCV-10A | PCV-10A | PCV-10A |
| VAL062 | O-Chol-rCTB-I | CHOL-SU-rCTB-O | O-Chol-rTCB-I | O-Chol-rCTB-I | O-Chol-rCTB-I | O-Chol-rCTB-I | O-Chol-rCTB-I |
| VAC0903 | Tollwutimpfstoff vom Typ Fuenzalida, nicht näher bezeichnet | Rabies vaccine Fuenzalida type, unspecified | Αντιλυσσικό εμβόλιο τύπου Fuenzalida, απροσδιόριστος | Vakcīna pret trakumsērgu Fuenzalida tipa, neprecizēta | Szczepionka przeciwko wściekliźnie typu Fuenzalida, nieokreślona | Vacina anti-rábica tipo Fuenzalida, não especificada | |
| VAL280 | BT | BT | BT | BT | BT | BT | BT |
| VAC0818 | Typhoid-Paratyphoid vaccine, unspecified | Typhoid-Paratyphoid vaccine, unspecified | Typhoid-Paratyphoid vaccine, unspecified | Typhoid-Paratyphoid vaccine, unspecified | Typhoid-Paratyphoid vaccine, unspecified | Typhoid-Paratyphoid vaccine, unspecified | |
| VAC1352 | |||||||
| VAC0902 | Tollwutimpfstoff Semple-Typ, nicht spezifiziert | Rabies vaccine Semple type, unspecified | Αντιλυσσικό εμβόλιο Semple τύπου, απροσδιόριστος | Vakcīna pret trakumsērgu Semple tips, neprecizēts | RSzczepionka przeciwko wściekliźnie typu Semple, nieokreślona | Vacina anti-rábica tipo Semple, não especificada | |
| VAC1267 | |||||||
| VAC1001 | |||||||
| VAC1134 | Live attenuated vaccine against Argentine hemorrhagic fever, Junin virus, unspecified | ||||||
| VAC1049 | |||||||
| VAC0590 |